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Abstract 
Nanotoxicology has emerged as a discipline of a result of the revolution of 
nanotechnology. While nanotoxicology is in its infancy, there is a lack of toxicological 
data for nanoparticles, naturally occurring or commercially produced. The need for 
information regarding mechanisms associated with nanoparticle uptake by biological 
cells, as well as internalisation and accumulation of nanoparticles once penetrating 
cell membranes, is imperative.  This project will focus on the internalisation studies 
of surface modified polystyrene nanoparticles. An in vitro lung model consisting of 
A549 (ATCC No: CRL185), a carcinogenic lung epithelial cell line, was employed to 
investigate the biocompatibility of nano scaled polystyrene particles in pulmonary 
systems. Biological effects of 40nm and 100nm carboxylated surface modified 
nanopolystyrene, 50nm and 100nm neutral nanopolystyrene and 60nm aminated 
nanopolystyrene were monitored. Prior to cellular studies, a full particle size 
characterisation was carried out using Dynamic Light Scattering, Atomic Force 
Microscopy, Zeta Potential and Electronic Spectroscopy. The cytotoxic effects of 
nano scale 40nm and 100nm carboxylated, 50nm and 100nm neutral 
nanopolystyrene and 60nm aminated nanopolystyrene were then evaluated using 
four cytotoxic endpoints, namely the Neutral Red, Alamar Blue, Comassie Blue and 
MTT assays, with both neutral and carboxylated modified particles exhibiting no 
cytotoxic effect at any of the concentrations or timepoints examined. Aminated 
nanoparticles were observed to elicit some toxic effects in cells, over certain test 
concentrations and exposure times. Cellular internalisation of the fluorescently 
labelled particles was monitored with the aid of fluorescent confocal microscopy. 
Nanoparticle internalisation and accumulation within specifically labelled cell 
organelles was then monitored and verified with the aid of commercially available 
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transfection labelling kits. Raman microscopy was then employed to 
spectroscopically image biological cells previously exposed to fluorescently labelled 
50nm and 100nm polystyrene nanoparticles. The use of K-means clustering and 
principal component analysis (PCA), demonstrated that the technique was capable 
of localising the nanoparticles and identifying the subcellular environment based on 
the molecular spectroscopic signatures.  
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Chapter 1 
1.1 Introduction to Nanotechnology 
At a conference on precision engineering in 1974 in Tokyo Science University, 
Professor, Norio Taniguchi, first used the term “nanotechnology” [1].  
The concept, however, was previously presented by physicist Richard Feynman at 
an American Physical Society in 1959. In Feynman’s lecture, “There’s Plenty of 
Room at the Bottom”, he describes the possible manipulation of atoms and 
molecules in order to create new materials and devices with a vast range of 
applications [2]. The massive potential of these materials later became evident, 
having applications in areas such as medicine, biomaterials and electronics, 
promising denser computer circuitry, and microscopes with higher resolution than 
before. His ideas were later realised in the middle of the 1980’s, when nanoscience 
was born with the invention of the Scanning Tunnelling Microscope, eventually 
leading to many important “nanomaterial” discoveries [3] [4] [5]. Today, 
nanotechnology has evolved into a highly competitive multidisciplinary research area 
encompassing an exceptional range of subdivisions from fuel cells [6] to food 
technology [7] and medical applications [8].  
The word “nano” itself refers to the length scale (one nanometre is one billionth of a 
metre), that is one thousand times smaller than the micro scale, the scale that was 
traditionally associated with the electronics industry. Viruses and DNA are examples 
of natural objects on the nanoscale; in contrast to which a human cell can appear 
enormous. The term nanotechnology refers to the engineering, measurement and 
understanding of nano-scaled materials and devices. Manipulating matter atom by 
atom and creating features on the atomic or “nano” scale is now a proven technology 
and there is an ever growing catalogue of industries that utilise nanotechnology. 
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Although variations in the exact definition of the term nanotechnology exist, the 
International Standards Organization, ISO, has defined the area of science as;  
‘Understanding and control of matter and processes at the nano-scale, typically, but 
not exclusively, below 100 nanometres in one or more dimensions where the onset 
of size dependent phenomena usually enables novel applications where one 
nanometre is one thousand millionth of a metre.’ [9]  
Sizes at the nano level are incredibly small. To conceptualise, if the distance 
between the Earth and the Sun was one metre, then the length of one nanometre 
would be equivalent to the size of a football field. Figure 1.1 attempts to put into 
context the macro, micro and nano scale. It can be seen from figure 1.1 that there 
are both manmade and natural nanostructures. Nanostructures have existed in 
nature since the dawn of time, examples including molecular structures, volcanic ash 
particles and indeed some proteins and viruses [10] . It is also important to note that 
such natural structures have existed alongside humans throughout their evolution. 
Manmade or engineered nanoparticles, are however a relatively new entity in the 
environment and, due to their undefined bioactivity, pose a potential risk to human 
and environment health. Examples include self-assembled nanostructures, diesel 
combustion particles, and structures such as carbon nanotubes [11] [12]  [13].   
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Figure 1.1 The nano-scale, highlighted is the progress from the macro world down to 
the nano-world with examples of both manmade and natural structures [14].   
 
There are many uses and applications of nanomaterial technology that are not 
possible using conventional materials. For applications that use a substance’s 
chemical properties, substantially less nanomaterial may be required to do the job of 
a conventional material. The chemical reactivity of a material is related to its surface 
area compared to its volume and the surface area for a nanoparticle per unit volume 
is significantly higher. Figure 1.2 illustrates how surface area increases when a 
material is dissected into nano sized particles.  
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Figure 1.2 Example of how surface area increases with increased dissection of a 
1cm3 cube into 1nm3 cubes [15].  
 
1.2 Engineered Nanoparticles  
The production of nanomaterials is one of the main areas in which the 
nanotechnology sector holds its focus. There are numerous synthetic methods for 
the production of nanomaterials including physical, chemical and biological 
approaches. However, most can be divided into either ‘top-down’ or ‘bottom-up’ 
methods. The top down method of fabrication generally involves physical 
approaches such as lithography and milling. Often described as the traditional 
approach to nanofabrication, it involves essentially the breaking down of a material 
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into nano-components [16]. The Bottom-up approach, in contrast to the top down 
method, is often emphasized in nanotechnology literature, though bottom-up is 
nothing new in materials synthesis. Typically, in material synthesis a structure is built 
atom by atom on a very large scale, and has been in industrial use for over a 
century. Examples include the production of salt and nitrate in chemical industry, the 
growth of single crystals and deposition of films in the electronics industry [17]. The 
Bottom-up approach can thus be defined as simply building-up a material atom-by-
atom or molecule-by-molecule. The bottom-up approach plays an important role in 
the fabrication and processing of nanostructures and nanomaterials [18] [19].  
1.2.1 Classification of Engineered Nanoparticles  
Engineered Nanoparticles, or man-made nanoparticles, have been classified in 
various ways, according to different academies or agencies. The OECD, for 
example, have a published a list of representative manufactured nanomaterial of 
interest, of which the listed nanomaterials may be classified into four different 
groups; 
• Fullerenes and carbon nanotubes  
• Metals  
• Polymeric  
• Semiconductors (quantum dots)  
Fullerenes are molecular forms of carbon and constitute 28 to more than 100 atoms, 
forming a hollow sphere. Carbon nanotubes (CNTs) are crystalline forms of pure 
carbon, and exist in many sizes. CNTs are composed of cylinders of graphite sheets 
wound around themselves in one or more layers. The diameter of a CNT can be as 
small as 0.7 nm and be several mm in length. Fullerenes and CNTs are similar, as 
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both can be bonded with organic or inorganic groups to form various products. 
Fullerenes are used in solar and lithium batteries, electronics, storage of gases, such 
as methane and oxygen and additives to rubber and plastics [20] [21]. CNTs have 
also been investigated for use in drug delivery. CNT’s can be functionalised with 
various functional groups to improve their solubilisation and to carry simultaneously 
several moieties for targeting, imaging, and therapy [22]. These moieties can then be 
delivered into the cytoplasm or the nucleus [23] making antibiotic, antiviral and anti-
cancer drug delivery possible [23].  
Metallic nanoparticles and oxides are based on inorganic materials such as metals, 
and derivatives of silicon. These materials differ from molecular or bulk species with 
their high surface areas and unique optical, magnetic, and electronic properties [24]. 
They find many uses in high technology areas right down to food storage devices. 
Examples of inorganic nanoparticles are nZnO, nAg [25]. Examples of metal 
nanoparticles include nanogold, nanosilver and nanocopper. Their biocompatibility  
have found use in biomedical sector and can be functionallised as specifically probes 
of intracellular processes and have been used for targeted drug delivery, vehicles for 
gene and drug delivery and more importantly diagnostic imaging [26]. For example, 
with the use of Surface Enhanced Raman Spectroscopy (SERS), nanosilver and 
nanogold have been used to detect unlabeled DNA [27].  
Polymeric nanoparticles are prepared from polymers and are considered potential 
drug delivery devices due to recent applications in drug targeting to particular organs 
and tissues. These nanoparticles are also used as DNA in gene therapy and delivery 
of proteins, peptides and genes through oral route administration. Dendrimers are a 
type of polymeric nanoparticles constructed by the successive addition of layers of 
branching groups. The properties of dendrimers are dominated by the functional 
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groups on the molecular surface [25] [28]. Dendrimers have been proposed to act as 
artifical proteins, due to their similar shape and size of various proteins, and have 
also been proposed as nano-scale containers for drug delivery [29] [30].  
A quantum dot is a nanoparticle made of any semiconductor material such as silicon, 
cadmium selenide, cadmium sulfide, or indium arsenide. They are small enough to 
display quantum mechanical properties; specifically the excitons are confined in all 
three spatial dimensions. The electronic properties of these materials are 
intermediate between those of bulk semiconductors and of discrete molecules [31] 
[32]. Quantum dots have specifically been developed as intracellular probes, as an 
alternative to conventional stains based on organic dyes [33] [34].  
1.3 Potential of Nanotechnology  
Countries such as the United States and Japan are investing heavily in the area of 
nanotechnology with groups not only identifying high-impact application properties, 
but also carrying out research in all aspects of the nano area, including nano-
medicine and nano-electronics.  With forecasts of US$2.6 trillion markets by 2015 
and estimated employment rates upwards of 2 million people [35], it is not surprising 
that there are many other nations with strong research centres, including China, 
Denmark, France, Germany, Russia, Sweden, and the United Kingdom. 
Nanotechnology is already enhancing everyday products such as sunscreens, golf 
clubs, clothing, and cell phones [36] [37] [38]. Within the next decade, it is likely to be 
commonplace in drug therapies, water filters, fuel cells, power lines, computers, and 
a wide range of other applications [15]. According to the Royal Society: 
“Nanotechnologies are widely seen as having huge potential in areas as diverse as 
healthcare, IT and energy storage.” 
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Widespread commercial adoption of nanotechnology is growing rapidly. Examples of 
areas in which nanotechnology is expected to have a high commercial impact 
include; [39] 
• Embedded nanotechnology (electronics, optoelectronics, building materials, 
sports equipment),  
• Films and coatings  (self-cleaning coatings, waterproofing, antimicrobial  
coatings e.g. medical equipment, food containers and appliances),  
• Biological nanotechnology (nano-sized motors, medical diagnostics),  
• Manufactured particles (food and cosmetic additives including sunscreens, 
anti-microbial uses, pollution clean-up)  
•  Nano-electrical mechanical systems (NEMS) (Drug delivery and diagnostics, 
smart sensors).  
1.4 Concerns Raised  
Materials with well known properties and documented toxicity values can exhibit 
entirely different characteristics when moving from their bulk to their nano state. 
When a material approaches the nanoscale, certain properties become scale-
dependent, particularly in particles below 20nm diameter. These include capillary 
forces, optical effects/colour, melting points, conductivity, ionization potential, 
electron affinity, magnetism, and, significantly, surface energy and reactivity [40]. It is 
generally considered that the smaller the particle, because of the greater surface 
area to volume ratio, the higher its chemical reactivity and biological activity. In 
biological cells, it has been shown that the greater chemical reactivity of 
nanomaterials results in increased production of reactive oxygen species (ROS), 
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including free radicals among other effects [41]. The large number of variables 
influencing toxicity means that it is difficult to generalise about health risks 
associated with exposure to nanomaterials, which brings to light the urgency for 
each new nanomaterial to be assessed individually and a full toxicological profile 
assembled with material properties taken into account. 
In 2004, the Royal Society and the Royal Academy of Engineering in the UK 
released a report which recommended a review of existing regulations to assess and 
control workplace exposure to nanoparticles and nanotubes [42]. The report 
expressed particular concern for the inhalation of large quantities of nanoparticles by 
workers involved in the manufacturing process. Assessment of health risks arising 
from exposure to chemicals or other substances requires understanding of the 
intrinsic toxicity of the substance, the levels of exposure that may occur (by 
inhalation, by ingestion or through the skin) and any relationship between exposure 
and health effects. Concerns about the lack of knowledge and possible risks arising 
from exposure to nanoparticles led the UK Government to request advice from the 
Royal Society and Royal Academy of Engineering, resulting in the formation of their 
Nanoscience and Nanotechnology Working Group. However, with a growing number 
of nanoparticles being used in consumer products from cosmetics to food and 
beverage packaging, it is important that the public’s perception be guided in the right 
direction with correct information. Unfortunately the rapid growth in the production 
and use of nanoparticles has left regulating bodies behind, due to the lack of 
knowledge of toxicological data. This highlights the need for full characterisation and 
toxicological study of nanoparticles [42].  
 
Page | 10  
 
Chapter 1 
1.5 This Thesis  
The use of model nanoparticles is imperative when attempting to gain a general 
understanding of the toxicity of nanoparticles, mechanisms of uptake of 
nanoparticles by cells as well as identifying particles localised within cells. However, 
from batch to batch, commercially produced nanoparticles often exhibit variable 
physical characteristics such as particle sizes, shapes, surface functionality, etc. The 
consideration of such information is important when choosing model nanoparticles 
for establishing structural activity relationships between particles and cells.  
For these reasons, this study examines three types of surface modified fluorescently 
labelled polystyrene model nanoparticles, of five different sizes, namely 40nm and 
100nm carboxylated nanopolystyrene, 50nm and 100nm neutral nanopolystyrene 
and 60nm aminated nanopolystyrene. It will explore the preliminary toxicity of these 
materials using in vitro cell culture techniques and will fully characterised the 
physicochemical properties of each particle in order to investigate any potential link 
to the any perceived toxicity. The thesis will also aim to obtain information about the 
possible internalisation of nanopolystyrene particles within lung cells. With the 
insufficient information provided about nanoparticles internalisation using 
conventional in vitro assays, here a conventional fluorescent microscopic method 
(confocal microscopy) will be used to explore the internalisation and localisation of 
fluorescently labelled nanoparticles and their possible internalisation within specific 
organelles. Also in this thesis, Raman spectroscopy is proposed and investigated as 
a potential label free method for the verification of generic nanoparticle 
internalisation and for tracking the intracellular trafficking, local environment and 
cellular metabolism.  
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2.1 Introduction 
Despite the huge benefits of nanotechnology, there are concerns regarding the 
potential toxicity of engineered materials on the nano scale [1]. Indeed the 
knowledge gaps in assessing and determining the potential toxicity of nanomaterials 
and nanoparticles may ultimately undermine the area by impacting on public 
confidence and acceptance of the technology in general [2].  
Since the dawn of time, humankind has been routinely exposed to natural ambient or 
background nanoparticles in the  environment, for example SiO2 in food and water 
[3]. However, the concentration of natural nanoparticles is generally relatively small, 
with only occasional increases in the background due to, for example, a volcanic 
eruption [4]. In contrast, as engineered or manmade nanoparticles become 
increasingly prevalent in consumer goods and find ever more applications, human 
exposure to nanoparticles is expected to grow significantly. However, it is unclear 
whether nanoparticles can cause adverse environmental or health effects. Literature 
reports have begun to emerge in recent years indicating that some engineered 
nanoparticles can cause acute toxicity , when compared to their larger counterparts 
[5] [6]. However, issues with respect to dosing, methodology and indeed basic 
understanding of mechanisms of nanotoxicity make it difficult to truly identify whether 
a nanomaterial is toxic or not.  Indeed, several international bodies, both 
governmental and nongovernmental, have highlighted the concerns in appropriately 
measuring nanotoxicity and have set as a priority the examination of nanoparticles 
with respect to a number of end points.  The most vocal of these bodies has been 
the Organisation for Economic Co-operation and Development (OECD) which has 
listed a number of toxicological endpoints as key [7] (Table 2.1).  
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Table 2.1 List of toxicological endpoints for physical-chemical characterisation of 
nanoparticles [7]. 
Physical-Chemical Properties and 
Material Characterization 
 
Mammalian Toxicology 
• Agglomeration/aggregation 
• Water solubility 
• Representative TEM picture(s) 
• Particle size distribution 
• Specific surface area 
• Zeta potential (surface charge) 
•Surface chemistry  
 
 
• Acute toxicity 
• Repeated dose toxicity 
• Chronic toxicity 
• Reproductive toxicity 
If available: 
• Developmental toxicity 
• Genetic toxicity 
• Experience with human exposure 
 
The focus of this study is on the clear and unambiguous identification of the uptake 
of model nanopolystyrene particles by human lung cells, the intracellular effects 
forming the underlying theme. Hence, many of the endpoints listed by the OECD are 
crucially important when examining the effects of model particle systems on cells in 
ensuring consistency of nanoparticle physical-chemical properties. To aid later 
discussion, this chapter will give a brief introduction to toxicology and attempt to 
develop the concept of nanotoxicology in particular. As part of this study is to focus 
on particle uptake, a discussion on the mechanisms behind particles entering cells 
will be given as well as any possible interactions between nanoparticles and 
biological systems. A discussion of the relevance and choice of nanopolystyrene as 
a material for this study will also be given, along with its current applications.  
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2.2 Nanotoxicology 
“Toxicology is the study of the adverse effects of chemical, physical or biological 
agents on living organisms and the ecosystem, including the prevention and 
amelioration of such adverse effects” [8]. Toxicology is an inter-disciplinary science 
that integrates the principles and methods of many fields. These include chemistry, 
biology, pharmacology, molecular biology, physiology and medicine. For example, by 
combining the study of the physiological effects of certain chemical structures and 
the molecular mechanisms underpinning those effects with their toxicology, a better 
understanding of the actions of an entire class of chemical substances can evolve.  
Nanotoxicology is a new and emerging sub-discipline of toxicology, which is 
concerned with looking at the toxicological effects caused by particles or materials 
with at least one dimension less than 100nm. Much of the current understanding of 
nanotoxicology has evolved from ultra fine particle toxicology performed in the latter 
part of the last century. Indeed particle toxicology has progressed from the 20th 
century, when coal and silica induced diseases were discovered, to currently, where 
the focus has moved to the decreased size of particles as a cause of increased 
toxicity [9].  
However, unlike particle toxicology, nanotoxicology faces a number of challenges 
and opportunities in the near future. These challenges include to:  
- generate an understanding of the biological action of nanomaterials,  
- use, communicate and adapt current particle toxicology paradigms,  
- bridge know-how between different application areas of nanomaterials,  
- communicate findings to the broad public in an increasing relevant society.  
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To meet these challenges, a number of basic research questions need to be 
answered. The most relevant ones to this thesis being   
1. Can poorly soluble nanoparticles penetrate cell membrane and organelles?  
2. What are the properties of nanoparticles that help them to internalise and 
accumulate within cells (e.g. size, solubility, reactivity) and how do these 
properties have an effect on particle uptake or toxicity? 
3. What are the mechanisms by which cells take up nanoparticles and what 
mechanisms govern nanoparticle transportation once they have been 
internalised?  
4. How can fluorescent and non fluorescently labelled nanoparticles be tracked 
or identified within cells?  
It is proposed that these questions will be answered over the course of this thesis.  
2.2.1 Possible Exposure Pathways of Nanoparticles 
Although current knowledge about the exact pathways taken by nanoparticles once 
inside the body is relatively scant, there is no reason to expect external exposure 
pathways would vary from the traditional or normal exposure routes.  
There are thus three main routes of expose for nanoparticles as follows;   
• Inhalation: where nanoparticle translocation from the lung into the 
bloodstream may cause direct effects on the central nervous system, and 
have the capacity to invoke inflammatory responses in the lung with 
subsequent effects [10].  
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• Dermal contact:  where, upon contact through exposure from products such 
as sunscreen, nanoparticles  penetrate the outer layer of human skin [11].  
• Ingestion:  where nanoparticles may be absorbed through the intestinal lining 
and translocate into the blood stream and may cause liver damage  [12] [13] 
[14].  
Due to potential occupational risks, the examination of nanoparticles through the 
inhalation pathway has been the subject of much attention and literature reports on 
this type of exposure far outweigh the other two exposure routes.  
The work reported in this thesis is no exception to this and focuses on a lung cell 
line. The A549 cell line was first developed by D.J Giard in 1972 [15] through the 
removal and culturing of cancerous lung tissue in the explanted tumour of a 58-year-
old Caucasian male. A549 cells are human alveolar basal epithelial cells. These are 
squamous in nature and responsible for the diffusion of substances, such as water 
and electrolytes, across the alveoli of lungs. The cells grow adherently, as a 
monolayer, in vivo [16].   
 Following inhalation, nanoparticles must cross cellular barriers to further enter the 
body. The walls, or epithelium, of the respiratory tract contain mucous or serous 
lining fluid.  Therefore, depending on the solubility of the nanoparticle, it may remain 
in the mucous lining for 1 – 2 days, where they may possibly be removed by 
coughing or to the larynx where they may be swallowed [17]. However, nanoparticles 
may also be deposited in the pulmonary alveolar region of the lungs, which is the 
region of the lungs responsible for gas exchange with the blood. This region also 
forms the termination point of the respiratory tract. Insoluble nanoparticles deposited 
in this region may be taken up by specialised defence cells called macrophages, 
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which are located in the alveoli. Remaining particles, not ingested by macrophages, 
will interact with the cells of the epithelium and be transported into the interstitial 
spaces. As a result, it is possible for nanoparticles to remain in the lungs for months 
or even years [17] [18]. While specific sites of contact with nanoparticles are of great 
interest when examining exposure pathways into the human body, so too are the 
portal entry of nanoparticles into cells.  
2.2.2 Mechanisms of Particle Uptake and Internalisation  
The information on mechanisms by which a cell may take-up a particle is vital in 
order for nanotoxicologists to develop a better understanding of how nanoparticles 
interact with cells [19]. In order for a substance to enter a cell interior, it must first 
pass through the plasma membrane. The plasma membrane is a dynamic structure 
that functions to segregate the chemically distinct intracellular milieu (the cytoplasm) 
from the extracellular environment by regulating and coordinating the entry and exit 
of small and large molecules. The uptake of substances is accomplished via a 
variety of processes that can be described as passive or active (energy requiring). 
Essentially small molecules, such as amino acids, sugars and ions, can cross the 
plasma membrane through diffusion or facilitated diffusion. Diffusion of small 
molecules across the plasma membrane results in selective permeability to low 
molecular weight substances and requires the action of essential membrane protein 
pumps or channels, that drive an electrochemical or concentration gradient [20].  
Larger macromolecules must be carried into the cell in membrane-bound vesicles by 
the folding inward and pinching-off of pieces of the plasma membrane in a process 
termed endocytosis. Endocytosis is a collective term that describes the energy-
dependant internalisation of substances which gain entry into a cell without passing 
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through the cell membrane [21].  Endocytosis occurs by multiple mechanisms that 
can be divided into two broad subdivisions: 'phagocytosis' or 'pinocytosis'.  
In the process of phagocytosis, the cell changes shape by sending out projections 
which are called pseudopodia (false feet). A phagocytic cell, such as a macrophage, 
may be attracted to a particle such as a bacteria or virus by chemical attractants. 
This process is called chemotaxis (movement toward a source of chemical 
attractant). The phagocytic cell sends out membrane projections that make contact 
with a particle. A receptor – ligand interaction occurs between the phagocytic cell 
surface and the particle that will be ingested. The pseudopodia then surround the 
particle and when the plasma membrane sections of the projection meet, membrane 
fusion occurs. This results in the formation of an intracellular vesicle [22] [23].  
Phagocytosis is typically restricted to specialized mammalian cells, whereas 
pinocytosis occurs in all cells by at least four basic mechanisms: macropinocytosis, 
caveolae-mediated endocytosis, clathrin-mediated endocytosis (CME) and clathrin- 
and caveolae-independent endocytosis. These diverse and highly regulated 
endocytic pathways function to control complex physiological processes such as 
hormone-mediated signal transduction and immune surveillance. Figure 2.1 displays 
the pathways of the different mechanisms by which particle uptake into a cell occurs. 
The endocytic pathways differ with regard to the size of the endocytic vesicle, the 
nature of the cargo (ligands, receptors and lipids) and the mechanism of vesicle 
formation [24].  
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Figure 2.1 Multiple portals of entry into a mammalian cell [24]. 
In the process of macropinocytosis, the plasma membrane forms an invagination, 
which then pinches off into the cell to form a vesicle filled with a large volume of 
extracellular fluid and is usually 0.5–5 µm in diameter. Whatever substance is found 
within the area of the invagination is brought into the cell. In general this material will 
be dissolved in water and thus this process is also referred to as "cellular drinking", 
to indicate that liquids and material dissolved in liquids are ingested by the cell [24].  
Caveolae are the most common reported non-clathrin coated plasma membrane 
buds, which exist on the surface of many, but not all cell types. They consist of the 
cholesterol-binding protein caveolin (Vip21) with a bilayer enriched in cholesterol and 
glycolipids. Caveolae are small (approx. 50 nm in diameter) flask-shape pits in the 
membrane which have several functions in signal transduction. They are also 
believed to play a role in oncogenesis and the uptake of pathogenic bacteria and 
certain viruses [25] [26].  
In the process of clathrin- and caveolae-independent endocytosis, small structures 
referred to as ‘rafts’ occur on the plasma membrane. These rafts are small 
structures, 40–50 nm in diameter, that diffuse freely on the cell surface. They have a 
unique lipid composition that provides a physical basis for specific sorting of 
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membrane proteins and/or glycolipids based on their transmembrane regions. 
Clathrin-independent mechanisms of endocytosis also occur in neurons and 
neuroendocrine cells, and function in the rapid recovery of membrane proteins after 
stimulated secretion [27] [24] [28]. Due to the size of the rafts, it is possible for 
nanoparticles to enter a cell via clathrin- and caveolae- independent endocytosis.  
Clathrin-mediated endocytosis, or CME, occurs in all mammalian cells, and is a 
process by which cells internalise molecules by the inward budding of plasma 
membrane vesicles containing proteins with receptor sites specific to the molecules 
being internalized [24]. These vesicles are approximately ~120nm in size, which 
suggests a possible portal of entry for nanoparticles 100nm in size or less. The 
process is responsible for the continuous uptake of essential nutrients, such as the 
cholesterol-laden low-density lipoprotein (LDL) and particles that bind to the LDL 
receptor. CME was previously referred to as 'receptor-mediated' endocytosis, but it is 
now clear that this is a misleading description, because most pinocytic pathways 
involve specific receptor–ligand interactions [29]. CME is crucial for intercellular 
communication during tissue and organ development and throughout the life of the 
organism, as it modulates signal transduction both by controlling the levels of surface 
signalling receptors, and by mediating the rapid clearance of activated signalling 
receptors [30] [31].  Figure 2.2 shows the process of clathrin-mediated endocytosis. 
Clathrin and cargo molecules are assembled into clathrin-coated pits on the plasma 
membrane together with an adaptor complex called AP-2 that links clathrin with 
transmembrane receptors, concluding in the formation of mature clathrin-coated 
vesicles (CCVs). CCVs are then actively uncoated and transported to early/sorting 
endosomes. [32].  
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Figure 2.2 Mechanism of clathrin-dependent endocytosis.[33] 
The size of the vesicles formed is different for each pathway, e.g. clathrin coated pits 
are approximately 120nm in diameter, caveolae generally 50 – 80m, and 
micropinosomes 1 – 5µm. Although the sizes of the vesicles is not definitive and 
there are exceptions to this general statement made, it is thought that size limits that 
exist act to restrict the size of the cargo that is internalised, thus introducing a form of 
selectivity to the endocytoic process  [34]. Such pathways therefore are a likely route 
of uptake of nanoparticles into cells. This is also likely for nanoparticles aggregates 
or agglomerates that may be broken up or dispersed once entry to the cell has been 
gained.  
It has been demonstrated that engineered nanoparticles of well-defined sizes 
actively interfere in the processes of regulating and modulating cellular responses 
[35]. One such study by Rejaman et al, 2004, demonstrated the use of intracellular 
potassium depletion and pre-treatment of cells with chlorpromazine to inhibit clathrin 
mediated endocytosis contribution to fluorescent polystyrene-based latex 
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microspheres. The observation of a size dependant method of uptake suggested that 
smaller particles (particles up to 200nm) were preferentially internalised via clatrin-
mediated endocytosis (the larger of the two bulbs in figure 2.1), and larger particles 
(>200nm, but smaller than 1µm) via caveolin- mediated endocytosis (the smaller of 
the two bulbs shown in figure 2.1). Smaller particles were also observed in 
lysosomes [35].  
While particle size has been demonstrated to influence the mechanism of particle 
uptake by cells, recent observations in biological systems suggest that other physical 
parameters of nanoparticles can affect their nonspecific uptake in cells, with potential 
to induce cellular responses. One such study determines the internalisation pathway 
of positive, negative and neutral charged 89nm and 96nm polyactide polyethylene 
glycol (PEG)ylated particles. It was determined that negatively charged particles 
were not internalised by clatherin or caveolin dependant pathways, in contrast to the 
positively charged nanoparticles that were internalised by these pathways in addition 
to a smaller contribution of macropinocytosis [36].  
However, it is also worth acknowledging that different types of endocytosis can 
operate simultaneously [35], so that more than one type of internalisation pathway 
could contribute to their uptake and that if one pathway doesn’t not function, another 
can take over.  
2.2.3 Nanoparticle-Bio Interactions 
While physical characteristics have been demonstrated to have an effect on particle 
uptake mechanism, it is important to examine the interactions between nanoparticles 
and the biological interface of contact materials such as biological media. This is of 
particular importance when examining the uptake of nanoparticles within cells in 
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vitro. In laboratory conditions, in order to expose cells to particles, particles are 
generally suspended within biological media. Biological media, designed to support 
the growth of cells in vitro, is comprised of trace elements, proteins and vitamins 
required by cells to stay alive. It is a rich source of salts and nitrates, and has an 
excellent potential for any nanoparticle interaction to occur on contact. These 
possible interactions may have significant consequences on how a nanoparticle is 
presented to a cell, and therefore must be examined closely.  
The ‘nano–bio’ interface “comprises the dynamic physicochemical interactions, 
kinetics and thermodynamic exchanges between nanomaterial surfaces and the 
surfaces of biological components” (for example proteins, membranes, 
phospholipids, endocytic vesicles, organelles, DNA and biological fluids) [37].  
In vitro there are some main concerns when examining the bio-nano interface of 
nanoparticles suspended in biological medium. These include;  
(i) The nanoparticle physicochemical surface characteristics.   
(ii) The solid–liquid interface and the changes that occur when the particle 
interacts with components in the surrounding medium.  
It had been demonstrated that physical parameters of nanoparticles can play a role 
in the interaction of proteins with nanoparticles [38]. It was found that both size and 
surface properties play a very significant role in determining the nanoparticle 
interactions with different biological particles such as proteins in biological media 
[39]. These are factors that can also influence how a nanoparticle is presented to a 
cell and subsequently influence the cellular uptake mechanism of particles by cells.  
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It is proposed that particle characteristics contribute actively to the interactions with 
the medium through: (i) promoting the adsorption of ions, proteins, natural organic 
materials and detergents; (ii) double-layer formation; and/or (iii) dissolution [40].  
Quantifiable properties, such as effective surface charge (zeta potential), particle 
aggregation, state of dispersion, stability/biodegradability, dissolution characteristics, 
are all factors which determined the degree of interaction of nanoparticles and the 
suspending media [6].  Characteristics of the suspending media are also a factor in 
determining the interactions that may occur at the bio-nano interface, including the 
ionic strength, pH, temperature and the presence of large organic molecules (for 
example proteins) or detergents. Interactive forces between the nanoparticle 
(depending on its own properties) and biological media include long range forces 
arising from attractive van der Waals and repulsive electrostatic doublelayer 
interactions, and short range forces arising from charge and solvent interactions [40]. 
Media interactions (for example protein interactions) could also induce large scale 
changes, such as nanoparticle dissolution, ion leaching, phase transformation and 
agglomeration [37].  
While information on biological media interaction with suspended nanoparticles could 
potentially provide invaluable information on how nanoparticles are taken up by cells, 
it is also important to consider the intracellular fate of nanoparticles upon entry to 
cells. After internalisation by clathrin mediated endocytosis, the endocytic vesicle 
delivers its contents to an early endosome (also known as a sorting endosome) [41] 
The endocytic vesicles fuse with an early endosome, which requires the presence of 
early endosome antigen -1 protein (involved in endosomal trafficking and vesicle 
fusion) and Rab5 (involved in the movement of endosomes along the cytoskeleton) 
on to early endosome membrane. These proteins allow early endosomes to 
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redistribute their contents to other intracellular locations [42]. For this reason, early 
endosomes are often called sorting endosomes [43]. The early endosome dictates 
the sub-cellular distribution of the internalised cargo [34], so that the vesicle is 
targeted to its appropriate sub-cellular destination. Such destinations include (i) 
delivery to late endosomes and lysosomes which subsequently target the substance 
for degradation, (ii) if the cargo is required by the cell it may be delivered to the 
endoplasmic reticulum (ER) or golgi apparatus [41] or (ii) the substance may be 
redirected out of the cell by exocytosis [44].   
Surface-functionalisation and incorporation of nanoparticles into various organic and 
inorganic polymers is another area of nanoparticle-bio interaction that is of interest to 
nanobiologists looking at internalisation and localisation of nanoparticles within cells. 
Nanoparticles can be specifically functionalised to target certain cell types [45] [46] 
and even subcellular localisations [47]. Recent reports reveal that the 
functionalisation of nanoparticles with specific chemical functional groups enhances 
the nanoparticle functionality and efficiency. It is also reported that this 
fictionalisation reduces known side effects, due to properties such as targeted 
localisation in tumours and active cellular uptake [48].  Functionalised SERS active 
nanoparticles have been shown to be valuable probes of subcellular processes and 
protein localisation [49]  [50] [51].  
Current information on the intracellular transportation mechanisms of nanoparticles 
within cells is poor, although there are reports that nanoparticles can localise within 
endosomal and lysosomal compartments [52] [53] [54].  
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2.2.4 Mechanisms of cell death 
Although intracellular tracking is important to nanobiologists, there are several 
substances that are known to cause toxicity at their nano size while being relatively 
inert in their bulk form. For example, while Zinc is a well know mineral required for 
healthy brain function, in its nano-sized counterpart as ZnO2 or zinc oxide, it has 
been found to cause toxicity to living cells  [55].  
The complexity of proposed mechanisms of cell death caused by nanoparticles, are 
beyond the scope of this thesis. However, knowing the types of cell death that may 
occur can give insight into the affect nanoparticles may have on cells.  
The two main types of cell death processes are apoptosis (programmed cell death) 
and necrosis (external factors causing death) [56] [57].  
Apoptosis, also known as programmed cell death (PCD), is a process whereby, cells 
which are no longer needed, commit suicide by activating an intracellular death 
program. In this process, the cell undergoes a reduction in size as its cellular 
components break down and condense. The breakdown of cellular components is 
caused by the release of specific proteins within the cell. The cell then breaks down 
into smaller fragments called apoptotic bodies. These fragments are enclosed in 
membranes so as not to harm near-by cells. The dying cell then sends signals to 
another type cells, known as phagocytic cells, which engulf and destroy the apoptotic 
bodies without causing an inflammatory reaction or harming neighbouring cells [57].  
Necrosis is caused by factors external to the cell or tissue, such as infection, toxins, 
or trauma that result in the unregulated digestion of cell components. It is regarded 
as unprogrammed cell death and is less orderly than apoptos. Necrosis is 
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accompanied by the release of special enzymes, which are stored in the lysosomes, 
which are capable of digesting cell components or the entire cell itself. The injuries 
received by the cell may compromise the lysosome membrane, or may initiate an 
unorganized chain reaction which causes the release in enzymes. Unlike in 
apoptosis, cells that die by necrosis may release harmful chemicals that damage 
other cells. Necrosis caused by the exposure of living cells to nanoparticles may 
undergo several types of internal or cell organelle damage that lead to eventual 
death [58].  A possible mechanism of toxicity is proposed which involves disruption 
of the mitochondrial respiratory chain leading to production of (reactive oxygen 
species or free radicals) ROS and interruption of ATP synthesis, which in turn cause 
DNA damage. [59] 
 
2.3 Polystyrene and Nanopolystyrene   
2.3.1 Choice of Material 
Polystyrene is a commonly used and well known polymer, with many applications in 
everyday life; interestingly it also has a nano-counterpart which is the primary focus 
of this thesis. The choice of nanopolystyrene was solely influenced by the explicit 
inclusion of the material in the OECD’s list of nanomaterials requiring immediate 
investigation with respect to determining both a human and an environmental risk 
assessments [7]. The chosen polystyrene nanoparticles are commercially available 
in different sizes, surface modifications, are fluorescently labelled and are used as 
immunofluorescent reagents, microinjectable cell tracers as well as standards for 
traceability and calibration reagents for microscopy and flow cytometry [60] . The 
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chosen particles are therefore considered as good model particles to investigate and 
examine nanopolystyrene-cellular interactions.  
2.3.2. Polystyrene 
Polystyrene is an aromatic polymer that is made from the monomer styrene. It is a 
long hydrocarbon chain with every second carbon connected to the phenyl group. 
Styrene is an aromatic monomer, commercially manufactured from petroleum. 
Polystyrene is a vinyl polymer, manufactured from the styrene monomer by free 
radical vinyl polymerization. The attractive forces at play in polystyrene are mostly 
due to short range Van der Waals attractions between chains. Figure 2.3 shows the 
repeating monomer unit of styrene that make polystyrene.  
 
Figure 2.3 Repeating unit of Polystyrene (Styrene Monomer)[61].  
Products containing styrene include insulation, fibreglass, plastic pipes, automobile 
parts, shoes, drinking cups and other food containers [62].  Most of these products 
contain styrene linked together in a long chain (polystyrene) as well as unlinked 
styrene. Low levels of styrene also occur naturally in a variety of foods such as fruits, 
Phenyl Group (Ring-C) 
Aromatic C=C bonds 
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vegetables, nuts, beverages, and meats [63]. In addition, small amounts of styrene 
can be transferred to food from styrene-based packaging material [64]. Polystyrene 
is a rigid, transparent thermoplastic, which is present in solid or glassy state at 
normal temperature. However, once heated above its glass transition temperature, 
the polymer turns to a liquid state and can be moulded or extruded. Polystyrene 
related products are mostly everyday, widely available consumer products. The 
largest market for polystyrene presently is packaging, such as food and dairy 
containers, closures, lids, produce baskets, vending cups and fast food containers 
[65].  
While polystyrene is widely used in an enormous variety of products, there are many 
styrene related products also available. For example, styrene sulfonate polymers are 
used in wound dressings and are used for the coating of implantable medical 
devices. Modern medical devices generally contain one or more polymeric region, 
with styrene one of the more widely used polymers in the medical device sector.  
Medical devices from which a therapeutic agent is released also require suitable 
materials for use that will typically exhibit a release profile appropriate for the disease 
or condition being treated. For example, numerous polymer-based medical devices 
have been developed for the delivery of therapeutic agents to the body. Examples 
include drug eluting coronary stents, which are commercially available from Boston 
Scientific Corp.  
Polystyrene in its bulk form is non-toxic. There are currently no international bodies 
that define polystyrene as toxic or as having carcinogenic effects to humans [66]. 
While there are no reported toxic effects from polystyrene, the majority of reports 
published examine the toxicity of the monomer styrene. The World Health 
Organisation (WHO) published a report in 2003  [67]  in which it revealed that it 
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classifies styrene to have a low acute toxicity. The report revealed that controlled 
laboratory studies in animals and humans have shown that uptake of styrene is rapid 
and that it is widely distributed to the whole body with a preference for lipids. 
Elimination from lipid deposits is slower (half-life 2–4 days) than from other tissues. 
The findings also revealed there is no tendency towards long-term accumulation. 
Styrene is bio-transformed mainly to styrene-7,8-oxide which occurs in the liver as 
well as in a number of other tissues and organs. The report also revealed that 
findings showed that a small percentage of the dose absorbed is excreted 
unchanged in the expired air in both laboratory animals and humans after exposure 
via various routes. More than 90% of an oral dose is excreted rapidly as metabolites, 
mainly via the urine. In general, the metabolites in the urine of laboratory animals 
and humans were found to be qualitatively the same, but the amounts were species-
dependent. [67]. Other reports have also found that bronchitis, emphysema, and 
asthma was not associated with long term human exposure to styrene [68].  
2.3.3 Nanopolystyrene  
While one can conclude from findings discussed in the previous section, that 
polystyrene in its nano form would make an excellent candidate for therapeutic drug 
delivery materials or to be used in in vivo bioimaging or for quantitative dosage 
requirements, nanopolystyrene is technically a new material with little verifiable 
toxicological data available for it, as with most nanomaterials due to difficulties with 
test methods and reproducibility.  
As previously discussed in Chapter 1, Section 1.3, materials with well known 
properties and documented toxicity values can exhibit entirely different 
characteristics when moving from their bulk to their nano state [69] . Modifications of 
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the physicochemical properties of the bulk material can create the opportunity for 
increased uptake and interaction with biological tissues. This combination of effects 
can generate adverse biological effects in living cells that would not otherwise be 
possible with the same material in larger form, be they desirable effects or 
undesirable [6]. So, while polystyrene and even styrene, in their bulk form may be 
non toxic, it is imperative for a full toxicological profile to be conducted for 
nanopolystyrene before it can be considered for use for in vivo development.  
The nanopolystyrene particles used throughout this thesis are three types of 
commercially available, surface modified fluorescent and non-fluorescent 
nanopolystyrene beads. The properties and specifications of these nanoparticles will 
be discussed in Chapter 3, Section 3.1, with details of their properties and 
specifications. While the nanoparticles tested are of similar size (40nm, 50nm, 60nm 
and 100nm), the different surface charges on each particle will allow for comparison 
of aggregation states in different dispersants, potential toxicity to cells, internalisation 
and accumulation rates within cells and other properties related to surface charge.  
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2.4 Chapter Summary   
Throughout this chapter, the discipline of toxicology, incorporating nanotoxicology, 
was presented. Particle uptake mechanisms were examined with recent literature 
results on nanoparticle uptake mechanisms also presented, describing several 
different methods that may be possible for nanoparticles to be taken up by cells. The 
nanoparticle bio-interface was examined, describing studies where the physical 
parameters of nanoparticles have played a role in the interaction of proteins with 
nanoparticles. Information on the polymer, polystyrene, used throughout this thesis, 
was also presented.  
Nanoparticles have greater potential to travel through living cells than other materials 
or larger particles. The various interactions of nanoparticles with fluids, cells, and 
tissues need to be considered, starting at the portal of entry and then via a range of 
possible pathways towards target organs. The potential for significant biological 
response at each of these sites requires investigation.  While nanotoxicology as a 
discipline is still in its infancy, there have been great concerns expressed at the 
current protocols used for nanotoxicology and the possible inaccuracies they may 
possess. There have been numerous reports expressing concern that new protocols 
should be developed for testing of all materials in the nanoscale, where there is the 
potential for substantial human exposure. With some known non toxic materials in 
their bulk form exhibiting toxic effects in their nano form, the need for nanoparticle 
toxicology profiling is imperative.   
The following chapter will discuss the techniques used throughout this thesis as the 
tools used in building a physical chemical characteristic profile which will directly 
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allow for the production of a toxicological profile to begin. Details of techniques will 
be described with relevant theory provided for each section.  
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3.1 Introduction 
This chapter further describes the general experimental techniques used in 
characterising and assessing the cytotoxic effects of the nanoparticles used, and briefly 
details the characteristics of the particles themselves. Details of microscopic and 
spectroscopic experimental techniques used to examine the internalisation and tracking 
of the nanoparticles are also discussed. A brief introduction to the underlying theory for 
each techniques is initially discussed, after which the general experimental arrangement 
and sample preparation is detailed. Further details of more specific arrangements or 
sample preparations will be given in the relevant results chapters as required.  
 
3.2 The Nanoparticles 
As mentioned in Chapter 2, Section 2.2, the particles chosen for this study are 
polystyrene based nanoparticles. The explicit inclusion of nanopolystyrene in the 
OECDs list of nanomaterials requiring immediate investigation was a determining factor 
in the choice of material used throughout this study. The choice of particle was also 
based on the known properties of the bulk materials, specifically the fact that 
polystyrene is known to be inert and has a variety of applications in consumer and 
medical goods, including food packaging and medical devices [1]. Significantly, 
polystyrene is also used as a substrate material in cell culture, were the cell adhesion 
on the polystyrene surface is so strong that cell detachment requires an enzymatic 
treatment (i.e. trypsinisation). In addition, applications of nano-polystyrene in the 
medical device sector are emerging [2].   
Page | 45  
 
Chapter 3 
In this study, bulk polystyrene obtained from Sigma Aldrich [product code 331651] was 
used as a control material and was subjected to the same characterisation and analysis 
as its nano-counterparts. The nanoparticles chosen were 40nm and 100nm 
carboxylated nanopolystyrene, 60nm aminated nanopolystyrene and, 50nm and 100nm 
neutral nanopolystyrene. The 40nm and 100nm carboxylated polystyrene, known by the 
trade name of FluoroSpheres® Fluorescent Microspheres were purchased from 
Invitrogen (USA) (product codes for 40nm and 100nm particles F-8795 and F-8803 
respectively). They emit in the yellow-green region of the spectrum when excited using 
a 488nm laser line and are coated with a hydrophilic polymer containing multiple 
carboxcylic acid groups. The carboxylated polymer coating renders the surface 
effectively anionic. The 50nm and 100nm neutral polystyrene, known as Fluorescent 
Microsphere Suspensions, were purchased from Duke Scientific Corporation, now 
Thermo Scientific. They are internally dyed using the company’s Firefli® process and 
emit in the green region of the spectrum. The 60nm aminated nanoparticles, or the 
polyethylenaimine polystyrene nanoparticles, were manufactured and supplied by the 
Centre for BioNano Interactions (UCD, Ireland). Briefly, these PEI-PS particles were 
synthesised from carboxylated polystyrene NPs (also manufactured by UCD), whereby 
the carboxylate surface group reacts with the amine of the polyethyleneimine using 
EDAC (N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride) as a dehydrating 
agent. These are the only nanoparticles used throughout this thesis that are not 
internally dyed with a fluorescent material and are not visible under a fluorescent 
microscope. The aminated polymer coating renders the surface effectively cationic.  
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The chosen polystyrene nanoparticles are commercially available in different sizes, 
surface modifications, are fluorescently labelled (with the exception of the aminated 
nanoparticles) and are used as immunofluorescent reagents, microinjectable cell tracers 
as well as standards for traceability and calibration reagents for microscopy and flow 
cytometry and are considered as excellent model particles for in vitro investigation. The 
size and chemical nature of all five particles were chosen to facilitate a comparison 
between the effect of size, surface charge and functionalisation on the cellular uptake of 
nano-polystyrene. Furthermore, literature reports indicate that particle sizes of less than 
100nm  are optimum for internalization  [3].  While below 20nm in diameter, polystyrene 
particles cannot be clearly distinguished as individual particles in techniques such as 
confocal microscopy [4].  The particle sizes in this study therefore were chosen to fit 
within the range of published particle sizes optimum for cellular uptake and detection.   
3.3 Nanoparticle Characterisation  
All nanoparticles were characterized in-house to confirm the manufacturer’s 
specifications and the stability of the particles. The particles were also characterised in 
cell culture media in order to determine the physiochemical properties of the particles in 
the media of exposure e.g. particle size in the media etc. This information is crucial prior 
to any cytotoxic testing if a valid traceable set of experiments is to be preformed [5].  As 
previously discussed in chapter 2, a comprehensive characterisation of the physical and 
chemical properties is vital in order to elucidate and interpret any adverse cellular 
effects. Indeed, the OECD working group on Nanomaterials, amongst others, has 
specified several physiochemical parameters which they recommend be tested in 
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advance of evaluating the toxicity of a nanomaterial [6]. However, as discussed in 
chapter 2, these recommendations specify a range of characterisation techniques 
properties which is often beyond the capabilities of any one laboratory. For this reason, 
this study will routinely characterize particle size, aggregation state, particle stability in 
solution and the fluorescence stability of the particles, in water and in culture medium, 
prior to conducting any cytotoxicity.  The importance and relevance of the property 
measured will be discussed in more detail in the 4th chapter.  
 
3.3.1 Particle sizing: Atomic Force Microscopy  
The Atomic Force Microscope (AFM) is an instrument that can analyze and characterize 
samples at the microscopic level with a resolution of 100 μm to less than 1nm.  
The AFM operates by allowing an extremely fine sharp tip to come in contact or in very 
close proximity to the sample that is being imaged. This tip is usually on the order of 
100 µm long and less than 100Å in diameter. The tip is located at the free end of a 
cantilever under which the sample is scanned. Between the tip and the sample a variety 
of forces exist depending on the situation. For example, there can be mechanical 
contact forces, capillary forces, chemical bonding, or electrostatic forces acting between 
the sample surface and the tip. The most common contributions however are from van 
der Waals forces. These forces will either attract or repel the tip. The relation between 
the effect of forces and distance from the tip is shown in Fig. 3.1.  
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Figure 3.1 Schematic representations of force and distance in AFM measurements. 
Different scanning modes operate in different regions of the curve; Non–contact in the 
attractive region, contact mode in the repulsive and intermittent or tapping mode 
fluctuates between the two [7].  
 
 
An AFM can be operated in a number of different modes, namely contact, non contact 
and tapping.  In the contact mode, the cantilever is held less than a few Angstroms (10-
10m) from the sample surface, and the interatomic force between the cantilever and the 
sample is repulsive. In the non-contact mode, the cantilever is held on the order of tens 
to hundreds of Angstroms from the sample surface, and the interatomic force between 
the cantilever and sample is attractive. In tapping mode, the cantilever is driven to 
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oscillate near its resonance frequency by a small piezoelectric element mounted in the 
AFM tip holder, similar to non-contact mode. This method of 'tapping' lessens the 
damage done to the surface and the tip compared to the amount done in contact mode.  
Regardless of which mode of operation, tip deflections are recorded via a laser focused 
on the back of the cantilever and any variations in cantilever height are deciphered by 
measuring the interference it causes to the light beam. The interpretation of the 
interference patterns results in a topographical representation of the sample surface.  
In this study, an Asylum MFP-3D BIO Atomic Force Microscope was used. It uses a He-
Ne laser light source to detect any deflections. In order to measure the particles using 
the instrument, the nanoparticles were drop cast on to a clean silicon wafer and the 
solvent allowed to evaporate. All measurements were done in tapping mode.  
 
3.3.2 Particle Sizing: Dynamic Light Scattering (DLS) 
Dynamic light scattering (DLS) is a technique used for measuring the size of particles 
typically in the submicron region. DLS (also known as PCS – Photon Correlation 
Spectroscopy) measures frequency fluctuations in the interference pattern caused as a 
beam of light is scattered by the Brownian motion of the solvated particles. Brownian 
motion is the random movement of particles due to the bombardment by the solvent 
molecules that surround them. The larger the particle, the slower the Brownian motion. 
In order for the Brownian motion to be considered truly random, the temperature must 
be stabilised to prevent convection currents from influencing the movement. Similarly, 
the solvent viscosity will also play a vital role and needs to be factored into the final 
calculation of particle diameter. DLS does not measure actual physical particle size, but 
Page | 50  
 
Chapter 3 
rather the effective particle diameter in its local environment. This effective diameter, 
known as the hydrodynamic diameter, can be calculated from the Stokes-Einstein 
Equation, Equation 3.1.  From the Stokes-Einstein Equation, the hydrodynamic 
diameters dependency on the particles translational diffusion (velocity), as well as the 
solvent viscosity and temperature is clear. In essence the hydrodynamic diameter refers 
to how a perfectly spherical particle diffuses within a fluid and in cases where the 
particle is non-spherical an equivalent sphere of the same diffusion coefficient is 
assumed.  
 
d (H) =      kT   
           3 x π x η x D 
 
Equation 3.1 Stokes – Einstein Equation 
where: 
d(H) = hydrodynamic diameter  
D = translational diffusion coefficient  
k = Boltzmann’s constant  
T = absolute temperature  
η = viscosity 
 
In this study, a Malvern Zetasizer Nano ZS was used for determining the hydrodynamic 
diameter/particle size of the polystyrene nanoparticles. The Zetasizer Nano ZS has a 
hydrodynamic diameter measurement range of 0.6nm to 6μm. The laser used to 
illuminate the sample is a red HeNe gas laser with a wavelength of 633nm. The detector 
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used to measure the intensity of the scattered light is an avalanche photodiode, 
quantum efficiency >50% at 633nm at 173° (backscatter detection). It contains 
automatic laser attenuation transmission, ranging from 100% to 0.0003%, to reduce or 
increase the intensity of scattering to be detected.   
 
Measurements were carried out in a number of different dispersants at different time 
points throughout the project. Particles were gently agitated for approximately 10 
seconds before being dispersed in the appropriate dispersants. The concentration of 
sample made up in each dispersant was 1 x1012 particles per ml (ppml). This 
concentration was determined using the formula below; equation 3.2 
 
Number of nanoparticles / mL  =   6C x 103 
           ρ x π x Φ3  
 
Equation 3.2 Nanoparticle concentration calculation 
 
where: 
C = concentration of nanoparticles in g/mL  
Φ = diameter of nanoparticle in µm.  
ρ = density of polymer in g/mL (1.05 for polystyrene)  
 
  The particles were measured in distilled water and 10% Foetal Calf Protein Serum 
supplemented cell culture medium. Measurements in both dispersants were carried out 
at 25°C (room temperature) and 37°C (physiological temperature). By measuring 
particle size at both room temperature and physiological temperature, it allows any 
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changes in size or any aggregation which might impact on the cytotoxicity 
measurements to be monitored with increasing temperature. Each sample was filtered 
through a 0.4µm sterile syringe filter before being measure to ensure there were no dust 
particles present within the sample that may lead to convection currents and 
interference with measurements. Measurements were taken an average of 10 times 
each for each temperature and dispersant. Averages were obtained and standard 
deviations were also calculated. All measurements were carried out in a 4 clear sided 
quartz cuvette.   
  
3.3.3 Suspension Stability and Zeta Potential  
Zeta potential is the measure of the stability of a colloid system [8]. When particles are 
suspended in a medium of different phase (e.g. solids suspended in liquid) their 
interaction with the medium surrounding them determines whether the particles will 
coagulate or stay dispersed. The interactions with the surrounding media occur in the 
area directly surrounding the particle. This region may be considered to consist of two 
separate layers, the Stern layer and the diffuse layer, figure 3.2. The innermost layer 
(Stern) is the region where ions suspended in the medium adhere to the particle quite 
strongly. The outer layer contains ions which are not as strongly bound and are said to 
be diffuse. The boundary of this diffuse layer has a specific potential which is known as 
zeta potential (ZP).  
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Figure 3.2 Schematic representation of Zeta Potential [9].  
 
In general, if all particles in suspension have a large negative or positive ZP, they will 
tend to repel each other and there is no tendency to flocculate (process of reversible 
aggregation of particles). However, if particles have a low ZP value, there is no force to 
prevent the particles coming together and flocculating. The dividing line between stable 
and unstable suspensions is generally taken at zeta potentials of either +30mV or -
30mV. Particles with Zeta potentials more positive than +30mV or more negative than -
30mV are normally considered stable, as summarized in table 3.1.  
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Table 3.1 Collodial behaviour and related Zeta Potential values [9] [8] 
 
Zeta Potential [mV] Stability behaviour of the colloid 
from 0 to ±5, Rapid coagulation or flocculation 
from ±10 to ±30 Incipient instability 
from ±30 to ±40 Moderate stability 
from ±40 to ±60 Good stability 
more than ±61 Excellent stability 
 
A Malvern Zetasizer Nano ZS was used for zeta potential measurements throughout 
this project, a schematic of which is shown in figure 3.3. The laser used to illuminate the 
sample is a red HeNe gas laser with a beam wavelength of 633nm. The detector used 
to measure the intensity of the scattered light is an avalanche photodiode, quantum 
efficiency >50% at 633nm at 17° (backscatter detection). It contains automatic laser 
attenuation transmission, ranging from 100% to 0.0003%, to reduce or increase the 
intensity of scattering to be detected. The light scattered at an angle of 17° is combined 
with the reference beam. This produces a fluctuating intensity signal where the rate of 
fluctuation is proportional to the speed of the particles. A digital signal processor is used 
to extract the characteristic frequencies in the scattered light.  
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Figure 3.3 Optical configurations of the Zetasizer Nano series for zeta potential 
measurements [9].   
 
As in the case of DLS, measurements were carried out in a number of different 
dispersants at different time points throughout the project. Particles were gently agitated 
for approximately 10 seconds before being dispersed in the appropriate dispersants. 
The concentration of sample made up in each dispersant was 1 x1012 ppml. The 
particles were measured in distilled water, and 10% Foetal Calf Protein Serum 
supplemented cell culture medium. Measurements in both dispersants were carried out 
at 25°C (room temperature) and 37°C (physiological temperature). Each sample was 
filtered through a 0.4µm sterile syringe filter before being measure to ensure there were 
Page | 56  
 
Chapter 3 
no dust particles present within the sample that may interfere with measurements. 
Measurements were taken an average of 10 times each for each temperature and 
dispersants. Averages were obtained and standard deviations were also calculated. 
 
3.3.4 Electronic Spectroscopy. 
Two electronic spectroscopic techniques, namely absorption and fluorescent emission 
spectroscopy, were used in this research. These complementary techniques examine 
the optical absorption and emission characteristics of the particles.  The process of 
optical absorption and emission of a molecule is depicted in the Jablonski diagram in 
figure 3.4. Absorption involves the interaction of electromagnetic radiation with the 
components of a molecule. S0 is the singlet ground electronic state and S1 is the singlet 
excited electronic state; with T1 representing the triplet state. The initial absorption step 
takes the molecule to an excited electronic state Sn. Such a transition is denoted as a 
Frank-Condon transition.  
 
Figure 3.4 Jablonski diagram showing the sequence of steps  
leading to radiative decay [10] 
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After initial absorption, the upper excited vibrational states undergo non radiative decay 
or internal conversion (IC) to the lowest lying excited state S1, by giving up energy to the 
surroundings. The excitation can then decay to the ground state S0 either radiatively, 
resulting in fluorescence, or nonradiatively by internal conversion. Alternatively, the 
excitation can undergo a spin flip to a metastable triplet state, Tn, (termed intersystem 
crossing, ISC)) from which it can again decay nonradiatively, or radiatively resulting in 
phosphorescence [11]. 
 
The absorption spectrometer used to characterise the materials in this research was a 
Perkin Elmer Lambda 900 UV/VIS/NIR Spectrometer. The spectrometer is a double-
beam, double monochromator ratio recording system with pre-aligned tungsten-halogen 
and deuterium lamps as sources.  The wavelength range is from 175 to 3,300 nm with 
an accuracy of 0.08 nm in the UV-Vis region and 0.3 nm in the NIR region.  It has a 
photometric range of ± 6 in absorbance. For all the experimental studies, the absorption 
was measured at all times with a reference sample in a double beam arrangement. 
Samples of 0.5ml of particles (approx 7.25 x 1013 ppml for 50nm and 7 x 1015 ppml for 
40nm polystyrene) in 2ml dispersants of each nanopolymer in H2O was prepared. 
Reference samples were blank H2O. UV absorption was measured from 40 nm to 1000 
nm in keeping within a range relavant to the reported manufacture’s reported excitation 
maxima (447nm for 50nm polystyrene and 417nm for 40nm polystyrene). Samples were 
measured in a four-sided clear quartz quvette.  
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A Perkin Elmer LS55 luminescence spectrometer was used throughout this research to 
record florescence spectra. In this instrument, excitation is provided by a pulsed Xenon 
discharge lamp with a pulse width at half peak height of < 10 µs and pulse power 20 
kW. The source is monochromated using a Monk-Gillieson type monochromator and 
can be scanned over the range of 200-800 nm. The luminescence is passed through a 
similar monochromator, which can be scanned over the range of 200-900 nm. A range 
of samples of different concentrations, ranging from stock solution (1.45 x10 14 particles 
per ml (ppml) for 50nm and 1.4 x 1016 ppml for 40nm polystyrene) to  1.4 x 1011 ppml of 
each nanopolymer in H2O and 10% DMEM F-12 media were prepared. This was in 
order to find the optimum concentration of particles per ml that would ensure optimum 
fluorescence reading where no fluorescence quenching would interfere with sample 
measurement. Reference samples were blank H2O or 10% DMEM - F12 media. 
Fluorescence emission was measured from 200 nm to 800 nm in keeping within a range 
relevant to the reported manufacture’s reported excitation maxima. Samples were 
measured in a four-sided clear quartz cuvette.  
 
3.4 Cell Culture. 
For this project A549 (ATCC number CCL-185) cells were used. A549 (ATCC number 
CCL-185) (figure 3.5) is a human epithelial cell line derived from a lung carcinoma 
tissue. Cells were cultured in DMEM F-12 with 10% foetal calf serum (FCS) and 5ml L-
glutamine and grown in a humidified incubator at 37oC (5% CO2).  
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Figure 3.5 Light Microscopy images of A549 (ATCC number CCL-185) after 24hrs 
(approximately 25% confluence) and 4 days of culture (approximately 80% confluence). 
 
3.4.1 Cell culture media and Reagents. 
Cell viability dyes MTT and Neutral Red (NR) were purchased from Sigma Aldrich Ltd. 
(Dublin, Ireland). Alamar Blue™ (AB) was purchased from Biosource (UK). The carbyl-
fushion staining solution was purchased from AGB Scientific (Dublin, Ireland). Cell 
culture media and supplements and the trypsinisation solution were purchased from 
Lonza (Wokingham, UK). 
 
3.4.2 Cytotoxicity Evaluation. 
To evaluate the cytotoxic response to nanoparticle exposure, cells were seeded at a 
density of 1 x 105 cells/ml for 24 hour test, 7 x 104 cells/ml for 48 hour test, 3 x 104 
cells/ml for 72 hour test and 2 x 104 cells/ml for 96 hour test in 96- well.   
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3.4.3 Dispersion of nano particles in medium. 
For particle size and zeta potential measurement, dispersions of nano particles were 
created in fresh DMEM F-12 media supplemented with 10% FCS and 5 ml L-glutamine. 
An initial stock concentration of 1 x 1012 particles per ml (ppml) was prepared for each 
particle by dispersing the nanopolystyrene directly into the media. Serial dilutions of the 
stock concentration were then made.  Solutions of 5 x 1011, 2.5 x 1011, 1.25 x 1011, 6.25 
x 1010, 3.125 x 1010, 1.56 x 1010, 7.8 x 109  and 3.9 x 109 ppml were then prepared from 
the 1 x 1012 ppml stock by serial dilution. Previous studies [12] have noted interactions 
between media components and additional supplements with carbonaceous 
nanoparticles. In this study, no such interactions were noted for the tested 
nanopolystyrene.  
 
3.4.4 Cytotoxicity assays. 
For cytotoxicity evaluation, cells were seeded in 96-well micro plates (Nunc, Denmark) 
in triplicate for each of the four time points studied 24, 48, 72, 96 hr. Plates were seeded 
at a density of 1.5 x 105 cells/ml for 24hr, 5 x 104 cells/ml for 48hr, 3 x 104 cells/ml for 
72hr and 2 x 104 cells/ml for 96hr exposure. These densities were found to be optimal to 
achieve the desired confluence at the end of the exposure period. After an initial 24 hr 
of cell attachment, the medium was removed and the plates were washed with 100 
μl/well phosphate buffered saline (PBS). Cells were then treated with increasing 
concentrations of each nanomaterial and with a positive control of a 10% 
dimethylsulfoxide (DMSO) 90% medium solution. The cells were then incubated for the 
desired time period and the cytotoxic effects evaluated. For each independent 
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experiment, six replicate wells were used each for negative and positive control and six 
replicate wells were used for each test concentration per micro plate. Fluorescence and 
absorbance were all quantified using a microplate reader (TECAN GENios, Grodig, 
Austria). Cytotoxicity was assessed using five assays as outlined below.  
 
Section 3.4.5 Alamar Blue, Neutral Red, Coomassie Blue and MTT assays: 
The Alamar Blue, Neutral Red and Coomassie Blue assays were conducted 
subsequently on the same set of plates. The Alamar Blue assay was performed first. 
The bioassay was carried out according to manufacturer’s instructions. Briefly, control 
media or test exposures were removed, the cells were rinsed with PBS and 100 μl of an 
AB/NR medium (5% [v/v] solution of AB and 1.25% [v/v] of NR dye) prepared in fresh 
medium (without FBS or supplements) was added to each well. The plates were then 
incubated for 3 hours. The AB assay measures the innate metabolic activity of cells. 
The oxidised indigo blue, non-fluorescing form of the dye is reduced by cellular 
dehydrogenases to a reduced pink fluorescent form, which can be easily monitored 
spectroscopically [13]. Following the 3hr incubation, AB fluorescence was quantified at 
the respective excitation and emission wavelengths of 540 and 595 nm. 
Viability determination of the cells following exposure to each chemical were then 
subsequently investigated using the Neutral Red and Coomassie Blue assays. The 
incorporation of the Neutral Red dye by the lysosomes of living cells and the 
quantification of the total amount of cellular proteins were performed according to 
Spielmann, et al, the modification of Coomassie Brilliant Blue dye being employed in 
place of Kenacid Blue R dye. Briefly, after measurement of Alamar Blue fluorescence, 
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the Alamar Blue / Neutral Red medium was discarded, the cells were washed with 100 
μl PBS and the Neutral Red dye was extracted with 100 μl of an acetic acid-ethanol 
solution (de-staining solution). The addition of the acetic acid-ethanol solution also acts 
as a cell fixative step so that cell viability determinations can be conducted 
subsequently. The plate was shaken at 240 rpm for 10 min and the fluorescence of 
Neutral Red was measured at excitation and emission values of 540 and 650 nm 
respectively with a micro plate reader. Protein determinations were performed on the 
same plates immediately following Neutral Red determination. Excess Neutral Red dye 
was removed from the cells by washing with 100 μl de-staining solution. Coomassie 
Blue dye was added to each well and the plate agitated for 10 min. The dye was 
removed and the plate washed with an acetic acid-ethanol solution. The wash solution 
was discarded and the dye extracted with measuring solution (1M Potassium acetate). 
The plate was shaken at approximately 200 rpm for 10 min and the absorbance of the 
extracted dye was read at 570 nm (reference filter 340 nm) using the micro plate reader.  
 
The MTT assay is a quantitative colorimetric method to determine cell proliferation by 
determining the amounts of incorporated titrated thymidine into freshly synthesized 
DNA. A second series of plates were set up for the MTT assay. These plates were 
seeded and exposed identically to the first series of plates prepared for the Alamar 
Blue, Neutral Red, and Coomassie Blue assays. Following the desired time point of 
nanomaterial exposure, control medium and test exposures were removed, the cells 
were rinsed with PBS and 100 μl of fresh medium (without FBS or supplements) was 
added to each well. Ten micro litres of MTT (1 mg/ml) was prepared in PBS were added 
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to each well. Plates were incubated for 3 h at 37oC in a 5% CO2 humidified incubator. 
After this incubation period the medium was discarded, the cells were washed with 100 
μl of PBS and 100 μl of DMSO were added to each well to extract the dye. The plate 
was shaken at approximately 200 rpm for 10 min and the absorbance was measured at 
570nm. 
 
3.4.6 Clonogenic Assay 
The procedure for the clonogenic assay was adapted from Puck and Marcus (1956) and 
Franken et al. (2006) and cells were treated after plating. Exponentially growing cells were 
harvested and seeded in 25cm3 closed cap cell culture flasks (Nunc, Denmark) at a density of 
500 cells/ flask. Each flask contained 3ml of cell culture medium. Cells were allowed to attach 
for approximately 14 hours. This attachment period was shorter than the population doubling 
time of the cell line which is reported to be approximately 22 hours for A549 cells (ATCC, CCL-
185) to ensure that single cells were present at the start of exposure. Cells were then washed 
with 5 ml of PBS and treated with 2 ml test solutions. Following exposure to the test solutions for 
10 days, cells were washed with PBS and finally fixed and stained using a 20% carbol fuchsin in 
formalin solution (BDH, Poole, UK) and the number of cell colonies was determined.  
 
3.5 Confocal Microscopy 
Confocal microscopy operates on the principle that only the in-focus fluorescent light is 
detected, while the out-of-focus fluorescent light is blocked out. This is done with the 
use of a pinhole. An electronic light detector is placed behind a pinhole at the image 
focal point and another pinhole is placed just before the detector. By doing this, only 
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one point in the specimen is focused upon at any one time. An image can then be 
constructed of the entire specimen by scanning a laser over the entire focal plane. The 
mechanical movement of the specimen allows the depth of the optical plane through the 
specimen to be adjusted, thus, allowing for a 3D representation of the specimen to be 
reconstructed, with all planes in focus, in the final reconstructed image.  A Zeiss LSM 
510 Confocal Laser Scanning Microscope was used throughout this study, a schematic 
of which is shown in figure 3.6.  
 
 
 
Figure 3.6 A schematic diagram of confocal instrumentation [14].  
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3.5.1 Sample preparation for confocal fluorescent microscopy  
For the confocal studies, approximately 10,000 A549 cells (200µl of cell suspension) 
were seeded onto 35mm uncoated glass bottom dishes bought from MatTek 
Corporation, USA. Cells were allowed to attach for approx 4 hours, after which, 2mls 
10% FCS DMEM - F12 media were added. Plates were incubated over night.  The 
medium was then removed and particles (suspended in 10% FCS DMEM - F12 media) 
were added. Exposure times before imaging ranged from 15 minutes to 96hrs. Samples 
were imaged in 0.9% NaCl saline solution.  
 
3.5.2 Imaging of A549 cells exposed to nanoparticles 
Fluorescence images were captured at room temperature on an inverted Zeiss LSM510 
confocal laser scanning microscope (Carl Zeiss Inc.). The excitation wavelength used 
was 488 nm set at 4% of laser power and the fluorescence emission was detected 
using a 505nm long pass filter. Images were obtained with a 63x oil immersion 
objective.   
 
3.6 Raman Spectroscopy.  
Raman spectroscopy is a vibrational spectroscopy where transitions between vibrational 
states can result from the inelastic scattering of radiation from molecules. In such 
scattering processes, the incident photon should be of an energy that is greater than the 
energy difference between the vibrational states, for example UV or visible radiation 
(figure 3.7). The incident photon can be scattered off the molecule in two different ways. 
The scattered light induces an oscillating polarisation in the scattering molecule and 
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when the photon exchanges energy with a quantum of vibrational energy from the 
molecule, then the scattered photon may have a higher (anti-Stokes) or lower (Stokes) 
frequency than the incident photon. The difference in energy corresponds to the energy 
of the vibrational mode of the molecular structure and results in a Raman shift. When 
the incident energy equals that of the scattered photon, the scattering is referred to as 
elastic or Rayleigh scattering. In Stokes Raman scattering, the molecule starts out in a 
lower vibrational energy state and as a result of the scattering process ends up in a 
higher energy state. Thus, the interaction of the incident light with the molecule creates 
a vibration in the material. In anti-Stokes scattering, the molecule begins in a higher 
vibrational energy state and after the scattering process ends up in a lower vibrational 
state. Thus the vibration in the material is lost as a result of the interaction. The 
frequency difference between Raman lines and the exciting lines are characteristic of 
the scattering molecule and are independent of the excitation frequency. Raman 
spectroscopy is analogous to Infrared absorption spectroscopy which probes transitions 
between the vibrational states of a material. In Infra Red spectroscopy, however, a 
change in dipole moment is required during the transition, whereas in Raman 
spectroscopy a change in polarisability is required. As polar bonds are not often very 
susceptible to polarisation, the two techniques are often mutually complementary  
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Figure 3.7.Schematic representation of (A) Raman Stokes scattering of laser photons 
by vibrating molecules in the sample: energy is transferred by laser photons to the 
molecules as vibrational energy, the energy loss correspond to the vibrational energy 
levels of the molecules (E1, E2, …);  and (B) experimental set-up for Raman 
spectroscopy measurements of cells [15].  
 
3.6.1 Sample preparation for Raman Spectroscopy 
For Raman analysis, A549 cells, approximately 10,000 per substrate (200µl of cell 
suspension), were seeded on CaF2 substrates (Hellma Ltd., UK) and then placed in 
Petri dishes (30 mm diameter, Stardest, USA). Cells were allowed to attach for 
approximately 4 hours, after which, 2mls 10% FCS DMEM - F12 medium was added. 
Plates were left to incubate over night.  Medium was then removed and particles 
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(suspended in 10% FCS DMEM - F12 media) were added. Exposure times before 
imaging ranged from 1hr to 24hrs. Samples were imaged in 0.9% NaCl saline solution.  
 
A Horiba Jobin-Yvon LabRAM HR800 spectrometer with an external 300 mW diode 
laser operating at 785 nm as source was used throughout this work. For all 
measurements, a x100 immersion objective (LUMPlanF1, Olympus) was employed 
which provided a spatial resolution of ~1 µm at the sample. The confocal hole was set 
at 100 µm for all measurements, the specified setting for confocal operation. The 
system was pre-calibrated to the 520.7 cm_1 spectral line of silicon. The Labram system 
is a confocal spectrometer that contains two interchangeable gratings (300 and 900 
lines per mm respectively). 300 lines per mm grating was used, which gave a spectral 
dispersion of around 1.5 cm-1 per pixel. The backscattered Raman signal was integrated 
for 30 seconds over the spectral ranges from 400 to 1800 cm-1 and accumulated 3 
times to improve the signal to noise ratio. The detector used was a 16 bit dynamic range 
Peltier cooled CCD detector. Images of the sample were acquired using a video camera 
within the system. Spectra were recorded from the cellular nucleus, with approximately 
25 spectra recorded per substrate.  
For Raman mapping, an area corresponding to the map to be acquired was defined 
around the cells on the optical image provided by the instrument video camera. The 
step between two successive measurements was set to 1.5 µm or 0.75 µm and the 
backscattered Raman signal was integrated for 10 seconds over the spectral ranges 
from 400 to 1800 cm-1 and accumulated twice to improve the signal to noise ratio.  
 
Page | 69  
 
Chapter 3 
3.7 Chapter Summary  
This chapter presented the experimental techniques used throughout this thesis and 
provided relevant information and theory about each of the techniques employed.  
Experimental procedures were described, with specifications and parameters used 
given for each relevant procedure.  
The following chapter will present the results of the characterisation of 40nm and 100nm 
carboxylated Invitrogen nanopolystyrene and 50nm and 100nm Duke Scientific 
nanopolystyrene, as well as 60nm aminated nanopolystyrene (UCD). The 
characterisation profiling will give results obtained for a range of techniques ranging 
from DLS and AFM for particle sizing, zeta potential for information on particle stability 
in solution and electronic spectroscopy for information on the absorbance and emission 
properties of the fluorescent particles. 
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4.1 Introduction   
In the introductory chapters it was highlighted that nanotoxcity studies require special 
consideration of the physico-chemical properties in conjunction with the biological 
characterisation. Verification of internalisation of nanoparticles within cells is also 
paramount in order to consider nanoparticle trafficking through cells and their 
organelles.  As discussed in Chapter 2, Section 2.1, the OECD, as well as other 
organisations, has highlighted several key properties which must be characterised in 
advance of a toxicity study being performed on a nanomaterial. Warheit et al has 
discussed this aspect in great detail and reinforced the importance and significance of 
such data for traceable and reproducible nanotoxicology. Indeed  physiochemical 
parameters such as size, shape and surface characteristics, play a crucial role in the 
elucidation and determination of the biological properties of nano particles, often 
influencing how these particles interact with proteins, lipids and surfactants in the local 
environment [1]. As a result, such information can be used to determine how particles 
behave in biological media and subsequently within cells during in vitro studies, as 
performed in this thesis. Characteristics such as changes in the environment or ionic 
strength, or a change in the particle concentration, may result in some aggregation or a 
shift in the particle size distribution, which will subsequently have an effect on the 
manner in which the particles are presented to the cell and or cellular structures. Hence, 
the nature of the particles in the cell culture media is undefined making the 
interpretation of toxicity results with respect to the nano aspects undeterminable. The 
importance of ‘in-lab’ characterisation is further highlighted by Park and Grassian (2009) 
who showed differences between label specifications of commercial nanoparticles and 
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independent characterisation. Their study highlighted important insights with respect to 
shelf-life and stability. Again this is  crucial in order to fully interpret the results of toxicity 
assessments [2] 
In the present chapter, a number of the OECD recommended characterisation 
techniques were performed in advance of the cytotoxicity evaluation, particle 
internalisation and localisation verification studies.  The properties chosen include;  
• Particle size/size distribution  
• Zeta Potential 
• Electronic Spectroscopy 
The importance and justification of these properties to nanotoxicology will be discussed 
within this chapter and will form the underlying theme. 
This section will discuss the physico-chemical properties and material characterization 
and spectroscopic techniques used to create a characteristic profile of 50nm and 100nm 
neutral polystyrene, 40nm and 100nm carboxylated polystyrene and 60nm aminated 
nanopolystyrene. Characterisation was carried out throughout the project to have a 
complete profile of nanomaterials and to monitor any changes that may have occurred 
in their size, fluorescence, etc. due to aggregation.  
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4.2 Particle Size  
Particle size is one of the main factors that affect the biological applications of 
nanomaterials. One of the major concerns of nanoparticles is the possible toxic effects 
due to the capacity of these materials to penetrate cells and potentially translocate to 
other cells, tissues and organs around the body.  The size and shape of mammalian 
cells are varied, mostly related to their specific functions. A typical mammalian cell is 
approximately 10µm in size. It is also known that the cell membrane, which is 
approximately 8nm – 180nm in thickness and has an overall negative charge, allows 
certain substances to cross through selective permeability by processes such as 
diffusion, facilitated diffusion, active transport and endocytosis. Surface area, particle 
size, temperature, concentration and surface charge are all factors which affect particle 
movement across the membrane [3].  
As discussed in Chapter 2, Section 2.1, there are a number pathways by which 
nanoparticles may cross the cell membrane, endocytosis being the most likely [4]. The 
size of the vesicles formed for each endocytic route is different. For example clathrin 
coated pits are approximately 120nm in diameter, caveolea generally 50nm – 80nm and 
micropinomes 1 - 5µm [4].   
There is much evidence of nanoparticle size influencing cellular uptake and toxicity of 
particles. The uptake of fluorescent polystyrene-based latex microspheres, 50, 100, 
200, 500 and 1000nm in size, by B16-F12 cells (murine melanoma cell line) was studied 
to investigate the size dependency of particle size uptake [5]. The study revealed that 
uptake of the 50nm particle was the greatest, with the degree of internalisation 
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decreasing as particle size increased. The authors concluded that smaller particles (up 
to 200nm) were preferentially internalised via clathrin-mediated endocytosis while larger 
particles (>200nm but not greater than 1µm) were internalised via caveolin-mediated 
endocytosis.  Such studies provide insight into the effects of nanoparticle internalisation 
due to size.  
Taking this information into consideration, correct and accurate particle size 
measurement is a critical factor for evaluating toxicity and uptake of nanoparticles. 
There are many recommended techniques for the measurement of particle size such as 
Atomic Force Microscopy (AFM), Scanning Tunnelling Microscopy (STM), Scanning 
Electron Microscopy (SEM), and Transmission Electron Microscopy (TEM) [1, 6, 7]. 
While such microscopic techniques are more modern methods of particle size 
measurement, there are also many older available techniques for the measurement of 
particle size. Dynamic light scattering (DLS), as explained in more detail in Chapter 
Three, is a technique used for measuring the size of particles typically in the sub micron 
region. DLS has the advantage that the measurements can be made in situ in the 
nanoparticle dispersion. 
4.2.1 Particle Size Results  
Size measurements were made using Dynamic Light Scattering (DLS) on a Malvern 
Zetasizer Nano ZS. Measurements were carried out in a number of different dispersants 
at different time points throughout the project. Lynch et al (2007) have argued that the 
representation of nanoparticles in a biological fluid is actually a representation of the 
nanoparticles plus the proteins associated with the nanoparticle surface, and it is the 
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amount and presentation of the proteins on the surface rather than the particles 
themselves that are the cause of numerous biological responses. It is this outer layer of 
proteins that is seen by the biological cells, and leads to their responses. Therefore, for 
this study, nanoparticles were characterised in both distilled Milli Q water and 10% FCS 
DMEM - F12 media. Measurements in both dispersants were carried out at 25°C (room 
temperature) and 37°C (physiological temperature). Measurements were taken an 
average of 10 x3 times each for each temperature and dispersant. Averages were 
obtained and standard deviations were also calculated. The results from DLS size 
measurements for 50nm and 100nm Duke Scientific Nanopolystyrene, 40nm and 
100nm carboxylated Invitrogen Nanopolystyrene and 60nm Aminated Nanopolystyrene 
are reported in Tables 4.1 to Table 4.5.  
 
Table 4.1 Size measurements for 50nm Duke Scientific Nanopolystyrene 
Dispersant Temperature °C Average Particle Size / nm 
Standard 
Deviation / nm 
H2O 25 52.05  0.29 
H2O 37 52.54 0.16 
10% FCS 
DMEM - 
F12 25 49.44 0.22 
10% FCS 
DMEM - 
F12 37 38.00 0.25 
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Table 4.2 Size measurements for 100nm Duke Scientific Nanopolystyrene 
Dispersant Temperature °C Average Particle Size / nm 
Standard 
Deviation / nm 
H2O 25 112.65 0.86 
H2O 37 88.36 0.35 
10% FCS 
DMEM - 
F12 25 133.80 0.59 
10% FCS 
DMEM - 
F12 37 102.00 0.86 
 
 
As previously discussed in Chapter 3, Section 3.2.2, the Malvern Zetasizer Nano ZS 
measures the Hydrodynamic Radius (HR), or Stokes – Einstein Radius, from the 
translational diffusion coefficient. According to Malvern, the hydrodynamic size 
measured by Dynamic Light Scattering (DLS) is defined as “the size of a hypothetical 
hard sphere that diffuses in the same fashion as that of the particle being measured” [8].  
Results for the 50nm and 100nm Neutral Duke Scientific Nanopolystyrene, table 4.1 
and 4.2 respectively, show there are variations from the manufacturers’ specifications. 
The measured result of 52nm in water at 25 and 37°C, with standard deviations of 0.29 
and 0.16 respectively, is above the manufacturer’s specification of 50nm ± 5nm. 
Similarly, for 100nm particles measured in H2O, there is a variation in the obtained 
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sizes, measuring in at 112nm for particles measure at 25°C and 88nm for particles 
measured at 37°C, with standard deviations 0.86 and 0.35 respectively.   
Measurements made in 10% FCS DMEM - F12 media, showing an apparent decrease 
in size, may be explained by the presence of salts in the media, which suppresses the 
electrical double layer, resulting in a decrease in ”apparent” hydrodynamic radius and a 
decrease in the overall particle measurement.  
 
Table 4.3 Size measurements for 40nm Carboxylated Invitrogen Nanopolystyrene 
Dispersant Temperature °C Average Particle Size / nm 
Standard 
Deviation / nm 
H2O 25 78.89 2.24 
H2O 37 80.41 0.98 
10% FCS 
DMEM - 
F12 25 40.55 0.24 
10% FCS 
DMEM - 
F12 37 31.26 1.13 
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Table 4.4 Size measurements for 100nm Carboxylated Invitrogen Nanopolystyrene 
 
Dispersant Temperature °C Average Particle Size / nm 
Standard 
Deviation / nm 
H2O 25 120.96 0.69 
H2O 37 95.24 0.36 
10% FCS 
DMEM - 
F12 25 180.75 1.20 
10% FCS 
DMEM - 
F12 37 141.65 0.63 
 
 
As can be seen from table 4.3 and 4.4, 40nm and 100nm Carboxylated Invitrogen 
Nanopolystyrene particles respectively show sizes which varied over a range of 
temperatures. The 40nm particle was observed to have twice the label value and 
manufacture’s size specifications when measured in H2O. In contrast, when measured 
in 10%FCS DMEM – F12, particle sizes were seen to return to the acceptable errors 
associated with the product specifications. This is not unusual for this type of 
measurement since it is not the physical particle diameter measured by the 
manufacturer. Typically, manufactures use TEM and/or calculate particle size using 
Brunauer–Emmett–Teller (BET) analyser rather than determining the hydrodynamic 
radius of the particle [9]. One explanation for the observed increase in particle sizes 
may be due to the fact that the hydrogen, or proton, of the -OH on the carboxylated 
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group can dissociate to form a hydronium ion with water if the particle containing a 
carboxyl group is water-soluble. A carboxyl group that has lost its -OH hydrogen due to 
dissociation is called a carboxylate ion. The carboxylate ion has a negative charge 
which is free to react with other ionic species present in the water. As previously 
explained, this will have an overall affect on the diffusion speed, affecting the apparent 
hydrodynamic radius thus affecting the overall measured particle size [10].  
As can be seen from the size results obtained for the 100nm carboxylated particles, the 
sizes observed were considerably higher than the manufactures specification supplied 
with the particle. This variation of particle size results in 10%FCS DMEM - F12 media 
may be due to the formation of a protein corona causing aggregation [11] and the 
presence of salts in the medium [12]. Studies investigating the formation of a protein 
corona, consist of examining the effects of various nanoparticle size and surface 
properties in determination of their effect on the formation of the protein corona 
(Lundqvist et al. 2008). The study consisted of examining negatively charged (by 
carboxyl modification) nominally ‘‘neutral’’ unmodified polystyrene particles, positively 
charged (by amine modification), and the formation of the protein corona from human 
plasma of various sizes (50nm and 100nm). It was found that when all particles were 
placed into media, they increased in size, due to the number of identified proteins that 
were attached to each nanoparticle. Interestingly, when all of the nanoparticles 
(positively charged, negatively charged and neutral) were placed into H2O and/or a 
buffer solution, they did in fact, also increase in size, as in keeping with the results 
obtained for this thesis. These results show that with commercially supplied samples, 
significant deviations from nominal specifications can be observed. The conformation of 
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surface coatings is also, as previously discussed in Chapter 2, Section 2.2, dependent 
on the exact nature of the dispersant media. As conformational changes occur, due to 
the absorption of ionic species present in the media, changes in the diffusion speed will 
occur, affecting the overall particle size measured.  
Table 4.5 Size measurements for 60nm Aminated Nanopolystyrene 
 
Dispersant 
Temperature 
°C Average Particle Size / nm Standard Deviation / nm 
H2O 25 67.32 0.61 
H2O 37 50.07 0.76 
10% FCS 
DMEM - 
F12 25 2425 203.33 
10% FCS 
DMEM - 
F12 37 1461 205.16 
 
 
The extremely high standard deviation values that can be seen in the table above, gives 
an indication of the wide range of particle sizes that was observed for the 60nm 
aminated nanoparticles when measured in complete biological media. However, while 
these results are largely outside of the expected size value ranges, this phenomenon 
has been previously observed in other studies examining the effect of surface charge on 
particle size. In a study to compare the abilities of ambient and manufactured 
nanoparticles to induce cellular toxicity, characteristics of each tested nanoparticle were 
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assessed in aqueous media and in complete culture medium (10%FCS RPMI). In the 
presence of complete medium, aminated nanopolystyrene particles showed a 
considerable increase in size due to agglomeration, while other nanoparticles showed 
smaller increases or no changes. The authors suggested that proteins in the culture 
media may be adsorbed onto the particle surface, leading to neutralization of charge 
and interference in electrostatic repulsion. [13]. Such reports suggest that the presence 
of protein in biological media has an effect on particle size of surface modified 
nanoparticles.  
The above results emphasise the importance of measuring particle size in biological 
media for accurate toxicological assessment as this gives the most accurate apparent 
particle size that is being presented to the cell. The addition of surfactant should also be 
taken into account when examining particle sizes measure in water, as this may have a 
slight effect on measured size. Surfactant such as Tween, may be added to aqueous 
nanoparticle solutions to prevent flocculation of nanoparticles.  
 
4.3 Atomic Force Microscopy  
While DLS is an established method of particle size measurement, there are also other 
complementary techniques to verify particle sizes. Verification of particle size is 
important, particularly when examining particle size in biological media, as ionic species 
in the protein rich solution can have an effect on particle stability and agglomeration.  
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Atomic Force Microscopy (AFM) is a well documented technique for the characterisation 
of nanoparticles [14] [15] [16]. The technique has the capability of 3D visualization and 
both qualitative and quantitative determination of many physical properties including 
size, morphology, surface texture and roughness. A wide range of particle sizes can be 
characterized in the same scan, from 1nm to 8µm.   
AFM was employed as a particle size verification tool. The results obtained from the 
AFM measurements of 40nm Carboxylated Invitrogen Nanopolystyrene and 50nm Duke 
Scientific Nanopolystyrene can be seen in the following section.  
Details of the instrument used and the sample preparation is given in chapter 3, section 
3.3.1 Particle sizing: Atomic Force Microscopy.  
4.3.1 AFM Results 
Figure 4.3 and 4.4 show AFM results obtained for 40nm Carboxylated Invitrogen 
Nanopolystyrene. Figure 4.3 is an optical image of the dropcast nanopolymer solution. 
The line drawn through the bright spots (particles) is an indication of the particles of 
which the measurements were taken. The height profile of the particles measured can 
be seen in figure 4.4. The height profile reveals particles to be approximately 40nm in 
height, as was expected. The width of the particles (x-axis) shows the particles to have 
a width of approximately 500nm. This can be attributed to particles clumping together 
on drying.  
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Figure 4.3 Optcal AFM image of dropcast solution of 40nm Carboxylated Invitrogen 
Nanopolystyrene.  
 
 
Figure 4.4 AFM Height profile measurement of 40nm Carboxylated Invitrogen 
Nanopolystyrene particles.  
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Figures 4.5 and 4.6 show an AFM optical image and a height profile measurement of 
50nm Duke Scientific Nanoparticles.  
 
Figure 4.5 Optcal AFM image of dropcast solution of 50nm Duke Scientific 
Nanopolystyrene.  
 
Figure 4.6 AFM Height profile measurement of 50nm Duke Scientific Nanopolystyrene 
particles. 
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The profile for the 40nm Carboxylated Invitrogen Nanopolystyrene particles revealed 
particles had a height of approximately 40nm when measured by AFM. 50nm Duke 
Scientific Nanopolystyrene particles revealed from their height profile, heights of 
approximately 45nm, which is within the manufacturer’s specifications.  
The results in both particle cases are in keeping with size values obtained by DLS, 
confirming particle sizes. Clumping of particles was observed, as revealed from width 
profile measurements. In both particle cases, images obtained were representative of 
the entire surface. Measurements were taken from multiple dropcast solutions, where 
multiple particles were detected upon the surface of the silica slides.  
 
4.4 Zeta Potential 
When examining particle characteristics in advance of any nanotoxicological study, it is 
imperative to know the state of the nanoparticles to be used and in particular in the 
appropriate test media. Surface charge is particularly important when looking at 
nanoparticles dispersed in biological test media. Zeta potential is considered to be an 
indication of the overall potential charge that a particle surface has in solution. The 
development of a net charge at the particle surface affects the distribution of ions in the 
surrounding interfacial region, resulting in an increased concentration of counter ions 
(ions of opposite charge to that of the particle) close to the surface. Thus an electrical 
double layer exists around each particle. When a particle moves (e.g. due to random 
Brownian motion), ions within the boundary move with it, but any ions beyond the 
Page | 88  
 
Chapter 4    
 
boundary do not travel with the particle. This boundary is called the surface of 
hydrodynamic shear or slipping plane. The potential that exists at this boundary is 
known as the Zeta potential. If all the particles in suspension have a large negative or 
positive zeta potential then they will tend to repel each other and there is no tendency 
for the particles to agglomerate. However, if the particles have low zeta potential values 
then there is no force to prevent the particles coming together and flocculating. This 
obviously has a massive influence on the measurement of the size and surface area of 
nanoparticles, which, depending on the dispersant, will have an effect on the actual true 
particle size.  
Zeta potential and overall surface charge is of particular interest when looking at how 
particles enter the cell. As discussed in previous chapters, there are several ways for a 
substance to enter a cells interior. The permeability of a membrane is the ease of 
molecules to pass through it. Permeability depends mainly on the electric charge of the 
molecule and to a lesser extent the molar mass of the molecule. Electrically neutral and 
small molecules pass through the membrane easier than charged, large ones. Within 
cells, the intermediate extracellular surface of the plasma membrane is negatively 
charged due to the negative charge of the phospholipid heads. Therefore, the surface of 
the membrane could influence the way in which charged particles interact with the cell 
membrane. The cell uses this negative electrical membrane potential to drive the 
transport of the substances, often against a concentration gradient, into or out of the cell 
[17, 18].  
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Zeta potential can potentially provide information on the particle’s absorbed species, 
such as proteins or salts.  Therefore, from this information it can be concluded that it is 
imperative that characterization measurements, particularly surface charge and zeta 
potential measurements, should always be carried out in an array of different 
dispersants including biological media. The interaction of nanoparticles and proteins are 
of great interest in nanomedicine and nanotoxicology recently, in particular with the 
development of the idea of the nanoparticle-protein ‘corona’ [12].  
As mention previously, a study by Lundgvist et al (2008) demonstrated the effect of 
surface charge in the formation of a protein corona. The report concluded that the 
nature of the proteins in the corona is determined by the local chemical property of the 
nanomaterial and differences in the particles surface charge were able to entirely 
change the nature of the biologically active proteins in the corona, and thereby possibly 
also the biological impacts. This is of particular interest to this thesis, due to the 
similarity of the particle surface modification examined. Specific proteomic information 
of the nanopolystyrene (neutral, carboxylated or aminated) bio-interface could be of 
huge benefit when examining particle uptake mechanisms and determining eventual 
nanoparticle fate within cells. Such studies highlight the need and possible invaluable 
importance of zeta potential measurements when building a characterisation profile of 
nanomaterials for toxicological assessment.  
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4.4.1 Zeta Potential Results 
As with particle size measurements, zeta potential measurements were carried out in 
distilled H2O and 10%FCS DMEM - F12 media at both 25°C (room temperature) and 
37°C (physiological temperature). The average values and their standard deviations 
from zeta potential measurements of 50nm and 100nm Duke Scientific 
Nanopolystyrene, 40nm and 100nm Carboxylated Invitrogen Nanopolystyrene and 
60nm Aminated Nanopolystyrene are reported in Tables 4.6 to Table 4.10.  
Measurements in both dispersants were carried out at 25°C and 37°C.  
 
Table 4.6 Zeta Potential measurements for 50nm Neutral Duke Scientific 
Nanopolystyrene 
 
Dispersant Temperature °C Average Zeta Potential / mV 
Standard 
Deviation / mV 
H2O 25 -62.00 1.37 
H2O 37 -53.72 2.61 
10% FCS 
DMEM - 
F12 25 -13.06 0.51 
10% FCS 
DMEM - 
F12 37 -12.78 0.99 
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Table 4.7 Zeta Potential measurements for 100nm Neutral Duke Scientific 
Nanopolystyrene 
 
Dispersant Temperature °C Average Zeta Potential / mV 
Standard 
Deviation / mV 
H2O 25 -36.58 4.17 
H2O 37 -37.62 4.40 
10% FCS 
DMEM - 
F12 25 -11.60 2.8 
10% FCS 
DMEM - 
F12 37 -12.34 1.44 
 
Table 4.8 Zeta potential measurements for 40nm Carboxylated Invitrogen 
Nanopolystyrene 
 
Dispersant Temperature °C Average Zeta Potential / mV 
Standard 
Deviation / mV  
H2O 25 -40.00 5.04 
H2O 37 -38.10 2.51 
10% FCS 
DMEM - 
F12 25 -297.25 184.60 
10% FCS 
DMEM - 
F12 37 -390.00 98.33 
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Table 4.9 Zeta Potential measurements for 100nm Carboxylated Invitrogen 
Nanopolystyrene 
 
Dispersant Temperature °C Average Zeta Potential / mV 
Standard 
Deviation / mV 
H2O 25 -40.24 2.0 
H2O 37 -38.42 5.42 
10% FCS 
DMEM - 
F12 25 -12.72 5.13 
10% FCS 
DMEM - 
F12 37 -11.39 1.87 
 
Table 4.10 Zeta Potential measurements for 60nm Aminated Nanoparticles 
 
Dispersant 
Temperature °C Average Zeta Potential / mV Standard 
Deviation / mV 
H2O 25 54.28 2.24 
H2O 37 54.18 4.17 
10% FCS 
DMEM - 
F12 
25 -4.12 
0.60 
10% FCS 
DMEM - 
F12 
37 -5.11 
1.03 
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As can be seen from table 4.8, 40nm Carboxylated Invitrogen Nanopolystyrene particles 
were most stable in 10% FCS DMEM - F12 media. The large zeta potential value 
indicates that particles are highly stable in solution containing protein. The large shift in 
zeta potential values for particles in H2O and 10% FCS DMEM - F12 can be attributed 
to the interaction between the carboxylated group on the nanoparticles and constituents 
in the surrounding media, effectively neutralising the surface charge of the 
nanopolymer, making it more stable in solution.   
However, as can been seen in tables 4.6 and 4.7, 50nm and 100nm Neutral Duke 
Scientific Nanopolystyrene respectively, both exhibit the opposite behaviour. While the 
zeta potential values of the 50nm and 100nm neutral nanopolymers in H2O reveal they 
are moderately stable in the aqueous solution, once placed in 10% FCS DMEM - F12, 
the values indicate the particles are less stable in the protein solution. The negative 
value obtained by these “neutral” particles may be due to the fact that although the 
nanoparticles are monodispered in water, there is 0.01% surfactant also in the solution 
(to prevent particles from aggregating). This tiny amount of surfactant may cause the 
“neutral” nanoparticles to have a negative zeta potential value. However, for the 
purpose of this thesis, they will be referred to as neutral nanoparticles. These values are 
in keeping with literature reports that also suggest that neutral nanopolystyrene exhibit 
stable zeta potential values when in aqueous media but  less stable values when 
dispersed in protein supplemented biological media [13].  
The values obtained from the zeta potential measurements of the 60nm aminated 
nanopolystyrene also comply with values in literature [19]. While in aqueous solution, 
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the particles exhibit a moderately stable state. However, once placed in complete 
media, the surface charge interaction with proteins can be seen to affect the stability of 
particles in the solution.  [13].  
 
4.5 Electronic Spectroscopy. 
The use of fluorescent nanoparticles for the development of suitable labelling systems 
for particle penetration and translocation has been an area of investigation for a number 
of years [20]. Current medical and biological fluorescent imaging methods are mainly 
based on dye markers, which are limited in light emission per molecule, as well as 
photostability [21] . Nanoparticles overcome these disadvantages offering strong and 
stable fluorescence. A tight control of the average particle size and a narrow distribution 
of sizes allow the creation of very efficient fluorescent probes that emit a narrow 
emission wavelength band of  light in a very wide range of wavelengths [21]. This helps 
with creating biomarkers with many and well distinguished colours. A study by Geys et 
al. (2006) to examine different optical techniques for measuring translocation across a 
cell monolayer reported that when fluorescent nanoparticles were studied, 6% transfer 
was observed for polystyrene nanoparticles. This work focused on the potential uptake 
and trafficking of nanoparticles through cells and gives a clear example of the relevance 
and importance fluorescent nanoparticles have in the area of nanotoxicology.    
UV-Vis absorption spectroscopy was the first technique employed to verify the 
excitation wavelength of each particle. A solution of 40nm carboxylated 
nanopolystyrene particles in water was prepared and measured with the absorption 
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spectra obtained. The excitation maximum was revealed as 417nm, which is within the 
manufacturer’s specifications. A second solution of 50nm nanopolystyrene particles in 
water was prepared and the absorption spectra of it obtained. The absorption spectrum 
revealed the solution of 50nm particles in water to have an excitation maximum of 
447nm, which is also in agreement of the manufacturer’s specification. Details of the 
experimental methods used can be found in Chapter 3, Section 3.2.4. Figure 4.9 shows 
the absorption spectra obtained for 40nm Carboxylated Invitrogen Nanopolystyrene and 
50nm Duke Scientific Nanopolystyrene particles. The spectral window has been cut 
from 300nm – 1000nm to 375nm – 700nm for clarity.  
 
 
Figure 4.9 Absorption spectra of 40nm Carboxylated Invitrogen Nanopolystyrene (solid 
line) and 50nm Duke Scientific Nanopolystyrene (dashed line). 
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The excitation wavelength measured for each particle was then used to determine the 
optimum fluorescence emission of particles in solution at specific concentrations.  The 
emission values obtained for 40nm carboxylated nanopolystyrene and 50nm neutral 
nanopolystyrene at different concentrations can be seen in figures 4.10. and 4.11, 
respectively.  
 
Figure 4.10. 40nm Carboxylated Invitrogen nanopolystyrene emission at 520nm by 
417nm excitation as a function of nanoparticle concentration (part/ml) 
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Figure 4.11 50nm Duke Scientific Nanopolystyrene emission at 508nm by 447nm 
excitation as a function of nanoparticle concentration (part/ml) 
 
As can be seen from the fluorescence emission spectra obtained of both particles, the 
fluorescence emission reaches a maximum at a specific concentration of particles per 
ml, before decreasing. At these specific concentrations the fluorescence emission from 
the particles is at its optimum intensity. Above these concentrations, the decrease in 
fluorescence may be attributed to reabsorption or fluorescence quenching.  
From the fluorescence emission spectrum obtained for both particles, it was concluded 
that optimum working concentrations of approximately 1 x1012 particles per ml would be 
adapted throughout this thesis.  
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4.6 Chapter Summary  
This chapter has presented the results of the characterisation on 50nm and 100nm 
Duke Scientific nanopolystyrene, 40nm and 100nm carboxylated Invitrogen 
nanopolystyrene and 60nm aminated nanopolystyrene. The characterisation profiling 
utilised a range of techniques ranging from DLS and AFM for particle sizing, zeta 
potential from information on particle stability in solution and electronic spectroscopy for 
information on the absorbance and emission properties of the fluorescent particles.  
The DLS and AFM results revealed particle sizes, for 50nm and 100nm Duke Scientific 
Nanopolystyrene, 40nm and 100nm carboxylated Invitrogen Nanopolystyrene. The 
presence of surfactant may have interfered with neutral and carboxylated nanoparticles 
measured in water and the apparent increase in their size. The 60nm Aminated 
Nanopolystyrene particle was found to drastically increase in size when placed in 
biological media, which may be attributed to the formation of a protein corona, which 
would have an affect on the apparent hydrodynamic radius and thus the measured 
particle size. All sizes were confirmed over a range of temperatures and dispersants. 
Zeta potential measurements revealed that the 100nm and 40nm carboxylated particles 
were stable in biological media, which was most likely due to the interaction between 
the carboxylated surface of the nanoparticle and the ionic species found in the media, 
while 50nm and 100nm “neutral” particles were found to have a negative zeta potential. 
This may have been due to a small amount of surfactant present within the aqueous 
solution to prevent flocculation. However, for the purpose of this thesis they will be 
referred to as “neutral” nanoparticles. Both Duke Scientific particles were found to be 
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stable in solution over a range of temperatures, while zeta potential values showed the 
60nm aminated nanoparticles to be unstable when placed in complete media. 
Absorbance and fluorescence emission spectroscopy revealed values which were also 
agreement with the supplied manufacturer’s specifications. From fluorescence emission 
spectra obtained of both 50nm and 40nm particles, a working concentration of 1 x 1012 
ppml was decided, as this concentration revealed optimum fluorescence, which will be 
benefit in later experimental procedures such as confocal microscopy.  
The following chapter will present and discuss the results obtained of the toxicity of 
50nm and 100nm Duke Scientific nanopolystyrene, 40nm and 100nm carboxylated 
Invitrogen nanopolystyrene and 60nm aminated nanopolystyrene. Five toxicity assays 
were employed, with theory and experimental results presented for each.  
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5.1 Introduction   
In the introductory chapters, Chapter 2, Section 2.1, it was highlighted that a critical 
issue with nanomaterials is the clear understanding of their potential toxicity. Several 
physico-chemical parameters have been proposed to be significant contributors in 
nanomaterial toxicity: size, crystalline structure, chemical composition, surface area 
and oxidation status [1]. However none of these parameters have been identified as 
being solely responsible for nanoparticle toxicity. In general, toxicity of particles is 
considered a consequence of a contribution of their physicochemical properties 
which allows them to evade or cause damage to defensive mechanisms within cells. 
[2].  
The aim of this section is to evaluate potential toxicological effects of polystyrene on 
A549 cells. It has been well documented that known nontoxic materials can at 
nanoscale exhibit toxic effects on cells in vitro. In its Working Report on 
Nanomaterials, the OECD listed nanopolystyrene as one of the worldwide 
manufactured nanomaterials that is of interest, within the bio-nano area [3].  Interest 
generated by nanopolystyrene in the area of bio-nano applications, may be due to 
the lack of toxicity effects noted for its bulk form. As described in Chapter 2, Section 
2.2, the toxicity of polystyrene is largely undocumented, although it is listed by The 
World Health Organisation (WHO) and the U.S. National Toxicology Program for 
Acute Toxicity Studies as having mild acute toxicity when exposed to humans or rats 
through various exposure routes [4]. The polymer and its associated monomer, 
styrene, are also listed as having no known carcinogenic effects and no endocrine 
disruption at the concentrations at which people are exposed to daily [5]. A report by 
the Health Protection Agency in the UK describe how approximately 90% of all 
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styrene absorbed by humans undergoes hepatic oxidation by cytochrome P450, to 
styrene 7,8-oxide, which is the active metabolite. Styrene 7,8-oxide is further 
metabolised into phenylglyoxylic acid, mandelic acid and hippuric acid which are 
excreted in the urine [6].  
The cytotoxicity of a substance is a measure of how toxic it is to a cell. Cells treated 
with a cytotoxic compound can result in a variety of cell fates. There are two 
experimentally distinguishable mechanisms of cell death: necrosis, the “accidental” 
cell death that occurs when cells are exposed to a serious physical or chemical 
insult, and apoptosis, the “normal” cell death that removes unwanted or useless 
cells. Apoptosis is characterized by well defined cytological and molecular events 
including a change in the refractive index of the cell, cytoplasmic shrinkage and 
nuclear condensation. These changes may be quantitatively measured through 
colorimetric and luminescence based assays. There are a wide range of cytotoxicity 
assays that have been developed which utilise different parameters associated with 
cell death and interference in proliferation [1].  
Although conventional colorimetric and luminescence based assays give an 
indication of the effect on proliferation and viability as well as organelle damage, they 
however, fail to recognise that although some nanoparticles may not produce 
immediate or semi-long term (10 days) toxic effects, nanoparticles have the ability to 
localise within cells and cell organelles. There is a strong likelihood that the 
biological activity of nanoparticles depends on physico-chemical parameters not 
routinely considered in toxicity screening studies. While there is an abundance of 
studies that examine the toxicity, accumulation and translocation of nanoparticles at 
short exposure times [7] [8], there is an inadequate amount of data on the long term 
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exposure of nanoparticles, particularly when considering the possible long term 
accumulation and translocation of particles around the body [9]. There is currently a 
lack of well characterized toxicological targets and assay methods for studying the 
effects of nanomaterials [1] [8]. Only recently has a working group report been 
published that details screening strategy for various biological targets that can be 
affected by nanomaterials [10].  
With polystyrene in its bulk size exhibiting non-hazardous effects to humans, and the 
knowledge that nanoparticles can migrate to different areas of the body, the interest 
in nanopolystyrene as a possible potential bio-nano polymer is justified. However, as 
with any potential material that may be used for biological application, a full 
toxicological profile for the material is imperative.  
While some literature presents the findings that nanopolystyrene in its cationic form 
can cause toxicity, and even induce cell death [11], there is however also substantial 
evidence that show neutral and anionic nanopolystyrene does not produce cytotoxic 
effects [12]. Instead, they have been shown to be taken up by cells and incorporated 
within cell organelles, such as endosomal, lysosomal and mitochondrial 
compartments of EAhy926 cells, a human umbilical vein endothelial cell line and 
human hepatocyte cell lines (HepG2) [13] [14]. Similar results were observed when 
red blood cells were used to investigate the uptake of fluorescent nanopolystyrene 
particles (78nm, neutral and anionic) [15]. There was no suggestion of any toxicity 
caused by nanoparticles, with confocal microscopy allowed for the monitoring of 
78nm polystyrene to be taken up by blood cells over a period of 4 – 24 hours.  
However, there are several studies that must be taken into account when examining 
the toxicity of charged nanopolystyrene, most notably in the case of positively 
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charged nanopolystyrene. For example, in a recent study conducted by Nel et al 
(2007), it was reported that 200nm positively charged polystyrene beads generated 
high levels of reactive molecules and induced oxidative stress in lung macrophages 
(defence cells engulf particulate matter). However, little activity was observed for 
negatively charged polystyrene beads, while in a previous study in 2006, Nel and 
colleges reported that 60nm cationic nanopolystyrene induced mitochondrial damage 
and cell death without inflammation. In another study, 97nm cationic nanoparticles 
were also found to have an immediate toxic effect at the blood brain barrier (BBB) 
whereas neutral and anionic nanoparticles were found to have no effect on the BBB 
integrity [12].  
In this chapter, the direct acute cytotoxicity of 50nm neutral, 40nm carboxylated and 
60nm aminated nanopolystyrene will be presented and discussed based on the use 
of Alamar Blue™ (AB), Neutral Red (NR), Commassie Blue (COMMASSIE) and 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays while the 
longer term effects will be monitored using the clonogenic assay. In all cases, data 
are expressed as a percentage of unexposed controls and, to verify experimental 
protocols, a positive control of a 10% DMSO 90% medium mixture was employed. 
For cytotoxicity, statistically significant differences were set at p≤0.05).   
5.2 Alamar Blue Assay  
The Alamar Blue™ (AB) assay is designed to quantify the proliferation, or effect or 
disruption on cell growth, of various cell lines and is widely utilized to measure 
cytotoxicity. The disruption of cell proliferation can give an indication on the effect of 
cell division, which may direct examination of the effect of a particle to possible DNA 
damage. Resazurin, a non-fluorescent indicator dye, is converted to bright red–
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fluorescent, Resorufin, via the reduction reactions of metabolically active cells. 
Viable proliferating cells cause a reduction of the dye causing a colour change from 
a non-fluorescing indigo blue (oxidised) to a fluorescent pink species (reduced) 
(figure 5.1).  
 
Figure 5.1 Conversion of Resazurin (oxidised form) to Resorufin (reduced form) 
The amount of fluorescence produced is proportional to the number of living cells. 
Damaged and nonviable cells have lower innate metabolic activity and thus generate 
a proportionally lower signal than healthy cells.  One main advantage of this assay 
lies in its water solubility. It requires no solvent extraction step and hence cellular 
viability is unaffected allowing multiple tests to be carried out on the cells. 
Measurements may be made by absorbance monitoring of AB supplemented cell 
culture medium or alternatively fluorescent measurements can be made (Biosource 
Inc, O’Brien et al., 2000). The absorbance spectra of the oxidised and the reduced 
forms overlap. Therefore, the absorbance measurements must be made at the 
absorbance maxima of each form, namely 570 nm and 600 nm. Fluorescent 
measurements can be made by exciting from 530 to 560 nm and recording emission 
at 590 nm (Biosource Inc, O’Brien et al., 2000).    
Figures 5.2, 5.3 and 5.4 display the cytotoxic response curves obtained for 50nm 
nanopolystyrene, 40nm carboxylated nanopolystyrene and 60nm aminated 
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nanopolystyrene respectively using the Alamar Blue assay. As can be seen from 
figure 5.2, 50nm nanopolystyrene did not produce any cytotoxic effects over the four 
time points measured. When cells are metabolising they maintain a reducing 
environment within their cytosol and this reduced state can be measured 
spectrophotometrically through the conversion of Resazurin, (indicator dye), to 
Resorufin. From the measurement of the percentage reduction in Alamar Blue in 
A549 cells exposed to 50nm nanopolystyrene particles, in comparison to the control; 
it is evident that over the four time points (24hr, 48hr, 72hr and 96hr) there was no 
decrease in the number of metabolising cells. This result indicates that particles did 
not have an effect on the proliferation of cells. As can be seen from the graph, 
particle concentration also did not have an effect on proliferation, as there is no 
decrease in reduction of Alamar Blue dye from of Resazurin to Resorufin, indicating 
cells did not have a decrease in metabolic activity over all time periods and particle 
concentrations.  
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Figure 5.2 Cytotoxicity of 50 nm Duke Scientific Nanopolystyrene to A549 cells after 
24, 48, 72 and 96 hour exposures determined by the AB assay. Data are expressed 
as percent of control mean ± SD of three independent experiments 
 
Figure 5.3 shows the results of the Alamar Blue assay for 40nm carboxylated 
nanopolystyrene particles. As with the 50nm PS, the 40nm nanopolystyrene particles 
showed no cytotoxicity effect over the four time points measured on A549 cells. The 
cytotoxic response curve obtained indicates no decrease in metabolic activity with 
particle concentration or exposure time, with particle concentration also having no 
cytotoxic effect.  
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Figure 5.3 Cytotoxicity of 40nm carboxylated Invitrogen Nanopolystyrene to A549 
cells after 24, 48, 72 and 96 hour exposures determined by the AB assay. Data are 
expressed as percent of control mean ± SD of three independent experiments.  
 
However, there are slight increases in fluorescence reading of Alamar blue reduction 
in comparison of the % control in both cases. In figure 5.3 the increase can be seen 
particularly over the 48 and 96hr exposures. The increase for the 40nm particle is 
more evident during the 48hr exposure period, figure 5.3. These small increases in 
respect to the classical unexposed control, fall within the standard deviation errors, 
are generally considered to be attributed to slight variations in the seeding densities 
of each well or plate. The results obtained in this experiment are in keeping with 
literature reports by Brunsten et al, in that 50nm neutral nanopolystyrene and 40nm 
carboxylated nanopolystyrene does not cause any cytotoxic effects when measured 
using the Alamar Blue assay.  
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The cytotoxic response of A549 cells after exposure to 60nm aminated 
nanopolystyrene, measured using the Alamar Blue assay can be seen in figure 5.4. 
Unlike the previous two particles exposed to cells, a toxic response can be seen 
cause by the highest test concentration of 1x1212 particles per ml (ppml), over a 
range of 24 to 96 hours. A slight toxic response of cells to particles can also be seen 
over same time points for the second highest test concentration of 5x1011ppml.  
For the highest concentration of 1x1012 ppml, it can be seen that an almost complete 
toxic response was observed for the 96hr exposure period. While the same 
concentration also caused sever cytotoxicity to cells over a 24 to 72 hour period. The 
number of metabolising cells observed for the test concentration 5x1011ppml, in 
comparison to the control, can be seen to have also sharply decreased over the test 
periods of 48 to 96 hour. A lesser cytotoxic response for this concentration can be 
observed for the 24hr exposure period. However, the remainder of the test 
concentration range from 2.5x1011 to 7.8x108ppml show no cytotoxic response was 
observed over the time periods of 24 to 96 hours.  
Toxicity results observed for A549 cells after exposure to higher test concentrations 
of 60nm aminated particles are in agreement with literature findings [11] .   
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Figure 5.4 Cytotoxicity of 60nm Aminated nanopolystyrene to A549 cells after 24, 
48, 72 and 96 hour exposures determined by the AB assay. Data are expressed as 
percent of control mean ± SD of three independent experiments.  
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5.3 Neutral Red Assay 
The Neutral Red (NR) cytotoxicity assay is based on the ability of viable cells to 
incorporate and bind neutral red, a weak cationic dye, dimethyl diaminophenazine 
chloride, figure 5.5, that readily penetrates cell membranes by non-ionic diffusion 
(Borenfreund et al., 1984, Borenfreund et al., 1988). It accumulates in the lysosomes 
of cells where it binds to the sensitive lysosomal membrane. Cells damaged by 
xenobiotic action have decreased ability of taking up and binding NR, so that viable 
cells can be distinguished from damaged or dead cells. The dye can be extracted 
from intact cells using a solution of 1 % (v/v) acetic acid and 50 % (v/v) ethanol and 
the absorbance or fluorescence of solubilised dye can be determined (Borenfreund 
et al., 1984; Borenfreund et al., 1988). The uptake of neutral red depends on the 
cell’s capacity to maintain pH gradients, through the production of ATP. At 
physiological pH, the dye presents a net charge close to zero, enabling it to 
penetrate the membranes of the cell. Inside the lysosomes, there is a proton gradient 
to maintain a pH lower than that of the cytoplasm. Thus, the dye becomes charged 
and is retained inside the lysosomes. The test is very sensitive, specific, and readily 
quantifiable. Cytotoxicity is expressed as a concentration dependent reduction of the 
uptake of the NR after chemical exposure thus providing a sensitive, integrated 
signal of both cell integrity and growth inhibition.  
 
Figure 5.5 Dimethyl diaminophenazine chloride dye (Neutral Red).   
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Figures 5.6, 5.7 and 5.8 displays the cytotoxic response curves obtained for 50nm 
Duke Scientific nanopolystyrene, 40nm carboxylated Invitrogen nanopolystyrene and 
60nm aminated nanopolystyrene respectively using the Neutral Red assay.  
The results of Neutral Red uptake for A549 cells exposed to 50nm nanopolystyrene 
over time periods of 24hr, 48hr, 72hr and 96hr can be seen in figure 5.6. As with the 
Alamar Blue assay, particle concentration did not have an effect on the proliferation 
or viability of exposed cells. The exposure time of cells to particles also had no effect 
and did not induce toxicity over 24 – 96 hours.   
 
 
Figure 5.6 Cytotoxicity of 50 nm Duke Scientific Nanopolystyrene to A549 cells after 
24, 48, 72 and 96 hour exposures determined by the NR assay. Data are expressed 
as percent of control mean ± SD of three independent experiments. 
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Figure 5.7 shows cytotoxicity results for the exposure 40nm aminated 
nanopolystyrene particles to A549 cells, as determined by NR assay. The results 
presented show there is no cytotoxic effects to A549 cells as a results of exposure to 
40nm PS particles.  As with the 50nm PS, the results show no cytotoxicity observed 
by cells as a result of exposure to particles. The results show no decrease in the 
uptake of NR dye over the measured time points, with particle concentration also 
having no effect on NR uptake by viable cells.  
 
 
Figure 5.7 Cytotoxicity of 40nm carboxylated Invitrogen Nanopolystyrene to A549 
cells after 24, 48, 72 and 96 hour exposures determined by the NR assay. Data are 
expressed as percent of control mean ± SD of three independent experiments.  
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Because cytotoxicity is expressed as a concentration dependent reduction of the 
uptake of NR after chemical exposure, it can be seen from the results in figure 5.6 
and 5.7 that there was no decrease in the uptake of NR upon exposure, hence no 
alterations of the cell surface or the sensitive lysosomal membrane, resulting in no 
toxicity by either particle over the exposure times observed.   
However, as can be seen in figure 5.8, NR uptake, within A549 cells after exposure 
to the highest test concentration of 60nm aminated nanoparticles, can be seen to 
have dramatically decreased, indicating a toxic response from cells. The 1x1012 ppml 
test concentration can be seen to have a toxic effect on cells after 24hr with the 
number of cells compared the control decreasing dramatically over the 96hr 
exposure period.  The second highest test concentration of 5x1011 can also be seen 
to have a slight toxic effect on cells, with toxicity increasing over the 96hr time 
period. The NR uptake by healthy, viable cells is decreasing over the exposure 
periods suggesting that, 60nm aminated particles at a concentration of 5x1011 cause 
some degree of toxicity to A549 cells with increasing exposure time.  
As with the previous Alamar Blue assay, the findings from this assay in also in 
keeping with literature reports that aminated nanopolystyrene can cause toxicity in 
cells.   
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Figure 5.8 Cytotoxicity of 60nm Aminated Nanopolystyrene to A549 cells after 24, 
48, 72 and 96 hour exposures determined by the NR assay. Data are expressed as 
percent of control mean ± SD of three independent experiments. 
 
As previously observed with the Alamar Blue assay, there are slight increases in 
absorbance reading of neutral red uptake in comparison of the % control particularly 
over the 48 and 96hr exposures for the 40nm particle, figure, 5.7 and for the 60nm 
particle over 72 and 96hr periods. These are small increases in respect to the 
classical unexposed control, that fall within the standard deviation errors, are 
generally considered to be attributed to slight variations in the seeding densities of 
each well or plate.  
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5.4 Coomassie Blue Assay  
The protein content of cells after exposure to a suspected toxicant is often used as a 
measure of cytotoxic effects in vitro. Different spectroscopic methods are routinely 
available for determination of protein concentrations, including measurement of 
protein's intrinsic UV absorbance, and methods generating a protein-dependent 
colour change, namely the Lowry assay, the Smith copper/bicinchoninic assay. The 
simplest and most sensitive is the Bradford assay, introduced in the mid 1970s, and 
is based on the equilibrium between three forms of Coomassie Blue-G250 
(Coomassie) dye (figure 5.9). Development of colour in Coomassie dye-based 
(Bradford) protein assays has been associated with the presence of certain basic 
amino acids in protein, although Interactions are chiefly with arginine rather than 
primary amino groups; the other basic (His, Lys) and aromatic residues (Try, Tyr, 
and Phe) give slight responses [16]. 
Under strongly acidic conditions, the dye is most stable in its double protienated red 
state. When bound to a protein, the un-protonated blue form becomes more stable. 
Van der Waals forces and hydrophobic interactions also participate in the binding of 
the dye to proteins. The number of Coomassie dye ligands bound to each protein 
molecule is approximately proportional to the number of positive charges found on 
the protein. Free amino acids, peptides and low molecular weight proteins do not 
produce colour with coomassie dye reagents (Bradford, 1976).  
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Figure 5.9 Chemical structure of Coomassie Blue G-250 
When Coomassie blue G-250 (figure 5.7) binds to proteins in acid solution, it has an 
absorbance shift from 465 nm to 595 nm. The absorbance data can then be used in 
Beer's law to determine protein concentration and ultimately the actual amount of 
protein in a given solution.  
The main disadvantage concerning this assay is the possibility to record some 
protein based material although no viable cells are present. The assay is very prone 
to influences from non protein sources, particularly detergents, and becomes 
progressively more non-linear at high protein concentrations (Borenfreund, 2006).  
The main advantage for multi-endpoint cytotoxicity studies is that after the 
absorbance/ fluorescence of another dye has been established, total cell protein can 
be measured on the same test cells using Coomassie dye.  
Figures 5.10, 5.11 and 5.12 display the cytotoxic response curves obtained for 50nm 
Duke Scientific nanopolystyrene, 40nm carboxylated Invitrogen Nanopolystyrene 
and 60nm aminated nanopolystyrene, respectively using the Comassie Blue assay.  
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Cytotoxicity results of toxicity to A549 cells after 24, 48, 72 and 96 hour exposures of 
50nm nanopolystyrene, determined by the Coomassie Blue assay, can be seen in 
figure 5.10. As can be seen for the diagram, particles did not induce any cytotoxic 
effects as measureable by the Coomassie Blue assay. As with previous assay 
conducted, particle concentration did not have an effect on the ability viable protein 
molecules within the cell to bind to the CB dye ligands. The results show that the 
exposure of the 50nm nanopolystyrene particles to A549 cells did not interfere with 
viable cells ability to produce amino acids, therefore, not having an effect on the cells 
function or proliferation.  
 
Figure 5.10 Cytotoxicity of 50 nm Duke Scientific Nanopolystyrene to A549 cells 
after 24, 48, 72 and 96 hour exposures determined by the CB assay. Data are 
expressed as percent of control mean ± SD of three independent experiments. 
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40 nm carboxylated nanopolystyrene exposed to A549 cells over a time range of 24 
– 96 hours also produced no cytotoxicity effects as measured by the CB assay as 
can be seen in Figure 5.11. Amino acid production within viable cells was not 
disrupted. This can be seen in the absorbance values obtained. Because the number 
Coomassie dye ligands bound to each protein molecule is approximately 
proportional to the number of positive charges found on the bound protein, 
absorbance values obtained of cells exposed to particles in percentage comparison 
to control, show that a high number of proteins within the viable cells bound to the 
dye ligands proving that protein production was not effected and no toxicity was 
induced from exposure to particles.   
 
Figure 5.11 Cytotoxicity of 40nm carboxylated Invitrogen Nanopolystyrene to A549 
cells after 24, 48, 72 and 96 hour exposures determined by the CB assay. Data are 
expressed as percent of control mean ± SD of three independent experiments.  
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Cytotoxicity results of toxicity to A549 cells after 24, 48, 72 and 96 hour exposures of 
60nm aminated nanopolystyrene, determined by the Coomassie Blue assay, can be 
seen in figure 5.12.  
As observed with previous assays, the highest test concentration of aminated 
nanoparticles is observed as causing cytotoxicity to A549 cells over a 24 to 96 hour 
exposure period. The concentration of 1x1012 ppml is found to induce a cytotoxic 
response from cells, with the highest level of toxicity found after 96 hours of 
exposure.  
After 96 hours, it can also be observed for the concentration of 5x1011 ppml, that a 
slight degree of cytotoxicity is experienced by A549 cells. Due to the nature of the 
Coomassie Blue assay, these toxicity results show less bonding of dye ligands, 
indicating that protein production of viable cells after exposure has been effected.  
As with the previous Alamar Blue assay, the findings from this assay in also in 
keeping with literature reports that aminated nanopolystyrene can cause toxicity in 
cells.   
 
Page 124 
 
Chapter 5 
 
Figure 5.12 Cytotoxicity of 60nm Aminated nanopolystyrene to A549 cells after 24, 
48, 72 and 96 hour exposures determined by the CB assay. Data are expressed as 
percent of control mean ± SD of three independent experiments 
 
For the cytotoxicity curves obtained for all particles, the standard deviation error bars 
are relatively large, indicating the Coomassie Blue assay may not have been as 
consistently stable as other assays performed.  
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5.5 MTT Assay  
The MTT colorimetric assay determines the ability of viable cells to reduce the 
soluble, yellow tetrazolium salt [3-(4,5-dimehtylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] (MTT) into an insoluble, purple formazan precipitate which can be 
solubilised by the addition of an organic solvent and quantified spectroscopically. 
Tetrazolium salts accept electrons from oxidized substrates or enzymes, such as 
NADH and NADPH. Reduction of MTT takes place at the ubiquinone and 
cytochrome b and c sites of the mitochondrial electron transport chain due to 
succinate dehydrogenase activity, figure 5.13. [17].  
 
       MTT (yellow tertazole salt)       Formazan 
Figure 5.13 Reduction of yellow tetrazole to purple formazan when reductase 
enzymes are active in living cells.  
 
Applications for the MTT assay include drug sensitivity and cytotoxicity. The assay is 
considered rapid, safe, versatile, quantitative, and highly reproducible with an intra-
test variation between data points of only +/- 15 percent. For each cell type, a linear 
relationship between cell number and absorbance can be established, enabling 
accurate quantification [18].  
 
Page 126 
 
Chapter 5 
The main disadvantage to the use of tetrazolium salts are their cytotoxicity. To 
solubilise the formazan crystals, solvents such as dimethylsulfoxide (DMSO) or 
HCl/isopropanol have to be used. This treatment results in destruction of 
investigated cells, allowing only a single time point [19]. Addition of DMSO destroys 
the cell membrane and results in liberation and solubilisation of the formazan 
crystals. The number of viable cells is thus directly proportional to the level of the 
initial formazan product created and can be quantified by measuring the absorbance 
at 570 nm (Magrez et al., 2006).   
Figures 5.14, 5.15 and 5.16 display the cytotoxic response curve obtained for 50nm 
Duke Scientific nanopolystyrene, 40nm carboxylated Invitrogen Nanopolystyrene 
and 60nm aminated nanopolystyrene, respectively using the MTT assay.  
As can be seen from figure 5.14, 50nm nanopolystyrene did not induce cytotoxic 
effects on A549 cells after exposures between 24 and 96 hours. The reduction of 
MTT to formazan within cells serves as an estimate for the number of mitochondria 
and hence the number of viable cells after exposure to nanoparticles. 50nm particles 
did not interfere with the production of NADH and NADPH nor had any effect on 
mitochondrial electron transport chains, as is seen from the absorbance 
measurements made for the assay.  
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Figure 5.14 Cytotoxicity of 50 nm Duke Scientific nanopolystyrene to A549 cells 
after 24, 48, 72 and 96 hour exposures determined by the MTT assay. Data are 
expressed as percent of control mean ± SD of three independent experiments.  
 
This is also applicable for the determination of cytotoxicity of 40nm carboxylated 
nanopolystyrene as can be seen in figure 5.15. The results show that A549 cells 
exposed to 40nm particles over exposure times of 24hr, 48hr, 72hr and 96hr were 
not affected and experienced no toxic effects. The tetrazolium salt is cleaved to 
formazan by a complex cellular mechanism that occurs primarily at the surface. This 
bioreduction is mostly dependent on the glycolytic NAD(P)H production of viable 
cells. The results show no decrease in the amount of reduced MTT to formazan dye, 
therefore, the absorbance of dye formed, directly correlates to the number of 
metabolically active cells not affected by exposure to particles.  
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Figure 5.15 Cytotoxicity of 40nm carboxylated Invitrogen nanopolystyrene to A549 
cells after 24, 48, 72 and 96 hour exposures determined by the MTT assay. Data are 
expressed as percent of control mean ± SD of three independent experiments.  
 
Cytotoxicity results of toxicity to A549 cells after 24, 48, 72 and 96 hour exposures of 
60nm aminated nanopolystyrene, determined by the MTT assay, can be seen in 
figure 5.16.  
Because the amount of reduced MTT to formazan dye directly correlates to the 
number of metabolically active cells, it can be observed from the graph that the 
highest test concentration of 1x1012 ppml of 60nm aminated particles causes a 
reduction in the number of metabolically active cells, hence inducing a toxic 
response from A549 cells over the exposure period of 24 to 96 hours.  
As was observed with other assays, the second highest test concentration of 5x1011 
ppml also induced a lesser amount of toxicity when exposed to cells. The toxicity to 
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viable cells when exposed to this concentration can be seen to increase over the 
exposure time periods, with 96hr exposure inducing the greatest level of toxicity, at 
this concentration.  
 
Figure 5.16 Cytotoxicity of 60nm Aminated nanopolystyrene to A549 cells after 24, 
48, 72 and 96 hour exposures determined by the MTT assay. Data are expressed as 
percent of control mean ± SD of three independent experiments 
 
As with all other assays performed, the results found for the highest test 
concentration of nanoparticle per ml were found to be in keeping with literature 
reports of the toxicity of aminated nanoparticles.  
Cytotoxicity data obtained for 100 nm neutral nanopolystyrene and 100nm 
carboxylated nanopolystyrene are not presented in this chapter. The cytotoxicity data 
obtained revealed the same results as particles of the same surface charges with 
smaller sizes. It was felt it was unnecessary to present and discuss large amounts of 
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similar results, as to not overload the reader with data and graphs that repeat results 
obtained.  
100nm neutral nanopolystyrene and 100nm carboxylated nanopolystryene were both 
found to have no cytotoxic effects on A549 cells after exposure times of 25, 48, 72 
and 96 hours. This nontoxic response was confirmed through all assays performed. 
The cytotoxic response curves obtained indicates no effect on proliferation or cell 
growth (Alamar Blue assay), no effect on cell viability (Neutral Red assay), no effect 
on the protein content of viable cells (Coomassie Blue assay) and no decrease in 
metabolic activity of cells (MTT assay) with particle concentration or exposure time 
having no cytotoxic effect.  
These findings are in keeping with literature, with neutral and carboxylated 
nanopolystyrene particles being reported as having no toxicity [12] [20] [21].   
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5.6 Clonogenic Studies  
The clonogenic assay was employed as an indication of the interference of particles 
on single cells to form colonies. As explained in more detail in Chapter 3, Section 
3.4.6, single cells were seeded and exposed to a range of concentrations of both 
particles and the effects monitored.  
40nm Carboxylated Invitrogen Nanopolystyrene and 50nm Duke Scientific 
Nanopolystyrene particles were exposed to A549 cells for 10 days. The results of 
which can be seen in figure 5.12.The results reveal that no toxicity was induced over 
the period of 10 days, for either particle, and particles did not have an affect on the 
ability of cells to form colonies.  
Figure 5.12 Cytotoxicity of 40nm Carboxylated Invitrogen Nanopolystyrene and 
50nm Duke Scientific Nanopolystyrene to A549 cells after 10 day exposures 
determined by the clonogenic assay. 
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As can be seen from figure 5.12, 40nm Carboxylated Invitrogen Nanopolystyrene 
and 50nm Duke Scientific Nanopolystyrene particles did not have an effect on colony 
formation when exposed to A459 cell for 10days.  
This clonogenic assay results provide valuable information, by verifying that the 
tested nanoparticles do not induce cytotoxic affects over a longer period of exposure 
time than other assays used.  
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5.7 Chapter Summary 
This chapter has highlighted the results obtained for the in vitro cytotoxicity of 50nm 
neutral, 40nm carboxylated and 60nm aminated nanopolystyrene. The cytotoxicity 
evaluation revealed through the use of Alamar Blue™ (AB), Neutral Red (NR), 
Coomassie Blue (COOMASSIE) and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and clonogenic assays that the 50nm neutral and 
the 40nm carboxylated nanoparticles induced no cytotoxic effects when exposed to 
A549 cells over a range of concentration and time points. The presented results in 
this chapter have comprehensively confirmed, in keeping with the reported literature 
findings, that neutral nanoparticles, of sizes 50nm and 100nm, and carboxylated 
nanoparticles, of sizes 40nm and 100nm, do not induce cytotoxic effects when 
exposed to A459 cells over a time range of 24 to 96 hours using conventional 
cytotoxicity assays.  
However, cytotoxicity results of A549 cells exposed to a range of concentration of 
60nm aminated nanopolystyrene after 24, 48, 72 and 96 hour exposures, revealed at 
some concentrations, the particle does induce toxic effects on the cell. As observed 
throughout all assays performed, the highest test concentration of 1x1012 ppml 
induced toxic effects on A549 cells over the 24 to 96 hour exposure time points, with 
the second highest test concentration of 5x1011 ppml causing toxicity to a lesser 
degree. This highest test concentration of particles (1x1012) was observed by Alamar 
Blue assay as having a toxic effect on the proliferation of healthy cells, with the 
largest degree of toxicity observed at the 96 hr time point. Similarly, the particle was 
found to have a toxic effect on the viability of healthy cells (NR assay), with the 
particle concentration also found to effect the protein production and content of 
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viable cells as measured by the Coomassie Blue assay. Finally, the MTT assay 
confirmed that 1x1012 ppml of 60nm aminated nanoparticles had an effect on the 
overall metabolic activity of healthy cells; hence concluding that at concentrations of 
1x1012 ppml cytotoxic effects were experienced by A549 cells, with the second 
highest concentration of 5x1011 ppmlhaving a slightly less toxic effect on cells.  
Although conventional colorimetric and luminescence based assays give an 
indication of the effect on proliferation and viability as well as organelle damage, they 
fail to recognise that although some nanoparticles may not produce immediate or 
semi-long term (10 days) toxic effects, nanoparticles have the ability to localise 
within cells and cell organelles. The ability of nanoparticles to penetrate cell 
membranes and translocate within cell organelles has been notably documented, 
which is where conventional assays fail in their attempt to give a full toxicological 
profile. Assays for screening on cell viability and cell number based on colorimetric, 
fluorescent and chemiluminescent detection may prove to be insufficient in the long 
term determination of nanoparticle toxicity [2]. Specific assays for membrane 
damage, generation of oxidative stress, mitochondrial damage, proliferation and 
apoptosis do allow insight into the mechanism of the toxic effect [1]. However, for 
nanomaterials that do not induce any of these effects short term, information about 
the exact migration and accumulation is imperative. Currently, there are various 
microscopic techniques, such as phase contrast, epifluorescence and confocal 
fluorescence microscopy analysis used to examine the co-localization of cell damage 
and particle-uptake and particle accumulation. Mapping of particles to organelles is 
also possible, which provides nanotoxicologists with a further understanding of 
nanoparticle behaviour once cell internalisation has been observed [22] [21].  
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The following chapter will explore the penetration and internalisation of 50nm and 
100 nm nanopolystyrene, 40nm and 100nm carboxylated nanopolystyrene within 
A549 lung cells through various microscopy and spectroscopy techniques. Particle 
accumulation within cell organelles will also be examined.  
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6.1 Introduction 
One of the major concerns regarding the possible long-term toxic effects of 
nanoparticles is the capacity of these materials to penetrate cells and possibly 
translocate to other cells around the body.  Conventional cytotoxicity assays do give 
an indication of interference to cell proliferation, viability, metabolic activity, 
lysosomal and mitochondrial activity. However, they fail to give a verification of 
internalisation of particles, or to what degree particles become internalised within 
cells. Penetration and internalisation of nanoparticles within cells and any associated 
toxicity to humans is still relatively unexplored. However, there are numerous studies 
that have demonstrated the ability of nanoparticles to cross membranes and 
internalise within many different cell types [1] [2]. A greater understanding of the 
migration of nanoparticles from organelle to organelle, cell to cell and essentially 
from one part of the body to another is needed, along with information on the 
translocation of nanoparticles within organelles. If information was available on the 
exact migration patterns of different types of nanoparticles within cells or around the 
body, this would be of enormous value in areas of nanomedicine and bio-
nanotechnology.  
In understanding possible mechanisms of nanoparticle uptake by cells, one must first 
examine how a cell regulates the uptake of substances. In order for a substance to 
enter a cell’s interior, it must pass through the diffuse layer surrounding the cell and 
the plasma membrane which segregates the internal and external environments of a 
cell and regulates the entry and exit of substances into and out of the cell. The 
uptake mechanisms employed by cells have been discussed in more detail in 
Chapter 2 Section 2.2.2.  It is known that size, shape and surface area all play a role 
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in determining the route of cellular uptake of liposomes, viruses and nanopolymers 
[3]. The sizes of many nanoparticles are similar to those of biological 
macromolecules such as proteins and DNA, as well as biological structures such as 
bacteria and viruses, all of which are readily taken up by cells, including lung cells.  
However, conventional assays do not take such physio-chemical properties into 
consideration and so questions remain as to what the effects are of particle 
accumulation within cell organelles and the subsequent effect on whole body 
organisms. It is thus proposed that in order to appropriately build a toxicological 
profile of a particle, a series of internalisation studies to both identify and assess the 
potential of nanoparticles to accumulate in cells and cellular structures must 
accompany the aforementioned cytotoxicity assays.  
A number of methods exist to monitor cellular internalisation and uptake, the most 
commonly employed being confocal microscopy. Advances in confocal microscopy 
have led to the ability to monitor the internalisation of nanoparticles both in vitro and 
in vivo [4], using a variety of spectroscopic detectors coupled to the microscope e.g. 
fluorescence and Raman spectroscopy. There are however a number of limitations 
to the use of confocal microscopy, some of which are listed below.  
 
1. As with conventional microscopy, confocal microscopy has inherent resolution 
limitations due to diffraction and the Rayleigh criterion.  
2. Confocal laser microscopy works on a point by point basis rather than imaging 
the entire sample, thus limiting the range of visibility. Commonly confocal 
laser scanning instruments raster the field of view to produce an image. 
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3. Particles within cells must be optically active e.g. intrinsically fluorescent or 
fluorescently labelled for Confocal Laser (fluorescence) Scanning Microscopy 
(CLSM).   
4. The optical sectioning capability of a confocal microscope derives from having 
a pinhole to reject out-of-focus light rays. As the pinhole size is reduced, so 
too are the number of photons that arrive at the detector from the specimen. 
This may lead to a reduced signal-to-noise ratio. To offset the weaker signal, 
more fluorescence is needed from the specimen. This usually can be done, to 
a limit, by raising the intensity of the excitation light. But high intensities can 
damage the specimen, and in the case of fluorescence, also degrade the 
fluorophore.  
5. Among the most important aspects of confocal fluorescence microscopy is the 
choice of fluorophore. It is typically influenced by several factors. The 
fluorophore must be sensitive enough for the given excitation wavelength, the 
fluorescence of the emitted light must be intense enough, etc.   
Throughout this study, confocal laser fluorescence scanning microscopy was 
employed to monitor the internalisation of 40nm and 100nm carboxylated 
nanopolystyrene and 50nm and 100 nm nanopolystyrene, after they have undergone 
exposure to A549 carcinogenic lung cells over various time points. The precise 
intracellular migrations of nanoparticles within specific regions of single cells were 
confirmed by 3D multicolour measurement, known as a Z-Stack. These single cell 
molecular morphology measurements provided confirmation that 40nm carboxylated 
nanopolystyrene and 50 nm nanopolystyrene had penetrated cell membranes and 
were internalised within individual cells. The 60nm aminated nanopolystyrene 
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particles were not available in a fluorescently labelled form and thus were not 
studied. However, confocal Raman spectroscopy was also used to confirm 
internalisation of nanopolystyrene particles within A549 lung cells, independent of 
any label, and will be discussed in more detail in the following chapter.  
 
6.2 Confocal Microscopy of Nanoparticles Within Cells 
Confocal microscopy was employed to investigate the internalisation of fluorescent 
nanoparticles within A549 cells. Confocal microscopy, along with the uses of 
molecular probes and biological dyes, is a conventional method in bio-imaging and 
has of late been extensively used in the monitoring of nanoparticle up-take by cells 
[5] [6]. In order to study the exact localisation and possible pathways taken by 
nanoparticles within cells, it is possible to expose cells to fluorescently labelled 
nanoparticles and track their fate after cell penetration. Co-localisation with organelle 
specific stains can help to identify the specific intracellular fate of the particles. It also 
gives the possibility to examine morphogenetic behaviours within specific cell 
populations of interest.  
The use of confocal microscopy for the monitoring of internalisation of fluorescent 
nanoparticles has been widely documented. In a study to investigate the 
incorporation of fluorescent 20-nm polystyrene NPs into early endosomes within 
human hepatocyte cell lines (C3A and HepG2), confocal microscopy was extensively 
used for the monitoring imaging of internalisation of particles, and is a widely 
accepted technique for the monitoring of fluorescent imaging of cells. [1] 
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The imaging of polystyrene particle uptake by live A549 cells was carried out in 0.9% 
saline solution. The exact specifications under which images were obtained were 
discussed in detail in Chapter 3, Section 3.7. Intracellular accumulation of 40nm and 
100nm carboxylated Invitrogen nanopolystyrene and 50nm and 100nm Duke 
Scientific nanopolystyrene particles after 4hr and 24 hr exposure was examined in 
A549 cells by imaging live cells in a 0.9% sterile saline solution. The confirmation of 
internalisation of 40nm carboxylated nanoparticles and 50nm nanoparticles was 
obtained by combining “z-stack” image series cutting through the cell in single z-
steps of approximately 10 µm along with the generated orthogonal projection 
obtained from the z- stack image series of the cells. The 60nm aminated particles 
that were used throughout the rest of the study were not monitored using confocal 
microscopy due to the unavailability of fluorescently labelled particles within the size 
range and surface charge required.  
6.2.1 Carboxylated Nanopolystyrene 
Figure 6.1 shows an image of A549 cells exposed to 40nm carboxylated Invitrogen 
nanopolystyrene after a 4 hour exposure period. The image shows a fluorescent 
confocal image on the left and a bright-field image of the same cells showing no 
fluorescence on the right. After 1 hour exposure, particles were found to be 
aggregated upon the cell membrane with few particles present within the cell (not 
shown). However, the number of aggregates was observed to increase over time 
and accumulations of internalised particles were visible after 4 hours (figure 6.1).  
Surface aggregates of nanoparticles can be seen in the confocal image labelled (a) 
while internalised nanoparticles are labelled (b).  
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Figure 6.1 A549 cells exposed to 40nm carboxylated Invitrogen nanopolystyrene 
x40 magnification after 4 hour exposure. (a) Surface aggregates nanoparticles. (b) 
Internalised nanoparticles.   
 
The image obtained for the uptake of 40nm carboxylated particles by A549 cells after 
24hrs can be seen in figure 6.2. From the confocal image, it can be seen that the 
distribution of the localisation evolves over time. Nanoparticles within the cells are 
gathered in cluster like accumulations resembling cell organelles, such as 
lysosomes. As previously discussed in chapter 2 section 2.2.3, nanoparticles are 
taken up by the cell in a number of possible ways. Clathrin-mediated endocytosis is 
one such possible way in which nanoparticles have been shown to be taken up by 
cells [7]. Nanoparticles or macromolecules, while undergoing this form of uptake, 
enter the cell in clathrin-coated vesicles known as endosomes. These endosomes 
then fuse to form lysosomes [8]. The accumulation of nanoparticles over time within 
lysosomes may explain the difference in fluorescence distrubtion after different 
exposure times.  
a   
a   
b   
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Figure 6.2 A549 cells exposed to 40nm carboxylated Invitrogen nanopolystyrene 
x60 magnification after 24 hour exposure. (a) Accumulations resembling possible 
lysosomal cell organelles 
 
Over both exposure periods, cells observed remained healthy and regular in size. 
Cell membranes and nuclei could be observed. 40 nm particles were not observed 
within the nucleus, as can be seen in the fluorescent confocal image in figure 6.1 
and 6.2, with confirmation of their absence from the nucleus revealed from the z-
stack imaging (figure 6.3). Figure 6.3 shows a gallery view of confocal slices through 
the volume of an A549 cell exposed to 40nm carboxylated Invitrogen 
nanopolystyrene after 24hrs. From the images it can be seen that the fluorescence 
signal originates from the cell interior and not from material adhered to the surface. 
The optical slices reveal that the accumulation of particles is greatest within the 
interior of the cell.  
a   
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Figure 6.3 Gallery view of 24 hr exposure of 40nm carboxylated Invitrogen 
nanopolystyrene internalised within A549 cells from Z-stack process. 
 
This z-stack imaging provides confirmation that the 40nm particles are internalised 
with the cells and have penetrated through the cell membrane.  Figure 6.4 shows the 
z,x section (upper panel) and the z,y section (right panel) cutting orthogonally 
through the cell obtained from the z-stack image series of the cells. Nanoparticles 
were observed in perinuclear clusters within cells, as most of the aggregates 
appeared to be situated around but external to the nucleus (24hr exposure).  
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Figure 6.4 Orthogonal-view through A549 cell exposed to 40nm carboxylated 
Invitrogen nanopolystyrene (24hr).  
 
This optical slicing of the 3D image of the cell represents an x, y, z slicing of a single 
cell exposed to the 40nm particles. From this image it can be concluded that 
particles are dispersed throughout the cell and not attached to the outer membrane. 
The image also gives an indication of the degree of dispersion of particles within the 
cell. There does not appear to be a spatially uniform fluorescence from the cells, but 
Z – Axis  
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rather it is concentrated in small areas, indicating that particles are 
compartmentalised within organelles and not just dispersed around the cytoplasm.  
 
A similar behaviour is seen in A549 cells after exposure to 100nm carboxylated 
nanoparticles after 4 hours as shown in Figure 6.5. Particles can be seen to be 
internalised within cells. After 24 hours, the nanoparticles had internalised to a 
greater extent than shorter exposure times, indicated by the apparent increase in 
fluorescence intensity of aggregated spots that can be seen in figure 6.6.  
 
Figure 6.5 A549 cells exposed to 100nm carboxylated Invitrogen nanopolystyrene 
x40 magnification after 4 hour exposure.  
 
As was observed for the 40nm particles, accumulations of the 100nm carboxylated 
nanoparticles appeared to be greater in, but not exclusive to, areas that resemble 
lysosomal cell organelles, labelled (a) in figure 6.6. The bright-field image in figure 
6.6 shows circular cell organelles that resemble lysosomes or possibly the 
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endoplasmic reticulum. Fluorescence was not visible within the interstitial space of 
the cell, but rather in aggregated spots around the cell.  
 
Figure 6.6 A549 cells exposed to 100nm carboxylated Invitrogen nanopolystyrene 
x40 magnification after 24 hour exposure. a) Accumulations resembling possible 
lysosomal cell organelles 
 
As previously discussed, particles taken up by cells by possible clathrin-mediated 
endocytosis firstly enter the cell within endosomes, which then mature to form 
lysosomes [9] . Because lysosomes function as the digestive system of the cell, 
serving both to degrade material taken up from outside the cell and to digest 
obsolete components of the cell itself, it is to be expected that nanoparticles are 
engulfed by these organelles shortly after cellular up-take. There have been several 
studies to show the intracellular accumulation of polymer nanoparticles within 
lysosomes. A study to examine the intracellular import of polymeric nanoparticles 
and small molecules by Salvati at al (2011) found that nanopolystyrene was co-
localised within lysosmes shortly after exposure to cells. Similarly, an examination of 
a
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the intracellular fate of hydrophobically modified glycol chitosan (HGC) nanoparticles 
after exposure to HeLa cells, showed co-localisation of nanoparticles within 
lysosomal vesicles, and eventually migration of the nanoparticles toward the 
perinuclear region [9]. The images presented here appear to be consistent with 
literature reports. However, the exact co-localisation of nanoparticles within specific 
cell organelles will be investigated further and discussed later in the chapter.  
6.2.2 Neutral Nanopolystyrene 
The confocal images of A549 cells, after exposure to 50nm, neutral Duke Scientific 
nanopolystyrene can be seen in figures 6.7 (4hr exposure) and 6.8 (24hr exposure). 
The figures show a fluorescent confocal image on the left and an bright-field image 
of the same cells showing no fluorescence on the right. The observations indicate 
that, compared to the carboxylated nanopolystyrene, 50nm neutral nanoparticles 
were rapidly internalised, as fluorescence could be visualised in the cytoplasm and 
interstitial space within 1 hour (not shown). Within 4 hours, particles were highly 
localised within, what appear to be, lysosomal compartments. Aggregates were 
observed to increase over the exposure time, with nanoparticles observed to 
preferentially accumulate in compartments located around the nucleus and within 
and between cell organelles on a timescale of 12-24hrs. Nanoparticles were present 
in all of the cells analysed, appearing as aggregates within the cell after 4 hours, 
indicating that the uptake was accomplished in a relatively short period of time. 
There are small concentrated areas where the fluorescence is stronger, indicating 
that particles are compartmentalised within organelles, such as lysosomes, as well 
as dispersed around the cytoplasm. The images reveal there is an overall 
fluorescence distribution that appears from all parts of the cell, with the exception of 
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the nucleus. The fluorescence observed from the particles suggest that particles 
have penetrated up to the nuclear membranes, which are visible, labelled (b) in 
figure 6.7. Notably, the fluorescence distribution of the 50nm neutral nanoparticles 
can be seen to be very different to that observed of the 40nm and 100 nm 
carboxylated nanoparticles. Unlike the 40nm and 100nm carboxylated nanoparticles, 
the fluorescence distribution of the 50nm neutral nanoparticles is much more diffuse, 
the interstitial space within cells appearing to be highly fluorescent.  
From the confocal images, figures 6.7 and 6.8, it can be seen that particles within the 
cell are highly fluorescent. There are larger areas within the cell, labelled (a), which 
appear to be of greater fluorescent intensity than surrounding areas, suggesting 
particles are accumulated within cell organelles, such as lysosomes or the 
endoplasmic reticulum.  The images reveal that fluorescent labelling of nuclear or 
vesicle membranes may have occurred (figure 6.7). In a study to evaluate the fate of 
TiO2 particles within A549 epithelial cells, particles were found to be contained in 
membrane bound vesicles in cells (Stearns et al., 2001), suggesting the potential of 
nanoparticles to enter vesicle membranes. Figure 6.7 reveals the possible 
penetration of 50nm fluorescent particles within vesicle or nuclear membranes. 
However, further investigation using fluorescent specific organelle labelling kits 
would be needed to confirm this possibility. 
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Figure 6.7 A549 cells exposed to 50nm neutral Duke Scientific nanopolystyrene x20 
magnification after 4 hour exposure. (a) Possible lysosomal structure (PLS). (b) 
Possible labelling of nuclear / vesicle membranes (PNM).  
 
 
Figure 6.8 A549 cells exposed to 50nm neutral Duke Scientific nanopolystyrene 
x100 magnification after 24 hour exposure. (a) perinuclear clusters (PNC) of 
nanoparticles around nucleus.  
 
a  (PLS) 
(PNM)  b 
a  (PNC) 
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50nm particles were not observed within the nucleus, as can be observed in the 
fluorescent confocal images previously shown (figures 6.7, 6.8), with confirmation of 
their absence from the nucleus revealed from the z-stack imaging (figure 6.9). Figure 
6.9 shows a gallery view of confocal slices through the volume of an A549 cell 
exposed to 50nm Duke Scientific nanopolystyrene. From the images, it can be seen 
that the fluorescence signal originates from the cell interior and not from material 
adhered to the surface. The optical slices reveal that the accumulation of particles is 
greatest within the centre of the cell. The absence of fluorescence from the nuclear 
area indicates that particles did not penetrate the nuclear membrane.  
 
Figure 6.9 Gallery view of 50nm neutral Duke Scientific nanopolystyrene internalised 
within A549 cells from Z-stack process after 24hr exposure.  
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This z-stack imaging provides confirmation that the 50nm particles are internalised 
with the cells and have penetrated through the cell membrane.  Figure 6.10 shows 
the z,x section (upper panel) and the z,y section (right panel) cutting orthogonally 
through the cell obtained from z-stack image series of the cells. Nanoparticles were 
observed in perinuclear clusters within cells, as most of the aggregates appeared to 
be situated around the nucleus. Figure 6.10 shows the z,x section (upper panel) and 
the z,y section (right panel), obtained from z-stack image series of the cells, cutting 
orthogonally through the cell. This optical slicing of the 3D image of the cell 
represents an x, y, z slicing of a single cell exposed to the 50nm particles, confirming 
that the particles are dispersed throughout the cell and not attached to the outer 
membrane.  
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Figure 6.10 Orthogonal view through A549 cell exposed to 50nm neutral Duke 
Scientific nanopolystyrene after 24hr exposure.   
 
A comparison of the z-stack images of the 40nm carboxylated nanoparticle (figures 
6.3 and 6.4) and the 50nm neutral nanoparticle (figures 6.9 and 6.10) confirms a 
significant difference in the subcellular distribution of the fluorescence of the 
respective nanoparticle samples. The 50nm neutral nanoparticle z-stack images 
display a much more diffuse fluorescence distribution when compared to the z-stack 
images of the 40nm carboxylated nanoparticles, which reveal accumulations of 
smaller fluorescent areas within the cells.  
 
Z- Axis  
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Figures 6.11 and 6.12 show A549 cells after exposure to 100nm Duke Scientific 
nanopolystyrene after 4 and 24 hrs respectively. The images show a fluorescent 
confocal image on the left and an bright-field image of the same cells showing no 
fluorescence on the right. As can be seen in figures, fluorescence intensities were 
greatest in areas around the nucleus, labelled (a). These aggregates appeared in 
perinuclear clusters. The accumulations around the nucleus suggest that particles 
have penetrated into the endoplasmic reticulum. The observations indicate that 
100nm neutral nanoparticles were rapidly internalised, as fluorescence could be 
visualised in the cytoplasm and interstitial space within 1 hour (not shown). As for the 
case of the 50nm neutral particles, however, the fluorescence is highly visible within 
the interstitial space of the cell, as well as in accumulated spots around the cell, as 
can be seen in figure 6.12. Fluorescence appeared to be more uniformly dispersed 
throughout the cell after the longer exposure times.  The fluorescence that appears 
more intense in perinuclear clusters may be due to the migration of nanoparticles 
toward the endoplasmic reticulum after internalisation within lysosmes [9].  
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Figure 6.11 A549 cells exposed to 100nm neutral Duke Scientific nanopolystyrene 
x40 magnification after 4 hour exposure. (a) perinuclear clusters of nanoparticles 
around nucleus 
 
 
 
Figure 6.12 A549 cells exposed to 100nm neutral Duke Scientific nanopolystyrene 
x40 magnification after 24 hour exposure. (a) perinuclear clusters (PNC) of 
nanoparticles around nucleus. 
 
a  
a  (PNC) 
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6.2.3 Discussion 
Although the confocal laser scanning microscopy studies indicated that both 
carboxylated and neutral polystyrene nanoparticles were readily taken up by A549 
cells in vitro, some striking differences in the behaviour of the two nanoparticle types 
were apparent. 
The uptake and migration time of 50nm and 100nm particles through the cell was 
considerably faster than that of the 40nm and 100nm carboxylated particles. 
Furthermore, the 50nm and 100nm neutral particles were seen result in a 
significantly different distribution of fluorescence than the 40nm and 100nm 
carboxylated particles. Whereas the latter appeared to be explusively 
compartmentalised, the former produced a fluorescence which was diffused over the 
entire cell volume, up to the nuclear membrane, in addition to a more localised 
fluorescence concentration.  
The migration time of carboxylated nanoparticles through the cell is known to be 
slower than that of neutral nanoparticles, which is most likely due to their anionic 
surface properties [10]. The extracellular surface of the plasma membrane is 
negatively charged due to the negative charge on the phospholipid heads. 
Therefore, the surface of the membrane could influence the way in which charged 
particles interact with the cell membrane. However, superimposed on this is an 
overall intracellular negative charge, caused by unequal distribution of ions across 
the plasma membrane driven by the activity of ion channels and pumps. The cell 
uses this negative electrical membrane potential to drive the transport of substances, 
often against a concentration gradient into or out of the cell. These factors potentially 
contribute to a relatively slow uptake of the negatively charged 40nm carboxylated 
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Invitrogen nanopolystyrene. The negative intracellular charge would also have an 
effect on the transportation rates of the negatively charged 40nm and 100nm 
carboxylated nanoparticles around the cell, once particles have been internalised.  
Neutral nanopolystyrene particles, 78nm in size, have been demonstrated to enter 
macrophages and red blood cells by a non-endocytic process, so that uptake may be 
mediated via diffusion or another unidentified mechanism [11]. Passive diffusion is 
usually driven by an electrochemical or concentration gradient, which results in the 
selective permeability of low molecular weight substances into the cells lipophylic 
plasma membrane. Facilitated diffusion is another form of passive transport which 
allows for substances to pass from an area of high to low concentration through 
selective membrane protein channels. No metabolic energy is required as cell entry 
is driven by the concentration gradient. Movement of nanoparticles into the cell via 
these means could explain the rapid uptake of neutral 50nm particles by cells. The 
cell would require no energy as particles were passively taken up, which may also 
explain why a larger volume of neutral Duke Scientific nanoparticles were 
internalised to a greater degree than carboxylated Invitrogen nanoparticles.  
However, from confocal images obtained of 50nm and 100nn neutral Duke Scientific 
nanopolystyrene particles, the fluorescence dispersion may also indicate there is 
some possible leaching of dye from the particles. Intracellular fluorescence from 
dispersions with molecular dye (or from the labile molecular dye fraction of a 
nanoparticle sample) increases rapidly via conventional physical transport, and is 
barely energy dependent. The fluorescence is then distributed between 
compartments in the cell, (and for this and many other hydrophobic dyes) mostly in 
the endoplasmic reticulum. Fluorescence accumulation is reversible; exposure to the 
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dye leads to a steady state intracellular concentration, with partitioning between the 
compartments. [12], [13].   
In a recent study by Salvati et al (2011), the uptake of labile dye from labelled 
manufactured nanoparticles by cells was examined. The study concluded that, for 
some commercially available samples, the uptake of fluorescence, for fluorescently 
labelled nanopolystyrene, was dominated by the presence of labile dye, rather than 
by the particles themselves. The authors also examined the uptake of pure 
fluorescent dye, concluding that fluorescence saturation is suggestive of a simple 
equilibration across a semi-permeable membrane. Dead and energy depleted cells 
were also found to reveal similar results as those for healthy cells after exposure to 
nanoparticles containing fluorescent dye and fluorescent dye only, suggesting that 
the fluorescent intensity is the result of the physiochemical process of diffusion 
across the cell membrane of the dye, which occurs without the cells expending 
energy [8].   
This uniform dispersion of the fluorescent 50nm and 100nm Duke Scientific 
nanopolystyrene around the cell, as discussed, may thus be accounted for by the 
leakage of fluorescent dye from the nanoparticles. Some regions of localised 
fluorescence, similar to those observed for the Invitrogen nanoparticles, are 
observable, and may be true indications of internalised nanoparticles. The study 
clearly demonstrates, however, than confocal imaging of the fluorescent lables them 
selves is not an unambiguous confirmation of the presence and distribution of 
nanoparticles in cells. 
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6.2.4 Summary of Nanoparticles Confocal Imagary  
The internalisation of 40nm and 100nm carboxylated Invitrogen nanopolystyrene 
50nm and 100nm Duke Scientific nanopolystyrene into A549 lung cells was 
observed. Fluorescent and bright-field images revealed 40nm and 100nm 
carboxylated nanoparticles accumulated into cellular organelles that resemble 
possible lysosomes after exposure times of 24hours. 40nm carboxylated 
nanoparticles examined were not observed within the nucleus as was revealed by 
combining “z-stack” image series cutting through the cell in single z-steps of 
approximately 10 µm with the generated orthogonal projection obtained from the z- 
stack image series of the cells. 50nm and 100nm Duke Scientific nanopolystyrene 
were observed to accumulate within cell organelles after 1 hour exposure to A549 
cells. Particles appeared to be occupying organelles that resembled lysosomes or 
possibly the endoplasmic reticulum surround the nucleus. 50nm particles also 
appeared to be contained within organelle membranes. However, after longer 
exposure times of 24 hours, the dispersion of the fluorescence due to exposure to 
50nm particles within the cell was more uniform, with possible dye leakage attribute 
to the apparent dispersion of particles. 50nm Duke Scientific nanopolystyrene 
particles were not observed within the nucleus, as was revealed from the z- stack 
image series of the cells. The generated orthogonal projection obtained by 
combining “z-stack” image series cutting through the cell in single z-steps of 
approximately 10 µm with, confirmed the absence of 50nm particles from the 
nucleus.  
Confocal images revealed that there was a difference in the dispersion of 
internalised nanoparticles between the different neutral and carboxlyated 
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nanoparticles, potentially due to their different physicochemical characteristics. 
Cellular up-take and migration times through the cell were observed to be slower for 
the carboxylated 40nm and 100nm particles, possibly due to their negative charge. 
While this negative charge may have affected the cellular up-take mechanism into 
the overall predominately negatively charged cell, it was suggested the 50nm and 
100nm neutral nanoparticles may have been taken up by cells through a less energy 
dependant mechanism such as diffusion (dyes diffuse). However, the possibility of 
free dye uptake from 50nm and 100nm Duke Scientific nanoparticles could also not 
be ruled out.  This may explain the reason as to why 50nm and 100nm neutral 
particles “appear” to be taken up faster and to a greater extent.  
The following sections will provide the results obtained for the examination of the 
internalisation of nanoparticles within several specific cell organelles. From the 
confocal images obtained of all nanoparticles, it was concluded that three possible 
cell organelles may be targeted; lysosomes, mitochondria and endoplasmic reticula.  
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6.3 Evaluating the Internalisation of Fluorescent Nanopolystyrene into 
Lysosomes  
Examination of intracellular localisation of 50nm and 100nm Duke Scientific 
nanoparticles and 40nm and 100nm carboxylated Invitrogen nanopolystyrene was 
carried out at room temperature using laser scanning confocal microscopy (LSM 510 
Meta, Carl Zeiss Inc.) equipped with Argon (488 nm) and HeNe (543 nm) lasers. 
Images were acquired by multitracking (505-530nm band pass filter to collect 
nanoparticles fluorescence and 560nm long pass filter for the Lysosome 
fluorescence) to avoid bleed through between the fluorophores, and the statistical 
analysis was carried out using LSM 510 software.  
From the examination of confocal images obtained of 40nm and 100nm carboxylated 
Invitrogen nanopolystyrene and 50nm and 100nm Duke Scientific nanopolystyrene 
within A549 lung cells in the previous section, the accumulation of nanoparticles 
within lysosomes was inferred. Confocal images of all particles revealed fluorescent 
accumulations of different sizes and distributions within the cells. As previously 
discussed, one of the major functions of lysosomes is the digestion of material taken 
up from outside the cell by endocytosis. Therefore, the incorporation of 
nanopolystyrene into lysosomes was considered, as these degradative organelles 
could represent a potential route of nanoparticle digestion or elimination from cells, 
subsequent to their internalisation. In the case of the 50nm and 100nm neutral 
nanoparticles, a more diffuse distribution of the fluorescence throughout the cell was 
observed, suggesting an alternative route of uptake and intracellular transport, or 
alternatively a release of labile fluorescent dye, resulting in a false representation of 
the nanoparticle distribution.   
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The precise cell organelle location of the accumulation of the nanopolystyrene 
particles will be explored through the use of commercially available transduction 
fluorescent staining kits, based on baculoviruses. Baculoviruses are insect cell 
viruses.  The use of baculovirus for protein production in insect cells has been used 
extensively for over two decades, although its application to mammalian cells is 
relatively new. The utilization of baculovirus to deliver genes to mammalian cells is 
referred to as BacMam technology [14] [15] .  
CellLight® Fluorescent Protein Constructs for Subcellular Structures *BacMam* 2.0 
were purchased from Invitrogen (USA). The CellLight® reagent contains a 
baculovirus which, upon entry into mammalian cells, directs the expression of 
autofluorescent proteins that are localized in specific subcellular compartments and 
organelles via a signal peptide or protein fusions. The protein associated with 
autofluorescence is the Lysosomal Lamp1, which is a lysosomal associated 
membrane protein. [16]. A549 lung cells were seeded at a density of 1x105 cells/ml, 
in glass bottom Petri dishes in 10% FBS supplemented DMEM - F12 media and 
incubated at 37°C in 5% CO2 for 24hrs for cell attachment before exposure to 
nanopolystyrene particles of concentration 1 x 1012 particles per ml. Following the 
exposure period of 24 hours, the cells were washed twice with pre-warmed PBS 
(37°C).  The appropriate volume of CellLight® reagent for the number of cells 
seeded was calculated by;  
 
Volume of CellLight® Reagent (mL) =  number of cells × desired PPC 
1 × 108 CellLight® particles/mL 
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Where the number of cells is the estimated total number of cells at the time of 
labelling, PPC is the number of particles per cell, and 1 × 108 is the number of 
particles per mL of the reagent. The volume of CellLight® reagent needed was 
added directly to the cells in complete cell medium and mixed gently. Cells were then 
reincubated over night in fresh media, to allow for the expression of the CellLight® 
fluorescent protein. The manufacturer states that there is a ~90% transduction 
efficiency achieved from CellLight® kits. Therefore not all cell organelles in each cell 
will be fluorescently transduced as the efficiency is also dependant on the number of 
desired transducer particles per cell,  
Figures 6.15 and 6.16 display confocal images obtained of 40nm and 100nm 
carboxylated nanopolystyrene, respectively, within A549 cells that have also been 
treated with the lysosomal fluorescent staining kit. Each image consists of four 
sections. The section labelled (a) is a confocal image showing the fluorescence of 
the particles only, using the 505-530nm band pass filter. The section labelled (b) is a 
confocal image of the fluorescent lysosomes of the cell following transduction with 
the CellLight®kit using the 560nm long pass filter. Section (c) is an bright-field image 
of the cell showing no fluorescence and section (d) shows an image of fluorescence 
overlap of both the particles and the fluorescently transduced lysosomes. The 
fluorescence overlap, and therefore colocalisation of nanoparticles and lysosomes, is 
shown in a yellow-orange colour.  
As can be seen in figure 6.15 (a), the fluorescent images of 40nm particles show that 
particles are mostly localised and accumulated in discrete regions and are not 
observed to occupy the interstitial space between organelles. The overlap image (d) 
in figure 6.15 shows the co-localisation of nanoparticles within lysosomes as an 
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orange fluorescence (overlap of green from particles and red from lysosomes). This 
orange/yellow fluorescence is visual confirmation of co-localisation of 40nm 
carboxylated nanoparticles within lysosomal structures.  
 
Figure 6.15 Confocal Images of 40nm Carboxylated Invitrogen Nanopolystyrene 
accumulated within lysosomes of A549 cells after 24hr exposure x60 magnification.  
 
Similarly, the fluorescent overlap image (d), of figure 6.16, shows that 100nm 
carboxylated nanoparticles are also internalised and largely co-localised within 
lysosomes. The orange/yellow fluorescent accumulations within the cell also confirm 
the presence of lysosomes containing green fluorescent nanoparticles.  
c 
a b 
d 
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Figure 6.16 Confocal Images of 100nm Carboxylated Invitrogen Nanopolystyrene 
accumulated within lysosomes of A549 cells after 24hr exposure x40 mag.   
 
Figures 6.17 and 6.18 display the confocal images obtained of 50nm and 100nm 
Duke Scientific nanopolystyrene, respectively, within A549 cells that have also been 
treated with the lysosomal fluorescent staining kit. The images each consist of four 
sections. The section labelled (a) is a confocal image showing the fluorescence of 
the particles only, using the 505-530nm band pass filter. The section labelled (b) is a 
confocal image of the fluorescent lysosomes of the cell following transduction with 
the CellLight®kit using the 560nm long pass filter. Section (c) is an bright-field image 
of the cell showing no fluorescence and section (d) shows an image of fluorescence 
c d 
a b 
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overlap of both the 50nm or 100nm particles and the fluorescently transduced 
lysosomes. The fluorescence overlap is shown in a yellow-orange colour.  
 
 
Figure 6.17 Confocal Images of 50nm neutral Duke Scientific Nanopolystyrene 
accumulated within lysosomes of A549 cells after 24hr exposure x60 mag.  
 
The fluorescence overlap image in figure 6.17 displays orange/yellow fluorescent 
spots that correspond to fluorescent 50nm nanoparticles internalised within 
lysosomes. The fluorescent overlap image (d) in figure 6.18 also shows a large 
number of ‘spots’ around the cell that have an orange/yellow fluorescence, 
confirming the internalisation and co-localisation of 100nm neutral nanoparticles 
c d 
a b 
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within lysosomes. However, the fluorescence distribution is notably different to that 
of the 40nm and 100nm carboxylated nanoparticles (figures 6.15 and 6.16). As 
previously described in section 6.2.2, the distribution of fluorescence from the 50 and 
100nm neutral nanoparticles may be due to the leakage of the fluorescent dye, 
which has the ability to diffuse into the cell and into organelle membranes. This 
molecular dye has the ability to passively diffuse into cell organelles with not much 
energy required (Salvati et al. 2011).  
 
 
Figure 6.18 Confocal Images of 100nm neutral Duke Scientific Nanopolystyrene 
accumulated within lysosomes of A549 cells after 24hr exposure x60 mag.  
 
b d 
a c 
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Images 6.17 and 6.18 reveal that the 50nm and 100nm neutral nanoparticles, as well 
as the 40nm and 100nm (figures 6.15 and 6.16) carboxylated nanoparticles 
examined did in fact accumulate within lysosomes in the cell type investigated.  It is 
expected that lysosomes could be capable of degrading polymer based 
nanoparticles such as those composed from polystyrene; however, it would be 
unlikely to occur within the short exposure times investigated.  
There are reports that nanoparticles have the ability to cross cell organelle 
membranes, and although these nanoparticles may not cause specific cell death, 
there is the possibility for nanoparticles to enter organelles such as mitochondria and 
interfere with biochemical reactions of the organelle [17] [2]. Taking such reports into 
consideration, the potential of nanoparticles to penetrate into other cell organelles 
must be investigated. 
 
6.4 Evaluating the Internalisation of Fluorescent Nanopolystyrene into 
Mitochondria  
Recent reports have suggested that nanoparticle migration from lysosmes to other 
cell organelles, such as the mitochondria or the endoplasmic reticulum, may take 
place [18] [2]. In the review article “Understanding biophysicochemical interactions at 
the nano–bio interface”, the authors describe a mechanism whereby nanoparticles 
cause lysosomal swelling as a result of the so-called proton sponge effect. This 
swelling eventually causes the lysosomes to rupture, which leads to particle 
deposition in the cytoplasm and the spillage of the lysosomal content into the cell [2]. 
In this instance, charged nanoparticles may undergo further interactions within the 
cytoplasm and therefore interfere with cellular mechanisms and subsequently have 
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an effect on, or enter into, other cell organelles, such as the mitochondria [17] [2] 
[19].  
As discussed in section 6.3, the fluorescent kits used to label mitochondria within 
A549 cells were CellLight® Fluorescent Protein Constructs for Subcellular Structures 
*BacMam* 2.0. The procedure for fluorescently labelling mitochondria, as described 
in section 6.3, was carried out as before. The protein associated with fluorescence is 
a mitochondria signal sequence of E1 alpha pyruvate dehydrogenase fused to 
TagRFP (red fluorescent protein). All cells imaged were healthy with the nucleus 
visible.  
Figures 6.19 and 6.20 display confocal images obtained of 40nm and 100nm 
carboxylated nanopolystyrene, respectively, within A549 cells that have also been 
treated with the mitochondrial fluorescent staining kit. The section labelled (a) is a 
confocal image showing the fluorescence of the particles only, using the 505-530nm 
band pass filter. The section labelled (b) is a confocal image of the fluorescent 
mitochondria of the cell following transduction with the CellLight®kit using the 560nm 
long pass filter. Section (c) shows an image of fluorescence overlap of both the 
nanoparticles and the fluorescently transduced mitochondria. Any fluorescence 
overlap is shown in a yellow-orange colour.  
Figure 6.19 shows A549 cells after fluorescent mitochondrial staining and 
subsequent 24hr exposure to 40nm carboxylated nanopolystyrene. No fluorescence 
overlap of nanoparticles and fluorescently transduced mitochondria can be seen in 
the section (c). This indicates that the nanoparticles do not enter the mitochondria. 
Close examination reveals no orange/yellow colour that would indicate any 
fluorescence overlap from nanoparticles with mitochondria.  
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Figure 6.19 Confocal Images of 40nm Carboxylated Invitrogen Nanopolystyrene and 
fluorescently labelled mitochondria within A549 cells after 24hr exposure x60 
magnification.  
 
Confocal images obtained of fluorescently tranduced mitochondria within cells after 
24hr exposure to 100nm carboxylated nanoparticles reveal similar results. The 
images obtained reveal nanoparticles accumulated in “spots” or small localised 
regions around the cell (section (a)). The fluorescently stained mitochondria can be 
clearly seen in section (b). Section (c) clearly shows no overlap in fluorescence from 
the nanoparticles or the fluorescent mitochondria. As previously seen with the 40nm 
c 
a b 
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carboxylated nanoparticles (figure 6.19), no orange/yellow fluorescence can be 
observed, indicating there is no overlap in fluorescence and that nanoparticles did 
not enter the mitochondria.  
 
Figure 6.20 Confocal Images of 100nm Carboxylated Invitrogen Nanopolystyrene 
and fluorescently labelled mitochondria within A549 cells after 24hr exposure x60 
magnification.  
 
As can be seen in figure 6.21 (a), the images of 50nm particle exposed cells show 
that the fluorescence is widely dispersed and is not observed to be isolated to 
specific cell regions. The overlap image (c) in figure 6.21 indicates the co-localisation 
c 
a b 
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of nanoparticles within mitochondria as an orange fluorescence (overlap of green 
from particles and red from mitochondria).  
 
Figure 6.21 Confocal Images of 50nm neutral Duke Scientific Nanopolystyrene 
accumulated within mitochondria of A549 cells after 24hr exposure x60 mag.  
 
Similarly, for the confocal images obtained for the examination of the 100nm neutral 
nanopolystryene particles, an overlap of fluorescence from nanoparticles and 
transduced mitochondria was observed. Figure 6.22, section (c) reveals a 
yellow/orange colour where fluorescence occurs in the same regions where there is 
fluorescence from stained mitochondria. As with the 50nm particle, this overlap in 
fluorescence suggests that the 100nm neutral nanopolystyrene particles did 
c 
a 
b 
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accumulate with mitochondria. However, the possibility remains that the large 
overlap in fluorescence may be due to the presence of labile dye from the 
nanoparticles, which, as previously discussed, has the ability the diffuse throughout 
interstitial areas of the cell and various organelles.  
 
 
Figure 6.22 Confocal Images of 100nm neutral Duke Scientific Nanopolystyrene 
accumulated within mitochondria of A549 cells after 24hr exposure x60 mag.  
 
Literature reports of the examination of nanoparticles entering the mitochondria 
suggest that anionic and neutral nanoparticles do not enter the mitochondria.  This 
c 
a b 
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may be due to the negative and neutral surface charge of the particles [2, 20, 21]. 
Positively charged nanoparticles have been known to have an overall effect on the 
proton pump of lysosomes, causing them to rupture and from there subsequently 
enter mitochondria. This can lead to mitochondrial damage, potentially leading to 
decreased ATP production and cellular apoptosis [2, 17] . However, there are no 
reports of anionic or neutral nanoparticles produce similar effects, and from the 
cytotoxicity results obtained for the nanoparticles examined (40nm and 100nm 
carboxylated nanopolystyrene and 50nm and 100nm neutral nanopolystyrene) and 
presented in Chapter 5, whereby they were found not to induce any toxic effects on 
cells, the results found here are more consistent with the localisation of labile dye 
within the mitochondria due to passive diffusion. 
Salvati et al. (2011) suggested that free or liable dye from nanoparticles may be 
easily taken up by organelles as the molecular dye has the ability to diffuse 
throughout the cell, not using any energy in the process. This fluorescence diffusion 
can then be easily mistaken for nanoparticle accumulation. From examination of 
confocal images obtained of A549 cells exposed to 40nm and 100nm carboxylated 
nanoparticles and 50nm and 100nm neutral nanopolystyrene, it can be seen that 
there is greater fluorescence intensity located around the nucleus in perinuclear 
clusters. These observations, along with the suggestion that nanoparticles do 
accumulate in other organelles and that liable fluorescent dye has the ability to 
diffuse throughout the cell, lead to the examination of the possibility of nanoparticles 
entering the endoplasmic reticulum (ER).  
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6.5 Evaluating the Internalisation of Fluorescent Nanopolystyrene into The 
Endoplasmic Reticulium  
While nanoparticles have been reported to accumulate in various organelles within 
cells [22], they have also been reported to enter the ER [23-25]. There are also 
reports that some substances enter cells via an unusual pathway that involves 
trafficking through endosomes to the ER [26, 27]. These reports, coupled with the 
images obtained of the fluorescent nanopolystyrene particles accumulations with 
A549 cells, led to the examination of nanoparticles co-localising within the ER. The 
images obtained of 40nm and 100nm carboxylated nanopolystryene and 50nm and 
100nm neutral nanopolystyrene particles internalised within A549 cells, appear to 
mostly gather in perinuclear clusters after certain exposure periods (section 6.2, 
figure 6.2: 40nm carboxylated nanopolystyrene 24hr exposure, figure 6.4: 100nm 
carboxylated nanopolystyrene 24hr exposure, figure 6.10: 50nm neutral 
nanopolystryene 24hr exposure, figure 6.12: 100nm neutral nanopolystyrene 24hr 
exposure).   
The fluorescent kits used to label ER within A549 cells were CellLight® Fluorescent 
Protein Constructs for Subcellular Structures *BacMam* 2.0. The procedure for 
fluorescently labelling ER, as described in section 6.3, was carried out as before. 
The protein associated with fluorescence is an ER signal sequence of calreticulin 
and KDEL (ER retention signal) fused to TagRFP (red fluorescent protein). All cells 
imaged were healthy with the nucleus clearly visible.  
Figures 6.23 and 6.24 display confocal images obtained of 40nm and 100nm 
carboxylated nanopolystyrene, respectively, within A549 cells after 24 hr exposure, 
that have also been treated with the ER fluorescent staining kit. The image consists 
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of four sections. The section labelled (a) is a confocal image showing the 
fluorescence of the particles only, using the 505-530nm band pass filter. The section 
labelled (b) is an bright-field image of the cell showing no fluorescence, (c) is a 
confocal image of the fluorescent ER of the cell following transduction with the 
CellLight®kit using the 560nm long pass filter and section (d) shows an image of 
fluorescence overlap of both the particles and the fluorescently transduced ER. The 
fluorescence overlap is shown in a yellow-orange colour.  
The fluorescence observed in section (d) of figure 6.23 can be considered to have no 
fluorescence overlap from 40nm carboxylated nanoparticles and fluorescently 
transduced ER. This indicates that the nanoparticles did not localise within the ER 
after 24hr exposure. The fluorescence image of nanoparticles only shown in section 
(a) of figure 6.23 reveals nanoparticles to be accumulated in small circular regions 
within the cells, similar to lysosmes.  
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Figure 6.23 Confocal Images of 40nm Carboxylated Invitrogen Nanopolystyrene and 
fluorescently labelled endoplasmic reticulum within A549 cells after 24hr exposure 
x60 magnification.  
 
Figure 6.24 also reveals that 100nm carboxylated nanoparticles did not internalise 
within the ER. Both the nanoparticles (section (a)) and the fluorescently transduced 
ER of the cells imaged (section (c)) can be seen clearly. While the fluorescence from 
the nanoparticles is localised to small circular regions resembling lysosmes 
throughout the cell, there appears to be no overlap with these regions and the over 
all fluorescently labelled ER.  
 
c d 
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Figure 6.24 Confocal Images of 100nm Carboxylated Invitrogen Nanopolystyrene 
and fluorescently labelled endoplasmic reticulum within A549 cells after 24hr 
exposure x60 magnification.  
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Figures 6.25 and 6.26 display confocal images obtained of 50nm and 100nm neutral 
nanopolystyrene, respectively, within A549 cells after 24 hrs exposure, that have 
also been treated with the ER fluorescent staining kit. The image consists of four 
sections. The section labelled (a) is a confocal image showing the fluorescence of 
the particles only, using the 505-530nm band pass filter. The section labelled (b) is 
an bright-field image of the cell showing no fluorescence, (c) is a confocal image of 
the fluorescent ER of the cell following transduction with the CellLight®kit using the 
560nm long pass filter and section (d) shows an image of fluorescence overlap of 
both the particles and the fluorescently transduced ER. The fluorescence overlap is 
shown in a yellow-orange colour.  
Figure 6.25 represents the confocal images obtained of fluorescently transduced 
A549 cells and internalised 50nm neutral polystyrene after 24 hr exposure. The ER 
is clearly visible in section (c). The fluorescence overlap in section (d) can be seen 
quite strongly. While there is still dispersed fluorescence throughout the cell, the 
majority of the fluorescence can be seen to be localised to the perinuclear region, 
specific to the ER. The intensity of the yellow/orange, caused by the overlap of 
fluorescence from the particles and the fluorescently transduced ER, is much 
stronger compared to that of the previous overlap image of the 40nm and 100nm 
carboxylated nanopolystryene and transduced ER images. However, once again the 
fluorescence distribution of the 50nm neutral nanopolystryene particles throughout 
the cell is notably different to that of both the 40nm and 100nm carboxylated 
nanopolystyrene particles.  
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Figure 6.25 Confocal Images of 50nm neutral Duke Scientific Nanopolystyrene 
accumulated within endoplasmic reticulum of A549 cells after 24hr exposure x60 
mag.  
 
Similarly, for images obtained of the 100nm neutral nanopolystyrene particles, the 
intensity of the fluorescence overlap of the particles and the fluorescently transduced 
ER is strong. Figure 6.26, section (d) reveals the intensity overlap. Nanoparticle 
internalisation of cells can be clearly seen in section (a). From the overlap image 
obtained, it can be assumed that nanoparticles were internalised within the ER, 
however, once again, the possibility of free dye causing the intense fluorescence 
overlap, must be considered.  
c d 
a b 
Page | 184  
 
Chapter 6  
 
Figure 6.26 Confocal Images of 100nm neutral Duke Scientific Nanopolystyrene 
accumulated within endoplasmic reticulum of A549 cells after 24hr exposure x60 
mag.  
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6.5 Summary of The Evaluation of Nanoparticles Internalisation Within Cell 
Organelles.   
The internalisation and accumulation of 40nm and 100nm carboxylated Invitrogen 
nanopolystyrene particles within A549 cells was investigated. Cells were first treated 
with a specific cell organelle CellLight® fluorescent transduction kit, as described in 
section 6.3. Cells were then exposed to 40nm or 100nm carboxylated 
nanopolystyrene for 24hrs and the fluorescence accumulation examined using 
confocal microscopy.  
The first cell organelle under examination for accumulation of nanoparticles was the 
lysosomes. From the confocal images obtained (figure 6.15 and 6.16), it was 
revealed that carboxylated nanoparticles, 40nm and 100nm respectively, were 
internalised by cells and accumulated within lysosomes. This can be seen from the 
fluorescent overlap images obtained (figures 6.15 and 6.16 40nm and 100nm 
respectively). These results are in keeping with literature reports that nanoparticles 
accumulate within lysosomes [8] [7, 28]. The examination of the internalisation of 
40nm and 100nm carboxylated within mitochondria was next examined. As was 
revealed by the fluorescence overlap images in figures 6.19 (40nm) and 6.20 
(100nm), carboxylated nanoparticles were not seen to be internalised within 
mitochondria. Similarly, 40nm and 100nm carboxylated nanoparticles were not found 
to be internalised within the ER upon examination of the fluorescent overlap images 
obtained (figures 6.23 and 6.24 respectively).  
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The internalisation and accumulation of 50nm and 100nm neutral Duke Scientific 
nanopolystyrene particles within A549 cells was investigated. As described before in 
section 6.3, cells were first treated with a specific cell organelle CellLight® 
fluorescent transduction kit. Cells were then exposed to 50nm or 100nm neutral 
nanopolystyrene for 24hrs and the fluorescence accumulation examined using 
confocal microscopy.  
The examination of fluorescent overlap images obtained for the investigation of 
neutral nanoparticles internalised within lysosmes revealed that both the 50nm and 
100nm nanoparticles were internalised within lysosomes (figures 6.17 and 6.18 
respectively). However, the issue of the fluorescence distribution throughout the cell 
was raised. Fluorescently transduced mitochondria were also seen to have 
internalised 50nm and 100nm nanoparticles. The images obtained show a large 
degree of fluorescence overlap between the 50 and 100nm particles (figures 6.21 
and 6.22 respectively) and the fluorescently tranduced mitochondria. The 
examination of the internalisation of the neutral nanoparticles within the endoplasmic 
reticulum also revealed a large fluorescence overlap between 50nm and 100nm and 
the fluorescently tranduced endoplasmic reticulum (figures 6.25 and 6.26 
respectively). However, once again the issue of possible free or liable dye was 
raised as the fluorescence distribution of the nanoparticles was questionable.  
While the results obtained for the internalisation of 50nm and 100nm neutral 
nanoparticles are in keeping with literature reports [7, 8, 28], the overall fluorescence 
distribution requires further investigation. The following section describes an 
experiment that was carried out to examine the possibility of the 50nm and 100nm 
neutral nanoparticles containing free or liable dye.  
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6.6 Fluorescence Up-take Study of Nanoparticles 
The possible uptake pathways of nanoparticles by a cell were previously described 
in Chapter 2, section 2.2.2. One of the pathways mentioned was passive diffusion. 
Passive diffusion is used by the cell to allow molecules of low molecular weight to 
“diffuse” through the cell membrane, and is usually driven by a concentration or 
electrochemical gradient. Because passive diffusion requires no energy from a cell, it 
is possible for molecules to diffuse through the cell membrane while the cell is 
inactive or dormant. Cells may be incubated at 4°C where they remain viable but 
inactive [29].  
Approximately 10,000 A549 cells (200µl of cell suspension) were seeded onto 35mm 
uncoated glass bottom dishes bought from MatTek Corporation, USA. Cells were 
allowed to attach for approx 4 hours, after which, 2mls of 10% FCS RPMI medium 
were added. Plates were incubated over night to ensure cells had completely 
attached. Cells were then removed from the incubator and placed into a fridge at 4°C 
overnight. After approximately 24hr, the cells were removed and the medium was 
replaced with fresh medium containing nanoparticles. Cells were incubated at 4°C 
for a further 24hr. Cells were then removed, washed with PBS then imaged in 0.9% 
NaCl saline solution using confocal microscopy. After images were obtained, cells 
were placed in fresh medium (nanoparticle free) and placed into an incubator at 
37°C for 24hrs. Cells were then removed, washed with PBS then imaged in 0.9% 
NaCl saline solution using confocal microscopy.  
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The following images show the results obtained for the exposure of A549 cells to 
40nm Invitrogen carboxylated nanoparticles and 50nm Duke neutral nanoparticles at 
4°C.  
Figure 6.27 and 6.28 display the results obtained for the exposure of A549 cells to 
40nm carboxylated nanoparticles after 24hr at 4°C. As can be seen from the images, 
nanoparticles have not internalised within cells. Fluorescence from the particles can 
be seen to be accumulated on the cell membrane and not inside the cell.  
 
 
Figure 6.27 Confocal Images of A549 cells after 24hr exposure to 40nm at 4°C  
x60 mag 
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Figure 6.28 Confocal Images of A549 cell after 24hr exposure to 40nm at 4°C  
x60 mag 
 
 
The results obtained for the exposure of A549 cells to 50nm neutral nanoparticles 
after 24hr at 4°C can be seen in figures 6.29 and 6.30. The images reveal that 
fluorescence can be seen distributed throughout the cell. The degree of fluorescence 
indicates that passive diffusion of free or liable dye from fluorescently labelled 
nanoparticles has occurred [8].  
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Figure 6.29 Confocal Images of A549 cells after 24hr exposure to  
50nm at 4°C x60 mag 
 
 
Figure 6.30 Confocal Images of A549 cells after 24hr exposure to 50nm at 4°C 
x60 mag 
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Figure 6.32 shows the Z-stack gallery of images of 50nm neutral nanoparticle 
fluorescent dye diffused into an A549 cells after 24hr exposure at 4°C. The Z-stack 
series provides confirmation that 50nm nanoparticle fluorescent dye has the 
capability to passively diffuse through the cell membrane.  
 
Figure 6.32 Z-stack of an A549 cell after 24hr exposure to 50nm at 4°C  
x60 mag 
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The fluorescent dye, fluorescien, used by the manufactures to fluorescently label 
nanoparticles has a molecular weight of 332.31 g mol−1 and is widely used as a 
biological fluorescent label.  Work by Salvait at al (2012) [8] suggests that molecular 
dyes, such as the one used to fluorescently label nanoparticles examined, disperse 
throughout the cell and cellular compartments, as it is barely energy dependant. The 
authors also found that, when exposed to nanoparticles that were known to contain 
free dye, the fluorescent images of the exposed cells obtained were the same as that 
of cells exposed to fluorescent dye only.  
The results obtained here reveal that the 50nm and 100nm neutral Duke Scientific 
nanoparticles examined do contain free molecular dye that diffuses through the cell 
membrane and into cell organelles. They also indicate that the pathway in which the 
40nm and 100nm carboxylated Invitrogen nanoparticles require energy from the cell 
to be internalised and therefore, passive diffusion may be ruled out. This suggests 
that another form of active uptake is necessary for nanoparticles to be internalised or 
taken up by cells, such as clathrin-mediated endocytosis. Although particles were 
visually confirmed to have penetrated cell membranes and have internalised within 
cells and cell organelles through the use of confocal microscopy, the issues raised 
about the concerns of fluorescent dye leakage from the particles was addressed 
through the fluorescent uptake study. The fluorescent uptake study revealed that the 
actual distribution of nanoparticles may be very different to the images obtained of 
fluorescently labelled nanoparticles. The labelling process by each manufacturer can 
differ and therefore can result in the amount of free or liable dye present within the 
nanoparticle solution.  
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While the cell organelle kits demonstrated that fluorescence from the 50nm and 
100nm neutral nanoparticles appear to overlap with the fluorescence from the 
tranduced organelle inside the cell, there is no indication that the fluorescence is in 
fact solely from the particles. These results reveal the necessity for a technique that 
can verify the internalisation of nanoparticles within cells without relying on 
fluorescent dyes or labels. One proposed method is that of Raman spectroscopy. 
Verification of nanoparticle internalisation will be addressed in the following chapter 
through the use of Raman spectroscopy.  
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The following chapter has been adapted from the journal article Analyst 2012 
(137(5): 1111-1119).  
“Identifying and Localising Intracellular Nanoparticles Using Raman 
Spectroscopy” 
Dorney J., Bonnier F., Garcia A., Casey A., Chambers G., Byrne, H. J.  
The following adaptation of the above publication addresses the issues that were 
raised in the previous chapter and the rationale behind the study was as a direct 
result of the results obtained in the previous. All work for this paper was carried out 
by the first named author with the exception of data processing simulations, which 
were run by Dr Franck Bonnier.  
7.1 Introduction 
One of the major concerns regarding the possible toxic effects of nanoparticles is the 
capacity of these materials to penetrate cells and possibly translocate to other cells 
around the body. Conventional in vitro cytotoxicity assays, such as Alamar Blue, 
Neutral Red, MTT, etc, provide indications of impact on cell proliferation, viability, 
metabolic activity, lysosomal and mitochondrial activity. However, they fail to provide 
a verification of nanoparticle internalisation or elucidate intracellular trafficking 
mechanisms and subcellular distribution within cells. Indeed, false positive results 
have been demonstrated due to the extracellular interaction of the nanoparticles with 
the cell culture medium in vitro, and with the cytotoxic assays themselves.1, 2 The 
underlying principles of internalisation and distribution of nanoparticles within cells 
and any associated toxicity to humans are still relatively poorly understood. 
However, there are numerous studies that have demonstrated the ability of 
nanoparticles to cross membranes and internalise within many different cell types.3-5 
Page | 200  
 
Chapter 7 
In order to assess potential risks, but also benefits in terms of nanomedicine, a 
greater understanding of migration of nanoparticles intra- and inter-cellularly and 
essentially from one part of the body to another, along with information on the 
translocation of nanoparticles within organelles, is urgently required. 
Among the main challenges faced by nanotoxicologists are the detection and 
identification of nanoparticles that have crossed the cell membrane and monitoring of 
their intracellular trafficking. Imaging cells exposed to fluorescently labelled 
nanoparticles using confocal fluorescence microscopy is one of the most common 
ways in which to ensure nanoparticles can be tracked and monitored as they enter 
and localise within cells.6-8  However, not all nanoparticles can be easily fluorescently 
labelled. Furthermore, there have been reports that labelled nanoparticles can 
release the dye into the surrounding biological environment, and so the distribution 
of fluorescence within the cell does not necessarily represent the presence or 
subcellular distribution of the nanoparticles.9-11 Furthermore, it is not clear that the 
transport mechanisms of smaller nanoparticles, fluorescently labelled with anionic 
moieties, are the same as their unlabelled counterparts. For example, it has been 
reported that extrinsic labelling of bovine serum albumin (BSA) with fluorescein-5-
isothiocyanate (FITC), in a ratio of 2:1, changes its adsorption and diffusion 
properties.12 Transmission Electron Microscopy can also be employed to visualise 
nanoparticles within cells, but significant sample processing (fixing and 
ultramicrotoming) is required and only particles with sufficient electronic contrast to 
the cellular environment can be visualised.13, 14 Thus, there is a requirement for a 
sensitive technique to localise and identify nanoparticles internalised in cells, ideally 
based on their chemical composition, rather than fluorescence labels or electronic 
contrast. Identification of their local environment (e.g. endosomes, lysosomes, 
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mitochondria) could aid in elucidating their intracellular trafficking and interaction 
mechanisms, and the resulting changes in cellular metabolism. 
Raman spectroscopy has been proposed as a potential technique for in vitro 
screening of the interaction of nanoparticles with cells.15 Raman is well established 
for chemically fingerprinting materials, with applications in, for example, forensics 
and the pharmacological industry.16-19 More recently, it has been explored for the 
analysis of disease and, when coupled with multivariate statistical analysis, has 
shown high sensitivity and specificity for diagnostic applications.20, 21 Raman 
microspectroscopy also presents several advantages for the study of live cells, 
combining molecular analysis with optical imaging. In comparison to infrared 
spectroscopic analysis, the weak contribution from water offers the possibility to 
study the cells in an aqueous environment, maintaining viability for the duration of 
the measurement.22 The specific information contained in the Raman spectrum of 
the cells or subcellular compartments provides a signature of the sample studied 
which can be related to molecular content or changes to the physiology as a result of 
external stimuli.23-28 In confocal microscopic mode, the spatial resolution is of the 
order of ≤1 µm, depending on source wavelength, providing access to the subcellular 
organisation of the cells.29, 30 Thus, Raman spectroscopy potentially offers a label 
free probe of nanoparticles within cells, which can potentially analyse their local 
environment, and ultimately changes in the cellular metabolism which can be 
correlated with cytotoxic responses31, oxidative stress, or inflammation. Kneipp et al. 
have previously demonstrated the use of Surface Enhanced Raman Scattering from 
gold nanoparticles and nanoaggregates to probe the environment of the subcellular 
compartments through which they are trafficked.32 33 They have also demonstrated 
the use of molecular labelled nanoparticles as more specific probes of the local 
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environment.34-36 However, the uptake rates and mechanisms as well as the 
subsequent trafficking may be specific to the nanoparticle type, size and surface 
chemistry. Furthermore, the molecular specificity of the surface enhancement 
process is not well understood. Therefore, a truly label free method for monitoring 
and characterising the cellular uptake and subcellular localisation of nanoparticles in 
general is still required. 
In this study, Raman spectroscopy will be evaluated for the label free detection and 
localisation of nanoparticles at the subcellular level. Polystyrene nanoparticles, 
labelled for parallel fluorescence uptake studies, are employed. Common cytotoxic 
assays show no observed effect over the concentration range studied. Confocal 
fluorescence microscopy indicates internalisation of the fluorescent label within the 
cells, but the spatially diffuse distribution does not allow unambiguous localisation of 
the nanoparticles. It is demonstrated that, based on spectroscopic fingerprint of 
polystyrene, Raman spectroscopy, coupled with routine multivariate analyses such 
as K-means clustering, is a more specific probe to detect and localise the particles. 
Furthermore, Principal Component Analysis can be employed to differentiate the 
local environment of the nanoparticles from the cytoplasm. 
The importance of optimised cell culture conditions and fixation procedures is 
highlighted, but ultimately, this work suggests the potential of Raman spectroscopy 
not only to detect and identify nanoparticles within the cellular environment, but also 
to identify their subcellular environment and changes to the cellular metabolism 
which underlie toxic responses.  
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7.2 Materials and methods 
7.2.1 Nanoparticles  
“Fluorescent Microsphere Suspensions” of 50nm and 100nm polystyrene beads 
were purchased from Duke Scientific Corporation, (now Thermo Scientific USA 
http://www.thermoscientific.com). Particle size measurements and zeta potential 
measurements were carried out in the respective media (distilled water and cell 
culture medium) as described in the Supplementary Information (7S.1).  
7.2.2 A549 Cell lines 
A549 cells from a human lung adenocarcinoma with the alveolar type II phenotype 
were obtained from ATTC (Manassas, VA, USA). Cells were cultured in DMEM-F12 
(Lonza, Wokingham, UK) supplemented with L-glutamine and 10% foetal calf serum 
(FCS, Lonza, Wokingham, UK) in a humidified atmosphere containing 5% CO2 at 37 
ºC.  
7.2.3 Cytotoxicity assays  
A range of colorimetric cytotoxicity assays were conducted to establish the effects of 
exposure of the A549 cells to the nanoparticles and the details are provided in the 
Supplementary Information (7S.2). 
7.2.4 Sample preparation for imaging 
Approximately 40,000 cells were seeded onto either 35 mm uncoated glass bottom 
dishes (MatTek Corporation, USA) for confocal imaging or CaF2 windows (Crystran 
Ltd., UK) for Raman acquisitions. The cells were incubated in 10% FCS DMEM-F12 
media at 37°C for 24 hr before observation with confocal microscopy. Media was 
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then removed and samples were rinsed with sterile PBS and kept in 0.2 µm sterile 
filtered 0.9% NaCl saline solution for imaging.  
Samples for confocal fluorescence imaging were obtained by seeding cells on 35mm 
uncoated glass bottom dishes (Mat Tek Corporation, USA) , as described above. 
Cells were allowed to attach for approximately 4 hrs, after which 2mls of 10% FCS 
RPMI media were added, containing 1x1012 nanoparticles per ml of media.  
Exposure times before imaging ranged from 4 hrs to 24 hrs. 
For Raman analysis, A549 cells were seeded on CaF2 windows as described above 
and allowed to attach for approximately 4 hrs, after which 2mls of 10% FCS RPMI 
media were added, containing 1x1012 nanoparticles per ml of media. Plates were left 
in an incubator over night for 24 hrs. Media was then removed and samples were 
rinsed with sterile PBS and kept in sterile 0.2 µm filtered 0.9% NaCl saline solution 
for imaging.  
As the Raman mapping of single cells can take up to a few hours using a 785nm 
laser source, the cells were fixed using formalin. Thus, the stability of the sample 
compared to live cells is greatly improved, allowing the collection of spectra precisely 
from the selected area. After washing the CaF2 windows using PBS, the samples 
were immersed in 10% formalin for 10 mins for fixation. After fixation, the samples 
were washed thrice in PBS to remove any trace of the fixative and kept in NaCl for 
measurement.  
For comparison of cellular spectra to constituent biochemical components, five 
different compounds were prepared for Raman spectroscopy analysis: Raman 
spectra were recorded from lyophilised DeoxyriboNucleic Acid from calf thymus 
deposited on CaF2 substrates. Ribonucleic acid from baker's yeast (S. cerevisiae) 
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was first suspended in water and deposited onto CaF2 substrates for drying before 
recording. Sphingomyelin from bovine brain and L-α-Phosphatidylcholine from egg 
yolk were first dispersed in chloroform and then deposited onto CaF2 substrates and 
left to dry before spectral acquisition. A few micro-litres of the nanoparticles 
suspension were deposited on a CaF2 and air dried before recording.  
7.2.5 Confocal Fluorescence imaging of cells 
In order to compare the cell morphologies, samples were imaged using the white 
light mode of an inverted Zeiss LSM510 confocal laser scanning microscope (Carl 
Zeiss Inc.) equipped with an x60 oil immersion objective. For nanoparticle exposed 
samples, fluorescence images were captured at room temperature using an inverted 
Zeiss LSM510 confocal laser scanning microscope (Carl Zeiss Inc.). The excitation 
wavelength used was 488nm, set at 4% of laser power and the fluorescence 
emission was detected using a 505nm long pass filter. Images were obtained with a 
60x oil immersion objective.  
7.2.6 Confocal Fluorescence imaging of cell organelles 
The CellLight® reagent, purchased from Invitrogen, was employed to image the 
subcellular components of the cells. It contains a baculovirus that, upon entry into 
mammalian cells, directs the expression of autofluorescent proteins that are 
localized to specific subcellular compartments and organelles via a signal peptide or 
protein fusions. The protein associated with autofluorescence is an endoplasmic 
reticulum (ER) signal sequence of calreticulin and KDEL (ER retention signal) fused 
to TagRFP (Red fluorescent protein).  
A549 lung cells were seeded at a density of 1x105 cells/ml, in glass bottom Petri 
dishes (MatTek Corporation, USA) in 10% FBS supplemented RPMI media and were 
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incubated at 37°C in 5% CO2 for 4 hrs for cell attachment before exposure to 
nanopolystyrene particles of concentration 1 x 1012 particles per ml. Following the 
exposure period, the cells were washed twice with pre-warmed PBS (37 °C). A pre 
determined amount of CellLight® transduction solution was administered evenly to 
the Petri dishes. Cells were then incubated at 37°C in 5% CO2 for 24 hrs. The 
appropriate volume of CellLight® reagent for the number of cells exposed was 
calculated according to the manufacture’s guidelines.  
Intracellular localisation of polystyrene nanoparticles was visualized at room 
temperature under the laser scanning confocal microscope (LSM 510 Meta, Carl 
Zeiss Inc.) equipped with Argon (488nm) and HeNe (543nm) lasers. Images were 
acquired by multitracking (505-530nm band pass filter to collect nanoparticles 
fluorescence and 560nm long pass filter for the cell organelle kit fluorescence) to 
avoid bleed through between the fluorophores, and the statistical analysis was 
carried out using the LSM 510 software.   
7.2.7 Raman spectroscopic measurements 
A Horiba Jobin-Yvon LabRAM HR800 spectrometer with an external 300 mW 785 
nm diode laser as source was used throughout this work. For all measurements, a 
x100 immersion objective (LUMPlanF1, Olympus) was employed to reduce the 
spectral background.37 The confocal hole was set at 100 µm for all measurements, 
the specified setting for confocal operation. The system was pre-calibrated to the 
520.7 cm-1 spectral line of silicon. The Labram system is a confocal spectrometer 
that contains two interchangeable gratings (300 and 900 lines/mm respectively). In 
the following experiments, the 300 lines/mm grating was used, which gave a spectral 
dispersion of around ~1.5 cm-1 per pixel. The detector used was a 16-bit dynamic 
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range Peltier cooled CCD detector. Images of the sample were acquired using a 
video camera within the system. 
For Raman mapping, an area corresponding to the map to be acquired was defined 
around the cells on the optical image provided by the instrument video camera. The 
step between two successive measurements was set to 1.5 µm or 0.75 µm 38 and 
the backscattered Raman signal was integrated for 10 seconds over the spectral 
ranges from 400 to 1800 cm-1 and accumulated twice to enable an automatic 
software elimination of any spurious peaks.  
7.2.8 Data Analysis 
The different data analysis steps were performed using Matlab (Mathworks, USA). 
Before statistical analysis, a Savitsky-Golay filter (5th order, 7 points) was applied to 
smooth the spectra and the reference spectrum constituting the background signal 
was subtracted.  
K-means clustering analysis was utilised for initial analysis of the spectral maps. It is 
one of the simplest unsupervised learning algorithms used for spectral image 
analysis. It groups the spectra according to their similarity, forming clusters, each 
one representing regions of the image with identical molecular properties.39 The 
distribution of chemical similarity can then be visualised across the sample image. 
The number of clusters (k) has to be determined a priori by the operator before 
initiation of the classification of the data set. K centroids are defined, ideally as far as 
possible from each other, and then each point belonging to a data set is associated 
to the nearest centroid. When all the points have been associated with a centroid, 
the initial grouping is done. The second step consists of the calculation of new 
centroids as barycentres of the clusters resulting from the previous step. A new 
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grouping is implemented based on the same data points and the new centroids. 
These operations are repeated until convergence is reached and there is no further 
movement of the centroids. Finally, k clusters are determined, each containing the 
most similar spectra from the image. From here, colours can be attributed to each 
cluster and false colours maps can be constructed to visualise the organisation of 
the clusters in the original image. 
As K-means cluster analysis groups and represents similar spectra by their mean, 
Principal Component Analysis (PCA) was employed to further analyse the grouped 
spectra. PCA is a method of multivariate analysis broadly used with datasets of 
multiple dimensions40. It allows the reduction of the number of variables in a 
multidimensional dataset, although it retains most of the variation within the dataset. 
The order of the PCs denotes their importance to the dataset. PC1 describes the 
highest amount of variation, PC2 the second greatest and so on. Therefore, var (PC1) 
≥ var (PC2) ≥ var (PCp), where var (PCi) represents the variance of PCi in the 
considered data set. Generally, the 3 first components represent more than 90% of 
the variance. This statistical method was preferred for this study to highlight the 
variability existing in the spectral data set recording during the different experiments. 
The other advantage of this method is the derivation of loadings which represent the 
variance for each variable (wavenumber) for a given PC. Analysis of the loadings of 
a PC can give information about the source of the variability inside a data set, 
derived from variations in the chemical components contributing to the spectra. 
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7.3 Results and Discussion 
7.3.1 Particle Characterisation 
Full details of the results of the physico-chemical characterisation of the nanoparticle 
samples are provided in the Supplementary Information (7S.1). In summary, the 
sizes of the nominally 50nm and 100nm nanoparticle samples were found to be 
somewhat dependent on the suspension medium and temperature, and the zeta 
potentials similarly varied, potentially consistent with interactions of the nanoparticle 
surface with the molecular components of the cell culture medium.2 Despite the 
variation in the exact nanoparticle sizes, for the purpose of brevity, the nanoparticles 
will be referred to as 50nm and 100nm particles throughout the manuscript. 
7.3.2 Cytotoxicity of Nanoparticles.  
For all assays employed, at all time points, no significant cytotoxicity was observed 
over the concentration range employed for both 50nm and 100nm polystyrene 
nanoparticles (see Supplementary Information 7S.2). The observations are 
consistent with previous reports of exposure to neutral nanoparticles 41 and indicate 
that the labelling of the nanoparticles with the fluorescent moiety does not impact 
significantly on the toxic response. 
7.3.3 Confocal Fluorescence Microscopy 
Figure 7.1 shows a confocal fluorescence and white light microscopic image of A549 
cells after exposure to 50nm neutral nanopolystyrene particles for a time of 24 hrs at 
a dose of 1x1012 particles per ml of media. The images are typical of a range of 
doses and time points for both nanoparticle sizes. The fluorescence is observed to 
be spatially diffuse throughout the subcellular environment, and no specific 
subcellular localization of nanoparticles is inferred.  
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The observations are not consistent with the increasingly accepted mechanisms of 
particle uptake by endocytosis and trafficking of nanoparticles through endosomes to 
lysosomes.14, 42 Such a diffuse distribution of fluorescence in cells exposed to 
labelled nanoparticles has recently been reported, however, and the phenomenon 
has been attributed to the uptake of labile fluorescent moieties, which become 
detached from the nanoparticles in the culture medium and are internalized in the 
cellular environment by passive molecular diffusion. Thus, the spatial distribution of 
the fluorescence profile does not reflect the subcellular9 distribution of the 
nanoparticles in the cells. The work of Salvati et al.9 highlights the importance of a 
complete screening of the nanoparticles employed for such studies in order to 
confirm the stability of the labelled nanoparticle and thus the validity of such 
fluorescent imaging procedures. For the purpose of this work, however, the 
observations of figure 7.1 highlight the importance of an independent technique to 
verify and profile the spatial distribution of nanoparticles in cells. Fluorescence 
microscopy identifies the distribution of the label, but notably is not chemically 
specific, and so is ineffective in independently and unambiguously locating the 
distribution of polystyrene. 
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Figure 7.1 A549 cells exposed to 50 nm polystyrene nanoparticles x20 magnification 
after 24 hour exposure. 
 
7.3.4 Raman Spectroscopy 
The literature contains many examples of works based on cell analysis using Raman 
spectroscopy43-46. In general, however, many problems arise due to substrate 
contributions, spectral background and poor signal to noise. Sampling in a confocal 
mode can minimize contributes due to substrates, and the use of substrates, such as 
CaF2, which have minimal contribution to the Raman spectra in the region of interest, 
improves matters further. In tissue samples, it has been demonstrated that working 
in immersion significantly reduces the spectral background37, and for the case of cell 
cultures on collagen gels, measured in immersion, the background has been shown 
to be reduced to that of the surrounding water 47. 
Although progress has been made in the measurement techniques, little attention 
has been paid to the quality of the cellular samples. The aim of this work is to detect 
and localize nanoparticles within the cytoplasm of the cells without the use of a 
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specific label. In order to achieve this goal, it is crucial to first optimise the sample 
preparation techniques to reduce as much as possible variations related to the cell 
handling. A full description of the optimization of the cell culturing and fixation 
process is provided in the Supplementary Information (7S.3).  
As the fixation process was shown to have negligible effect on the Raman spectra, 
A549 cells exposed to 100nm polystyrene nanoparticles at a concentration of 1x1012 
nanoparticles per ml of media for a period of 24 hrs were formalin fixed in CaF2 
substrates and were mapped for their Raman spectral profile. 
The two main factors influencing the time needed to map a full cell are the step size 
and the acquisition time. Using a 785nm laser as source, a 10 s acquisition gives a 
signal to noise ratio more than acceptable for the identification of the different 
spectral features present.22, 38 However, two accumulations are required by the 
software to remove any spurious spikes in the spectra recorded, and thus the total 
acquisition time per spectrum was 20 s. A mild smoothing was applied to further 
improve the spectral quality, as described in Section 7.2.8. The instrument software 
allows the selection of customised areas for mapping, as presented in figure 7.2A, 
considerably reducing the measurement time, and a step size of 1.5 µm has been 
used in order not to exceed ~4 hrs per cell, a timescale which is most feasible for 
maintaining sample integrity and stable conditions for spectral mapping. After 
completion of the spectral recording, the map was exported to Matlab for analysis 
using K-means clustering. For cells exposed to nanopolystyrene, it is expected that 
the K-means clustering will be able to localise the nanoparticles within the cellular 
environment. 
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Using a 100x objective, the visible image obtained from the cells is rather detailed 
(Figure 7.2A). The nucleus is clearly identifiable and the nucleoli can also be seen. 
The membrane of the cells is well defined and the cytoplasm presents different 
structures and the region containing the endoplasmic reticulum can be easily 
recognised. Figure 7.2B presents the results obtained using 10 different groups for 
the K-means cluster analysis. Increasing the number of groups to 10 allows 
consideration of the variability existing in the spectra recorded from the edge of the 
cells which have a lower intensity and therefore a weaker signal to noise ratio. A 
cluster has been formed corresponding to the nuclear area (cluster 1) but the 
analysis does not discriminate between the nucleus and nucleoli. Similarly, distinct 
clusters are assigned to the cytoplasm and membrane.  
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Figure 7.2 Top; (A) Microscopic image of an A549 cell, showing the area identified 
for spectral mapping. (B) K-means cluster map of the Raman profile of the same cell. 
Bottom; Raman spectra of (C) cytoplasm, (D) cytoplasm showing the contribution of 
spectral features of (E) polystyrene nanoparticles. Grey shading is a guide to 
identification of characteristic Raman features of polystyrene. Spectra are offset for 
clarity 
 
Notably however, none of the 10 clusters identified by the analysis exhibit clear 
signatures which can be associated with polystyrene (figure 7.2 bottom). It is 
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expected that the nanoparticles will be predominantly localised within the 
cytoplasmic region, but there is no evidence of specific polystyrene peaks in the 
spectrum of the cytoplasm (Figure 7.2C). Although it overlaps with the strong and 
sharp phenyl group of aromatic amino acids in cells, the best indicator of the 
presence of nanopolystyrene in the spectra recorded remains the intensity of the 
strong 1004 cm-1 peak. Based on this observation, it has been possible to manually 
screen the map and identify the presence of these features in individual Raman 
spectra (figure 7.2D). The manually identified polystyrene spectra are, however, 
sparsely located throughout the cell, a strong indication that the fluorescence map of 
figure 7.1 is not representative of the distribution of polystyrene nanoparticles within 
the cell. Although Raman spectroscopy can detect the presence of nanoparticles in 
the cells, the K-means clustering analysis does not group their signature as a 
spatially defined cluster.   
The use of a 100x objective provides maximum lateral resolution and helps to obtain 
visible images which detail the cell morphology. However, the focal depth is 
minimised and, in an automated map, it is difficult to optimise acquisition conditions 
over the spatial extent of the cell. The visible image in figure 7.2A highlights this 
phenomenon, as, although the focus is optimised for the nucleus, the edge of the cell 
remains blurry. This difference is enough to create a loss in the Raman intensity 
when recording spectra on the outer parts of the cells, reducing considerably the 
signal to noise ratio. For this reason, the area selected for spectral mapping was 
reduced, as indicated in figure 7.3 IA. Moreover, scanning a smaller area allows a 
decrease of the lateral step size to 0.75 µm without increasing the overall acquisition 
time. Thus, the definition of the map recorded is improved and a more precise 
localisation of the nanopolystyrene can be achieved.   
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Figure 7.3: I; (A) Microscopic image of an A549 cell, showing the reduced area 
identified for spectral mapping. (B) K-means cluster map of the Raman profile of the 
same reduced area. II; K-means spectra of clusters 3 (A – representing nucleoli), 6 
(B – representing nucleus), 1 and 4 (C and D, both from the cytoplasm). Spectra are 
offset for clarity. III; K-means spectrum of Cluster 5 (A), compared to the Raman 
spectrum polystyrene nanoparticles (B). Spectra are offset for clarity 
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Under these conditions, the K-means clustering analysis run using 10 groups yields 
more specific clusters, as shown in figure 7.3 IB. The nucleoli spectra form a specific 
group (cluster 3), distinct from the nucleus (cluster 6). The corresponding mean 
spectra are displayed in figure 7.3 II. The cytoplasm is represented by a number of 
different clusters (1, 2, 4, 8, 9, 10). Notably, nanopolysterene can now be localised in 
the cytoplasm according to cluster 5, the corresponding mean spectrum of which is 
presented in figure 7.3 IIIA. Although some cellular features clearly contribute to the 
cluster spectrum, it is dominated by specific features originating from polystyrene. 
Notably, in comparison to figure 7.1, figure 7.3 IB gives a map of the distribution of 
the fingerprint of the molecular structure of polystyrene, rather than the fluorescent 
label. 
K-means cluster analysis yields the average spectra for the identified clusters. These 
average spectra can contain contributions from points on the boundaries between 
the cellular regions and a direct comparison does not always easily facilitate 
identification of the differences in the biochemical composition. Cluster 5 clearly 
identifies the presence of polystyrene nanoparticles localised in the cytoplasm, but 
the averaged spectrum also exhibits clear contributions of the biological 
environment. PCA can be employed to highlight the biochemical differences between 
the subcellular regions.48 In figure 7.3 IB, cluster 5 is predominantly surrounded by 
cytoplasmic regions grouped within cluster 1.  
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Figure 7.4 Top; Scatter plot of the PCA of spectra associated with clusters 1 (Blue) 
and 5 (Green). Bottom; (A) Loading of PC1 (B) Raman Spectrum of polystyrene 
nanoparticles (C) of L--Phosphatidylcholine, (D) of Sphingomyelin, (E) of DNA and 
(F) of RNA. 
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Figure 7.4 (top) is a scatter plot of the PCA of spectra associated with K-means 
clusters 1 and 5. For visualisation purposes, spectra associated with cluster 1 are 
coloured blue, while those from cluster 5 are coloured green, and although the data 
is rather dispersed, some differentiation between the two clusters according to PC1 
is apparent. PC1 accounts for 61% of the variance and, as shown in the loadings 
plot of figure 7.4 (bottom), it is dominated by positive contributions of polystyrene 
(figure 7.4 B). Notably, the negative contributions of PC1 match well with the Raman 
features of lipids such as L-α-Phosphatidylcholine (figure 7.4 C) and also 
sphingomyelin (figure 7.4 D). For comparison, the Raman spectra of DNA (figure 4 
E) and RNA (figure 7.4 F) are also shown, and it is clear that they exhibit few or no 
similarities with PC1. High loadings of PC1 for cluster 5 are therefore an indication of 
the dominance of polystyrene. Positive loadings of PC1 for some of Cluster 1 may 
indicate regions of overlap between the localised nanoparticles and the surrounding 
cytoplasm, which, although they have significant polystyrene contributions, are 
represented in the K-means cluster analysis by the average spectrum of cluster 1.  
An established mechanism for the transport of nanoparticles in cells is via 
endosomes and later lysosomes.42 A number of studies have also demonstrated 
that, in the later stages of trafficking, individually endocytosed nanoparticles 
accumulate in larger multivescular bodies 33 and they have also been seen to be 
localized in the endoplasmic reticulum and Gogli apparatus.49 Notably, in figure 7.3 
IA, the majority of the nanoparticles, identified in green as cluster 5, are surrounded 
by cytoplasmic regions of cluster 1, which is relatively spatially extensive, particularly 
compared to typical sizes of lysosomes (1-2µm). In the white light image of figure 7.3 
IB, this region can be identified as the ER, which may be expected to be rich in lipidic 
compounds, and a PCA of the different regions of the cytoplasm, as shown in the 
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scatter plot of figure 7.5 (top) and the corresponding loadings of figure 7.5 (bottom), 
confirms this. Cluster 4, on the other hand is relatively rich in nucleic acids, which 
may be due to the presence of mitochondria. 
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Figure 7.5 Top; Scatter plot of the PCA of spectra associated with clusters 1 (red) 
and 4 (blue). Bottom; (A) Raman Spectrum of RNA (B) Raman Spectrum of DNA 
(C) Loading of PC1, (D) Raman spectrum of Sphingomyelin, (E) Raman spectrum of 
L--Phosphatidylcholine. 
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Figure 7.6 shows an image of A549 cells exposed for 24 hrs to 50 nm fluorescently 
labelled polystyrene nanoparticles, also stained for ER, as described in section 7.2.6. 
Although, as outlined in relation to Figure 7.1, the fluorescence distribution is diffuse 
and therefore not exclusively attributable to the presence of nanoparticles within the 
cell, the confocal image indicates a strong correlation between the ER stain and the 
fluorescence of the nanoparticle label, and any locally concentrated fluorescence 
which may be indicative of encapsulated nanoparticles is contained within the ER, 
clearly visible in the white light image of figure 7.6B. The analysis supports the 
attribution of the subcellular environment of K-means cluster 1 as endoplasmic 
reticulum. 
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Figure 7.6 Confocal microscopic images obtained of 50 nm polystyrene 
nanoparticles within A549 cells that have also been treated with CellLight® 
Endoplasmic Reticulum staining kit. (A) Confocal image showing the fluorescence of 
the particles only, using the 505-530 nm band pass filter. (B) Optical image of the 
cell showing no fluorescence. (C) Confocal image of the fluorescent endoplasmic 
reticulum of the cell following transduction with the CellLight® kit using the 560 nm 
long pass filter and (D) Image of fluorescence overlap of both the 50 nm particles 
and the fluorescently transduced ER. The fluorescence overlap is shown in a yellow-
orange colour. 
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7.4 Discussion 
The work presented here represents an initial proof of concept, to demonstrate the 
potential use of Raman spectroscopy to identify and locate nanoparticles in cells and 
to probe their subcellular environment. No attempt has, as yet, been made to 
quantify the amount of nanoparticles located or the sensitivity and detection limit of 
the technique. Instrumentally, the spatial resolution can be improved by moving to 
lower wavelength sources, although the excitation of any fluorescence from the 
nanoparticles and the cell constituents should be avoided. However, as it scales 
linearly with wavelength, a move from 785nm to 473nm should result in an 
improvement in lateral resolution by a factor of ~1.7. Ultimately, the confocal mode of 
operation can provide 3D localisation of the nanoparticles at submicron resolution.  
Fixed cells were employed in this work to facilitate prolonged mapping. However, the 
technique can be applied to live cells38, and the identification of a characteristic 
spectral marker for the nanoparticles or a cell metabolite could ultimately facilitate 
real time monitoring. The subcellular environment of the cell is complex, and 
differentiation of the subcellular environments based on characteristic Raman 
spectra is best facilitated using multivariate statistics, two examples of which are 
illustrated here. A range of other data mining techniques are available, however, 
which could improve the molecular sensitivity of the technique.  
It is notable that the initial attempts to locate the nanoparticles within the cell, using a 
1.5 µm step size over the whole cell area proved inconclusive. The mapping 
conditions also failed to identify the nucleoli within the nucleus, however. In the 
automated mapping protocol, no adjustment of the focussing conditions was 
performed, and, using the x100 objective in a confocal geometry, the focussing 
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conditions, optimised in the region of the nucleus, are less well optimised over the 
extent of the whole cell. Therefore, the variability of spectra from the outer part of the 
cell is significantly higher than the variability which should differentiate the spectra 
containing polysterene from those containing only cellular features. An increase of 
the number of clusters resulted only in the creation of more clusters in the membrane 
region of the cells. Restricting the mapping to the centre part of the cells provides a 
more consistent signal without adjustment of the focus. In this case, both K-means 
clustering and PCA differentiate regions with clear contributions of polystyrene to the 
spectra. Improved automated mapping protocols which include auto-focusing could 
improve the routine application of the technique. 
Polystyrene nanoparticles are emerging as potential standards for nanotoxicity, 
notably in their aminated form. The aromatic styrene unit is a relatively strong 
Raman scatterer, and thus they are particularly suitable for Raman mapping. The 
example of fluorescently labelled nanoparticles which potentially lose the label, with 
the result that fluorescence microscopy does not unambiguously identify the 
nanoparticles within the cells, highlights the potential of the technique as a label free 
probe applicable to a broad range of nanoparticles. To demonstrate the universality 
of the technique, the study will be extended in the future to a broader range of both 
organic and inorganic nanoparticles.  
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7.5 Conclusion 
This study demonstrates the ability of Raman microspectroscopy to localise 
nanoparticles in the subcellular environment, based on their chemical structure. The 
measurements also indicate that the technique can be employed to identify the 
subcellular environment. Raman has previously been employed to monitor changes 
in the metabolism of cells, particularly due to external agents, and thus this label 
free, non invasive tool can potentially simultaneously, locate and identify 
nanoparticles, probe their local environment and ultimately changes to the 
metabolism of the cell due to cell-nanoparticle interactions. 
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7S Supplementary Information 
7S.1 Physico Chemical Characterisation of the Nanoparticles 
Physico-chemical characterization of the particles was performed by dynamic light 
scattering using a Malvern Zetasizer ZS. A HeNe laser with a wavelength of 633nm 
and an avalanche photodiode detector, Q.E. >50% at 633nm at 173° (backscatter 
detection) was used. Particle size measurements and zeta potential measurements 
were carried out in the respective biological media at a concentration of 1x1012 
particles per ml at 37° C. The number of particles per ml of suspension may be 
determined from the following equation, as specified by the supplier: 
 
 Number of particles/ ml =  6C x 1012  
      ρ x π x Φ 
Where: C = Concentration of suspended beads in g/ml 
 ρ = Density of polymer in g/ml  
 Φ = Diameter of suspended particles in µm.  
 
The size and zeta potential of both the nominally 50nm and 100nm sized particles 
differed slightly according to the medium in which they were suspended, when 
measured by dynamic light scattering. Nominally 50 nm particles were found to have 
an average particle size in H2O at 25°C and 37°C of 52 nm and 53 nm, respectively, 
while 50nm particles in 10% FBS RPMI media at 25°C and 37°C were determined to 
have particle sizes of 49 nm and 38 nm respectively. The average particle sizes for 
the 100nm samples in H2O at 25°C and 37°C were found to be 169nm and 138nm 
respectively, while average particle sizes for 100nm samples measured in medium at 
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25°C and 37°C were found to be 149nm and 116nm respectively. Zeta potential 
measurements of the 50nm samples revealed that particles dispersed in H2O at 
25°C and 37°C were found to be -62 mV and -53 mV respectively, and in media at 
25°C and 37°C to be -13 mV and -12 mV indicating that the solution was moderately 
stable at the temperatures measured. 100nm particles were found to have zeta 
potential values, in H2O at 25°C and 37°C, of -18.62 mV and -15.09 mV respectively. 
Similarly, zeta potential measurements of 100nm particles in H2O at 25°C and 37°C 
were found to have values of -42.32 mV and -38.27 mV respectively, also indicating 
the solution was moderately stable at both temperatures. Changes in zeta potential 
between H2O and cell culture medium are well documented and are proposed to 
result from the interaction of the nanoparticle surface with the molecular components 
of the cell culture medium 1. Despite the uncertainty in the exact nanoparticle sizes, 
for the purpose of brevity, the nanoparticles will be referred to as 50nm and 100nm 
particles throughout the manuscript. 
7S.2 Cytotoxicity Assays  
The cytotoxicity assays employed during this experiment were Alamar Blue™ (AB), 
Neutral Red (NR), Coomassie Blue (CB) and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT).  For cytotoxicity evaluation, cells were seeded in 
96-well micro plates (Nunc, Denmark) in triplicate for each of the four time points 
studied 24, 48, 72, 96 hr. Plates were seeded at a density of 1.5 x 105 cells/ml for 
24hr, 5 x 104 cells/ml for 48hr, 3 x 104 cells/ml for 72hr and 2 x 104 cells/ml for 96hr 
exposure. These densities were found to be optimal to achieve the desired 
confluence at the end of the exposure period. After an initial 24hr of cell attachment, 
the media was removed and the plates were washed with 100 μl/well phosphate 
buffered saline (PBS). Cells were then treated with increasing concentrations of each 
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nanomaterial and with a positive control of a 10% DMSO 90% media solution. The 
cells were then incubated for the desired time period and the cytotoxic effects 
evaluated. For each independent experiment, six replicate wells were used for 
control, six replicate wells were employed for the positive control and six replicate 
wells were used for each test concentration per micro plate. For cytotoxicity 
evaluation, fluorescence and absorbance were all quantified using a microplate 
reader (TECAN GENios, Grodig, Austria). Further details for each of the assays 
performed can be found in 2.  
For all assays employed, at all time points, no significant cytotoxicity was observed 
over the concentration range employed for both 50 and 100 nm polystyrene 
nanoparticles. As an example, Figure 7S.1 shows the MTT response to exposure of 
50nm polystyrene nanoparticles. The observations are consistent with previous 
reports of exposure to neutral nanoparticles 3 and indicate that the labelling of the 
nanoparticles with the fluorescent moiety does not impact significantly on the toxic 
response. 
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Figure 7S.1: Cytotoxicity of 50nm Duke Scientific Nanopolystyrene after 24, 48, 72 
and 96 hour exposures determined by the MTT assay. Data are expressed as 
percent of control mean ± SD of three independent experiments. 
 
7S.3 Sample Preparation and Cell Morphology  
When working with A549 cells, the first observation made was the inconsistency of 
the cell morphology while preparing the samples. The cells were seeded on CaF2 
substrates, left overnight in the incubator and used for Raman analysis the next day 
for both live cell and fixed cell analysis. The protocols used were standard, but still 
the cells could exhibit particular characteristics and “stressed” samples seemed to be 
regularly observed. The main characteristic of these cells was the presence of 
microscopic “droplets” (~1-5 µm) in the cytoplasm. Their number was seen to vary 
considerably from sample to sample and thus the ability to resolve different 
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structures present in the cytoplasm varied significantly. This phenomenon is 
independent of the cell fixation using formalin as the features can be seen in both 
live cells (figure 7S2.A) and fixed cells (figure 7S2.B). The droplets are observed to 
exhibit consistent Raman spectra which vary little in fixed (figure 7S2.D) compared to 
live cells (figure 7S2.C), and comparison with spectra of common lipids such as 
phosphatydylinositol (figure 7S2.E) and phosphatydyl-L-serine (figure 7S2.E) 
confirms that they are lipidic in structure, an obvious candidate being peroxisomes. 
Regardless of their origin, the main concern was the strong Raman scattering of 
these droplets and therefore the probable interference with the detection of 
nanoparticles in the cells. It was therefore deemed imperative to optimize the 
protocols for the cell sample preparation and to reproducibly obtain cells with similar 
morphologies. 
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Figure S2 Microscopic images of live (A) and formaline fixed (B) A549 cells with 
“stressed” morphologies. Raman Spectra of droplets in (C) live cells (D) fixed cells 
compared to (E) phosphatidylinositol and (F) Phosphatidyl-L-serine. Spectra are 
offset for clarity 
 
Different parameters have to be taken into consideration during the cell culture and 
the preparation of the samples. The cells are commonly split when they have 
reached between 80-85% of confluency in the cell culture flasks. However, 
performing a splitting when the cells were only about 60% confluent greatly 
diminished the number of the droplets per cell. Under such conditions, after several 
Page | 236  
 
Chapter 7 
splits, almost no droplets can be seen in cells either in the cell growth flasks or on 
the substrates used for confocal imaging or Raman mapping. Subsequently, the 
temperature of the PBS solution used to wash the cells has to be 37 ˚C, and it was 
further noted that the quality of the fixation can be affected by the temperature of the 
formalin used. Although, the formalin is usually kept at room temperature, warming 
to 37 ˚C before fixation showed a better conservation of the cell morphology after 
fixation. Once the sample preparation procedures have been optimised, cells of 
consistently “unstressed” morphology can be routinely obtained, as shown in Figure 
7S3. Fewer vacuoles or lipid droplets are evident, and there is a better definition of 
the endoplasmic reticulum (marked with arrows in figure 7S3). 
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Figure 7S3 Microscopic images of cells with “stressed” (A, B) and “unstressed” 
morphology (C, D). 
 
 
7S.4Effect of Cell Fixation on Raman Spectra  
Mapping of single cells using Raman spectroscopy can be time consuming and, 
depending on the quality of spectra required, many hours are usually needed to 
complete a single map. As the viability of cells removed from an incubation 
environment is compromised, fixation of cells remains a popular option for extended 
measurements. Different approaches to fixation can be employed, including dry 
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fixation, alcohol fixation or formalin fixation. These different methods have been 
recently compared by Raman spectroscopy 4-6. In order to preserve the cell 
morphology, dry fixation has been excluded for this study, as the modification in the 
cell shape and thickness due to the drying will make comparison with live cells 
difficult. Formalin fixation is the more promising approach, as the cells are 
maintained in a hydrated state and, therefore, as close as possible to the living state 
4. Based on the observations made above, the protocols for cell fixation were 
optimised and the sample preparation standardised. Under these conditions, the 
localisation of the different subcellular organelles can be precisely visualised and 
Raman spectra recorded from similar structures more accurately. Figure 7S4 
presents spectra recorded from the nucleus and cytoplasm from live and formalin 
fixed cells. The spectra exhibit similar intensities and no contribution from the CaF2 
substrate can be seen. The spectral signatures obtained after fixation using formalin 
are identical to those recorded from the live cells. Using adapted protocols for the 
cell culture and fixation, the effect of the fixatives used can be greatly reduced.  
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Figure S4 Raman spectra of the nuclear region of fixed (A) and live (B) cells and the 
cytoplasmic region of fixed (C) and live (D) cells. All Spectra have been recorded 
using the 785 nm laser source and are the result of two accumulations of 20 seconds 
per spot. Spectra are offset for clarity 
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8.1 Summary of Findings  
Over the course of this thesis, several different commercially available 
nanopolystyrene particles of different sizes and surface charges were examined. The 
nanoparticles chosen were; 40nm and 100nm carboxylated Invitrogen 
nanopolystyrene, 60nm aminated nanopolystyrene (UCD) and, 50nm and 100nm 
Duke Scientific (now Thermo Scientific) neutral nanopolystyrene.  
In Chapter 4, the results of the characterisation of 40nm and 100nm carboxylated 
nanopolystyrene, 50nm and 100nm nanopolystyrene, and 60nm aminated 
nanopolystyrene were presented. DLS investigation confirmed neutral and 
carboxylated nanoparticle sizes to increase in water, possibly due to the presence of 
surfactant, which would interfere with the measurement of the apparent 
hydrodynamic radius. However, all particles differed in size when placed in biological 
media. In particular, the 60nm aminated nanopolystyrene particle was found to 
significantly increase in size when placed in biological media, which may be 
attributed to the formation of a protein corona, which would have an effect on the 
apparent hydrodynamic radius and thus the measured particle size. Zeta potential 
measurements revealed that the 100nm and 40nm carboxylated particles were 
stable in biological media, which was most likely due to the interaction between the 
carboxylated surface of the nanoparticle and the ionic species found in the media. 
Both neutral particles, 50nm and 100nm, were found to be stable in H2O over a 
range of temperatures and less stable when placed in biological media. However the 
“neutral” nanoparticles were found to have an overall negative zeta potential, which 
again, may possibly be attributed to the presence of surfactant within the aqueous 
solution. While zeta potential values showed the 60nm aminated nanoparticles to be 
unstable when placed in complete media. Absorbance and fluorescence emission 
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spectroscopy revealed values which were also in agreement with the supplied 
manufacturer’s specifications. From fluorescence emission spectra obtained of both 
50nm and 40nm particles, a working concentration of 1 x 1012 ppml was chosen, as 
this concentration revealed optimum fluorescence.  
The results obtained and presented in Chapter 5, of the toxicity of 50nm and 100nm 
Duke Scientific nanopolystyrene, 40nm and 100nm carboxylated Invitrogen 
nanopolystyrene and 60nm aminated nanopolystyrene, were much in keeping with 
literature findings on the toxicity of nanopolystyrene. Five toxicity assays were 
employed, with experimental results presented for each. The cytotoxicity evaluation 
revealed, through the use of Alamar Blue™ (AB), Neutral Red (NR), Coomassie Blue 
(COOMASSIE) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assays, that the 50nm and 100nm neutral and the 40nm and 100nm 
carboxylated nanoparticles induced no cytotoxic effects in A549 cells over a range of 
concentration and time points. However, cytotoxicity results of A549 cells exposed to 
a range of concentration of 60nm aminated nanopolystyrene after 24, 48, 72 and 96 
hour exposures, revealed, at some concentrations, that the particle does induce toxic 
effects in A549 cells. As observed throughout all assays performed, the highest test 
concentration of 1x1012 ppml induced toxic effects on A549 cells over the 24 to 96 
hour exposure time points, the second highest test concentration of 5x1011 ppml 
causing toxicity to a lesser degree.  
Chapter 6 presented the results obtained for the examination of the internalisation of 
50nm and 100nm nanopolystyrene and 40nm and 100nm carboxylated 
nanopolystyrene within A549 lung cells through the use of confocal microscopy. 
Fluorescent and optical images revealed 40nm and 100nm carboxylated 
nanoparticles were taken up by cells and accumulated into cellular organelles, which 
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resembled lysosomes, after exposure times of 24hours. 50nm and 100nm Duke 
Scientific nanopolystyrene were observed to be rapidly taken up by cells and 
accumulate within cell organelles after 1 hour exposure to A549 cells. 50nm particles 
also appeared to be contained within organelle membranes. However, after longer 
exposure times of 24 hours, the dispersion of the fluorescence within the cell was 
widely distributed throughout the cell.  
From the z- stack image series of the cells, it was revealed that neither 40nm 
carboxylated or 50nm neutral nanoparticles were found in the nucleus. The 
generated orthogonal projection obtained by combining “z-stack” image series 
cutting through the cell in single z-steps of approximately 10 µm width, confirmed the 
absence of 40nm carboxylated and 50nm neutral particles from the nucleus.  
Confocal images revealed that there was a difference in the degree and dispersion 
of fluorescence between the different neutral and carboxylated nanoparticles, 
potentially due to their different physiochemical characteristics. Cellular up-take and 
migration times through the cell were observed to be slower for the carboxylated 
40nm and 100nm particles. It was suggested the 50nm and 100nm neutral 
nanoparticles may be taken up by cells through a less energy dependant mechanism 
such as diffusion. However, the possibility of free dye uptake from 50nm and 100nm 
Duke Scientific nanoparticles could also not be ruled out. The diffusion of free dye 
into cells was suggested as the reason as to why 50nm and 100nm neutral particles 
“appear” to be taken up faster and the observation that the fluorescence within the 
cell was distributed to a greater extent, rather than contained within isolated 
organelles.  
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 From the confocal images obtained of all nanoparticles, it was concluded that three 
possible cell organelles may have been targeted by nanoparticles; lysosomes, 
mitochondria and endoplasmic reticulum. The first cell organelle examined for 
accumulation of nanoparticles was the lysosomes. From the confocal images 
obtained, it was revealed that carboxylated nanoparticles, 40nm and 100nm 
respectively, were internalised by cells and accumulated within lysosomes. These 
results are in keeping with literature reports that nanoparticles are endocytosed and 
that early stage endosomes evolve into lysosmes [1, 2] The internalisation of 40nm 
and 100nm carboxylated within mitochondria was examined next. As was revealed 
by the fluorescence overlap images, carboxylated nanoparticles were not seen to be 
specifically internalised within mitochondria. Similarly, 40nm and 100nm 
carboxylated nanoparticles were not found to be internalised within the endoplasmic 
reticulum upon examination of the fluorescent overlap images obtained.  
The examination of fluorescent overlap images obtained for the investigation of 
neutral nanoparticles internalised within lysosmes revealed that both the 50nm and 
100nm nanoparticles have a large fluorescent distribution and appear to have been 
internalised within lysosomes. However, the issue of the degree fluorescence 
distribution throughout the cell was raised once again. Fluorescently transduced 
mitochondria were also seen to have internalised 50nm and 100nm nanoparticles. 
The images obtained show a large degree of fluorescence overlap between the 50 
and 100nm particles and the fluorescently tranduced mitochondria. The examination 
of the internalisation of the neutral nanoparticles within the endoplasmic reticulum 
also revealed a large fluorescence overlap between 50nm and 100nm and the 
fluorescently tranduced endoplasmic reticulum. However, once again the issue of 
possible free or liable dye was raised as the fluorescence distribution of the 
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nanoparticles was questionable. While the results obtained for the internalisation of 
50nm and 100nm neutral nanoparticles are in keeping with literature reports, the 
overall fluorescence distribution required further investigation.  
Although 50nm and 100nm neutral nanoparticles were visually confirmed to have 
penetrated cell membranes and have internalised within cells and cell organelles 
through the use of confocal microscopy, the issues raised about the concerns of 
fluorescent dye leakage from the particles were addressed through the energy 
dependent uptake study. Quenching the cellular energy revealed that the actual 
distribution of nanoparticles may be very different to the images obtained of 
fluorescently labelled nanoparticles. 40nm carboxylated nanoparticles and 50nm 
neutral nanoparticles were exposed to A549 cells which had been incubated at 4°C. 
Because cells are “inactive” at 4°C, only passive diffusion of substances through the 
cell membrane may occur, as this requires no energy from the cell.  At 4°C, 40nm 
carboxylated nanoparticles were not found to have diffused through the cell 
membrane.  Particles were observed to “sit” on top of the cell membrane, but were 
not internalised within cells. However, cells incubated at 4°C which were exposed to 
50nm neutral nanopolystyrene particles were found have exhibit internal 
fluorescence, indicating that free or liable molecular dye from the nanoparticles had 
diffused through the cell membrane into the cells. The results obtained in the energy 
dependent uptake study revealed that fluorescently labelled nanoparticles produced 
from different manufacturers exhibit different characteristics, with dye leakage a 
possible factor which impacts on fluorescent imaging results.  
While the issue of possible fluorescent dye leakage from nanoparticles was 
addressed in the energy dependent uptake study, the question was then raised as to 
whether nanopolystyrene was actually entering the cell.  Raman spectroscopy was 
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then proposed to identify and locate nanoparticles in cells. Chapter 7 was adapted 
from the published paper “Identifying and Localising Intracellular Nanoparticles 
Using Raman Spectroscopy”. The fixation process of cells was examined and was 
shown to have negligible effect on the Raman spectra of A549 cells exposed to 
nanopolystyrene particles. The results of K-means cluster analysis of Raman maps 
of the cells confirmed that 50nm neutral nanopolystyrene particles were in fact 
internalised and are predominantly localised within the cytoplasmic region and the 
endoplasmic reticulum region. Several spectra in these regions were dominated by 
the sharp and strong peak of the polystyrene phenyl group. Principal components 
analysis of several of the K-means clusters revealed that the nanopolystyrene 
particles were located in a lipidic rich environment, such as that of the ER. This study 
demonstrated the ability of Raman microspectroscopy to locate and identify 
nanoparticles in the subcellular environment, based on their chemical structure. The 
results obtained also indicated that the technique can be employed to identify the 
subcellular environment.   
8.2 Future perspectives  
With the number of engineered nanoparticles being produced annually having risen 
to an estimated 11 million tonnes, [3] the need for toxicological information about 
these novel materials is of utmost importance for both general health and safety of 
the public who may come in contact with these material and also for the ecological 
impact that such materials may have on our environment. The potential use of 
nanoparticles within various areas of science and engineering is boundless. 
However, in order for nanoparticles to fulfil their full potential in areas such as 
nanomedicine, nano-drug delivery, etc., it is imperative that a full risk assessment 
profile of nanoparticles first be constructed.  While the continual research in this area 
Page | 247  
 
Chapter 8  
 
should focus predominately on the building of toxicological profiles of nanomaterials, 
there are some other issues which need to be addressed.   
The development of additional toxicological assays which are specifically designed 
with nanoparticle testing in mind, to accompany traditional assays, is an area that 
should be fully explored. Regardless of the toxicity of nanoparticles, the capability of 
these materials to penetrate cell membranes and cell organelle membranes raises 
many questions about the potential long term effects of the accumulation of 
nanoparticles within cells, as well as raising questions as to their potential use in 
drug delivery and nanomedicine.  
Commercially manufactured nanoparticles, specifically those containing fluorescent 
labels, may be unreliable when using conventional methods of monitoring 
fluorescent materials, such as confocal microscopy. Ideally, label free methods to 
locate nanoparticles, probe their local environment and the overall effects on the cell 
should be investigated. From the work produced in this thesis, Raman spectroscopy 
is one such proposed method. The capability of Raman spectroscopy to not only 
locate nanoparticles within cells, but also to probe the local environment of the 
nanoparticle and the ability of detect any changes in the local environment or within 
the cell, offers a label free method for the tracking of nanoparticles within cells and 
the monitoring of the internalisation of nanoparticles within cell organelles. 
While in this thesis, spontaneous Raman spectroscopy was proposed as a label free 
method for the monitoring of nanoparticles within cells, there are other forms or 
Raman spectroscopy which may potentially add to the list of label free methods.  
Surface Enhanced Raman Spectroscopy or SERS is one such possible method. The 
enhancement process of Raman intensities can be achieved using a number of 
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substrates including roughened metallic surfaces, structured metal arrays and 
specially imprinted surfaces. The effect has largely been attributed to an electronic 
enhancement due to local fields generated by surface plasmon resonances at the 
metal surface. SERS has been applied to many different applications including a 
number of biological scenarios, which include diagnostic studies in vitro, ex-vivo and 
in-vivo [4] [5] [6] , novel bio assay as well as cellular studies [7] . The proposal of 
SERS to probe the chemical nature of the subcellular environment and the 
intracellular distribution of biomolecules also makes it an ideal method for the 
investigation of nanoparticle internalisation within cells [8] [6].    
Coherent anti-Stokes Raman spectroscopy or CARS is also another method 
proposed for the monitoring of internalisation and localisation of nanoparticles within 
cells. CARS employs two laser beams, which are used to generate a coherent anti-
Stokes frequency beam. The anti-Stokes signal can be then enhanced by 
resonance. CARS allows the enhancement of the weak Raman signal by means of 
nonlinear excitation, enabling imaging to speed up to video rate. The nonlinear 
CARS signal is generated only at the focus where the excitation intensities are the 
highest. This leads to 3D sectioning capability, which is essential for imaging cells 
and cellular structures. CARS has notably been used for the monitoring of 
intracellular trafficking, drug delivery, as well as nanoparticle uptake by living 
organisms.  With promising results, CARS is another viable potential method for the 
investigation of internalised nanoparticles within cells.  
Raman spectroscopic methods hold the potential to supply nanotoxicologists with 
intracellular and environmental information about the interaction of nanoparticles with 
cells, but areas such as proteomics should also be investigated to give a complete 
understanding of nano-bio interactions. Spectroscopic and proteomic data could feed 
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directly into the development of a risk assessment method for nano-safety, as well 
as helping to validate alternative toxicity screening methodologies which could 
reduce the cost and complexity of nanoparticle safety screening, reducing the 
reliance on animal tests and enabling high-throughput screens to emerge. 
8.3 Concluding Remarks  
Over the course of this thesis, the reliability of commercially manufactured 
fluorescently labelled nanopolystyrene was questioned. Fluorescently labelled 
nanoparticles from one manufacturer were shown to contain free or liable dye which 
inhibited the accuracy of localisation results using conventional fluorescent 
microscopy methods. Raman spectroscopic analysis revealed that there was a 
significant difference between the apparent fluorescence distribution of nanoparticles 
and the actual distribution of nanoparticles within cells. It is concluded that liable dye 
within commercially manufactured nanoparticles can in fact hinder the monitoring of 
nanoparticle trafficking within cells.  
The results presented have raised a very important question; as to whether 
fluorescently labelling of nanoparticles reliable for correct, accurate intercellular 
monitoring and trafficking of nanoparticles within cells?  Furthermore, can 
conventional fluorescent microscopic techniques be relied upon for the most 
accurate and reproducible data needed by nanotoxicologists to build the necessary 
toxicological profile required for the safe us of these novel materials?  
The answer to these questions, undoubtedly, like nanotoxicology, is complicated. It 
is the general consensus of researchers in the field of nanotoxicology, that if it is to 
move forward as a discipline and reach the overall goal of providing reliable 
toxicological data on the ever increasing range of engineered nanoparticles then it 
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will rely heavily on the collaboration of materials and biological scientists. 
Collaborations of this manner will facilitate all the contributing factors to nanoparticle 
toxicity, from both physical/chemical and biological viewpoints, to be identified and 
classified in order of toxicological relevance. Nanotoxicology does not necessitate a 
new toxicological science as such, but it does demand the communication between 
different disciplines of science as was seen throughout his thesis which employed 
both physical/chemical and biological techniques to assess the internalisation of 
nanopolystyrene particles.  
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